<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>AFAP1 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>AFAP1</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q8N556" target="_blank" class="term-link">
                        Q8N556
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "AFAP1";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q8N556" data-a="DESCRIPTION: AFAP1 (Actin filament-associated protein 1, also k..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>AFAP1 (Actin filament-associated protein 1, also known as AFAP-110) is a modular adaptor/scaffold protein that crosslinks F-actin and directly regulates Src-family kinase signaling. The protein contains two PH domains (PH1 binds PKCalpha), N-terminal proline-rich SH3-binding motifs and SH2-binding motifs that engage c-Src, a central leucine-zipper/coiled-coil for multimerization, and a C-terminal actin-binding domain (ABD) that mediates F-actin binding. AFAP1 localizes to stress fibers and focal adhesions under basal conditions but redistributes to podosomes/invadopodia upon PKC/Src activation. It functions as an adapter linking Src and PKC to the actin cytoskeleton, and is required for proper c-Src activity spatially and temporally during lactation in mammary epithelium. AFAP1 is implicated in cancer cell invasion and metastasis through its role in cytoskeletal remodeling and podosome/invadopodia formation.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005884" target="_blank" class="term-link">
                                    GO:0005884
                                </a>
                            </span>
                            <span class="term-label">actin filament</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0005884" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 localizes to actin filaments through its C-terminal actin-binding domain (ABD). The protein is distributed along actin filaments and can directly activate c-Src through binding to its SH3 and/or SH2 domains (PMID:15485829). Deep research confirms that AFAP1 contains a C-terminal ABD that mediates F-actin binding and multimerization enables actin cross-linking (AFAP1-deep-research-falcon.md).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is well-supported by the phylogenetic analysis (IBA) and is consistent with the extensive literature documenting AFAP1 localization to actin filaments via its C-terminal ABD. PMID:15485829 demonstrates AFAP1 distribution along actin filaments.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15485829" target="_blank" class="term-link">
                                        PMID:15485829
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Distributed along the actin filaments, AFAP can directly active c-Src through binding to its Src homology 3 and/or 2 domains</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AFAP1/AFAP1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">C-terminal actin-binding domain (ABD) with mapped ABD motifs (~residues 593-637) [from deep research summary]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009966" target="_blank" class="term-link">
                                    GO:0009966
                                </a>
                            </span>
                            <span class="term-label">regulation of signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0009966" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 regulates Src-family kinase signaling through direct binding to c-Src via proline-rich SH3-binding motifs and can activate Src. Mechanical stretch-induced c-Src protein tyrosine kinase activation is mediated through AFAP (PMID:15485829). The deep research confirms AFAP1 functions in the PKC-AFAP1-Src signaling axis (AFAP1-deep-research-falcon.md).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This biological process annotation is appropriate for AFAP1, which functions as an adaptor that regulates Src kinase signaling. The IBA evidence is supported by extensive experimental literature showing AFAP1&#39;s role in signal transduction pathways.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15485829" target="_blank" class="term-link">
                                        PMID:15485829
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">mechanical stretch-induced c-Src protein tyrosine kinase activation is mediated through the actin filament-associated protein (AFAP)</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AFAP1/AFAP1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Key axes include PKC-&gt;AFAP1-&gt;Src (PKCalpha binding to PH1 and Ser277 phosphorylation facilitate Src activation) [from deep research summary]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0005829" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 can exist in the cytosolic fraction, particularly when not associated with the actin cytoskeleton. The deep research indicates that deletion of the actin-binding domain shifts AFAP1 from the Triton-insoluble cytoskeletal fraction to the soluble fraction (AFAP1-deep-research-falcon.md).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The IBA annotation is consistent with biochemical fractionation studies showing that AFAP1 partitions between cytoskeletal and soluble fractions. While the primary functional localization is at actin structures and focal adhesions, cytosolic localization is a valid secondary location.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AFAP1/AFAP1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Deletion of the ABD shifts AFAP1 from the Triton-insoluble cytoskeletal fraction to the soluble fraction [from deep research summary citing Xiao et al. 2012]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001725" target="_blank" class="term-link">
                                    GO:0001725
                                </a>
                            </span>
                            <span class="term-label">stress fiber</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0001725" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 localizes to stress fibers under basal conditions. Knockdown of AFAP-110 expression in MDA-MB-231 cells results in loss of actin stress fiber cross-linking (PMID:17520695), demonstrating a functional requirement for stress fiber formation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This IEA annotation based on UniProt subcellular location vocabulary mapping is well-supported by primary literature. AFAP1 localization to stress fibers is a core aspect of its function, and the annotation is consistent with experimental evidence showing that AFAP1 is required for stress fiber formation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17520695" target="_blank" class="term-link">
                                        PMID:17520695
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Knockdown of AFAP-110 expression in MDA-MB-231 cells does not result in any changes in cell proliferation but did result in a loss of actin stress fiber cross-linking and decreased adhesion to fibronectin</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003779" target="_blank" class="term-link">
                                    GO:0003779
                                </a>
                            </span>
                            <span class="term-label">actin binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0003779" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 binds F-actin directly through its C-terminal actin-binding domain. The protein is an actin-binding and cross-linking protein that can cross-link actin filaments into both network and bundle structures through multimerization. AFAP-110 is described as an actin cross-linking protein in PMID:17885682.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The IEA annotation based on UniProt keyword mapping accurately reflects the core molecular function of AFAP1. The actin-binding activity is well-documented through functional studies. This is a defining function of the protein.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17885682" target="_blank" class="term-link">
                                        PMID:17885682
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The actin filament-associated protein AFAP-110 is an actin cross-linking protein first identified as a substrate of the viral oncogene v-Src</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AFAP1/AFAP1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">C-terminal ABD mediates F-actin binding; AFAP1 multimerizes enabling actin cross-linking similar to alpha-actinin [from deep research summary]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0005886" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 contains PH domains that mediate membrane binding and can localize to the plasma membrane, particularly at sites of cell-matrix adhesion and in podosomes/ invadopodia at the cell periphery. The annotation is transferred from mouse ortholog.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The IEA annotation from Ensembl ortholog transfer is consistent with AFAP1 domain architecture (two PH domains for membrane binding) and its functional localization at membrane-associated structures like focal adhesions and podosomes. While not the primary localization, plasma membrane association is biologically relevant.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/AFAP1/AFAP1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">AFAP1 relocates to podosomes/invadopodia and lamellipodia upon PKC/Src activation [from deep research summary]</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060090" target="_blank" class="term-link">
                                    GO:0060090
                                </a>
                            </span>
                            <span class="term-label">molecular adaptor activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0060090" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 functions as an adaptor/scaffold protein linking Src kinase and PKC to the actin cytoskeleton. It regulates actin cytoskeleton integrity but also functions as an adaptor protein that affects crosstalk between Src and PKC (PMID:17885682).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This molecular function annotation accurately captures the core role of AFAP1 as an adaptor protein. The IEA annotation from Ensembl ortholog transfer is well-supported by primary literature describing AFAP1 as an adapter molecule linking Src and PKC to the actin cytoskeleton.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17885682" target="_blank" class="term-link">
                                        PMID:17885682
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">AFAP-110 regulates actin cytoskeleton integrity but also functions as an adaptor protein that affects crosstalk between Src and PKC</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0015629" target="_blank" class="term-link">
                                    GO:0015629
                                </a>
                            </span>
                            <span class="term-label">actin cytoskeleton</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000052
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0015629" data-r="GO_REF:0000052" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 localization to the actin cytoskeleton is documented by immunofluorescence data from the Human Protein Atlas. This is consistent with extensive literature showing AFAP1 association with F-actin stress fibers, focal adhesions, and podosomes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The IDA annotation based on immunofluorescence data provides direct experimental evidence for AFAP1 localization to the actin cytoskeleton. This is a well-supported core localization for AFAP1 and is consistent with its role as an actin-binding adaptor protein.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/15485829" target="_blank" class="term-link">
                                        PMID:15485829
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Distributed along the actin filaments, AFAP can directly active c-Src through binding to its Src homology 3 and/or 2 domains</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005925" target="_blank" class="term-link">
                                    GO:0005925
                                </a>
                            </span>
                            <span class="term-label">focal adhesion</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">HDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/21423176" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:21423176
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Analysis of the myosin-II-responsive focal adhesion proteome...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q8N556" data-a="GO:0005925" data-r="PMID:21423176" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> AFAP1 was identified in the focal adhesion proteome by mass spectrometry (Kuo et al. 2011, PMID:21423176). AFAP1 localization to focal adhesions is consistent with its role in cell-matrix adhesion and regulation of focal contact dynamics. Downmodulation of AFAP-110 results in defective focal adhesions (PMID:17885682).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The HDA (high-throughput direct assay) annotation is based on proteomic identification of AFAP1 in isolated focal adhesions. The finding is consistent with the known function of AFAP1 in regulating cell-matrix adhesions and focal contacts.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/21423176" target="_blank" class="term-link">
                                        PMID:21423176
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We identified 905 focal adhesion proteins, 459 of which changed in abundance with myosin II inhibition, defining the myosin-II-responsive focal adhesion proteome</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/17885682" target="_blank" class="term-link">
                                        PMID:17885682
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">downmodulation of AFAP-110 resulted in decreased cell-matrix adhesion and cell migration, defective focal adhesions, and reduced integrin beta1 expression</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>AFAP1 functions as an actin-binding adaptor protein that links Src kinase and PKC to the actin cytoskeleton, regulating cytoskeletal dynamics and signal transduction.</h3>
                <span class="vote-buttons" data-g="Q8N556" data-a="FUNCTION: AFAP1 functions as an actin-binding adaptor protei..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003779" target="_blank" class="term-link">
                            actin binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009966" target="_blank" class="term-link">
                                regulation of signal transduction
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005884" target="_blank" class="term-link">
                                actin filament
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001725" target="_blank" class="term-link">
                                stress fiber
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005925" target="_blank" class="term-link">
                                focal adhesion
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>AFAP1 acts as a molecular adaptor linking Src and PKC to cytoskeletal structures, facilitating signal transduction at sites of cell-matrix adhesion.</h3>
                <span class="vote-buttons" data-g="Q8N556" data-a="FUNCTION: AFAP1 acts as a molecular adaptor linking Src and ..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0060090" target="_blank" class="term-link">
                            molecular adaptor activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009966" target="_blank" class="term-link">
                                regulation of signal transduction
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0015629" target="_blank" class="term-link">
                                actin cytoskeleton
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                plasma membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IBA annotations for actin filament localization, regulation of signal transduction, and cytosol</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IEA annotation for actin binding based on Actin-binding keyword</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IEA annotation for stress fiber localization</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000052.md" target="_blank" class="term-link">
                            GO_REF:0000052
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on curation of immunofluorescence data</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IDA annotation for actin cytoskeleton localization from Human Protein Atlas</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IEA annotations for plasma membrane and molecular adaptor activity from mouse ortholog</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21423176" target="_blank" class="term-link">
                            PMID:21423176
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for Œ≤-Pix in negative regulation of focal adhesion maturation.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Proteomic identification of AFAP1 in isolated focal adhesions from HFF1 fibroblasts</div>
                        
                        <div class="finding-text">"We identified 905 focal adhesion proteins, 459 of which changed in abundance with myosin II inhibition, defining the myosin-II-responsive focal adhesion proteome"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15485829" target="_blank" class="term-link">
                            PMID:15485829
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Conversion of mechanical force into biochemical signaling.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 is distributed along actin filaments</div>
                        
                        <div class="finding-text">"Distributed along the actin filaments, AFAP can directly active c-Src through binding to its Src homology 3 and/or 2 domains"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP mediates mechanical stretch-induced c-Src activation</div>
                        
                        <div class="finding-text">"mechanical stretch-induced c-Src protein tyrosine kinase activation is mediated through the actin filament-associated protein (AFAP)"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/17520695" target="_blank" class="term-link">
                            PMID:17520695
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Knockdown causes loss of actin stress fibers</div>
                        
                        <div class="finding-text">"Knockdown of AFAP-110 expression in MDA-MB-231 cells does not result in any changes in cell proliferation but did result in a loss of actin stress fiber cross-linking and decreased adhesion to fibronectin"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/17885682" target="_blank" class="term-link">
                            PMID:17885682
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP-110 is an actin cross-linking protein and adaptor</div>
                        
                        <div class="finding-text">"The actin filament-associated protein AFAP-110 is an actin cross-linking protein first identified as a substrate of the viral oncogene v-Src. AFAP-110 regulates actin cytoskeleton integrity but also functions as an adaptor protein that affects crosstalk between Src and PKC"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP-110 regulates focal contacts</div>
                        
                        <div class="finding-text">"downmodulation of AFAP-110 resulted in decreased cell-matrix adhesion and cell migration, defective focal adhesions, and reduced integrin beta1 expression"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/AFAP1/AFAP1-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research synthesis for AFAP1</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 domain architecture and function from literature synthesis</div>
                        
                        <div class="finding-text">"AFAP1 contains two PH domains (PH1 binds PKCalpha), multiple SH2- and SH3-binding motifs, a central leucine-zipper/coiled-coil that mediates multimerization, and a C-terminal actin-binding domain (ABD)"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/AFAP1/AFAP1-deep-research-cyberian.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Comprehensive deep research synthesis for AFAP1</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Original identification of AFAP-110 as v-Src substrate and cloning by Flynn et al.</div>
                        
                        <div class="finding-text">"The protein was first identified in the early 1990s as a major substrate of the oncogenic viral tyrosine kinase v-Src and was subsequently cloned by Flynn and colleagues [PMID:8247004]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Leucine zipper mediates auto-inhibition through intramolecular contacts with PH1 domain</div>
                        
                        <div class="finding-text">"The leucine zipper motif serves a dual regulatory role in AFAP1 function. On one hand, it facilitates multimerization and thus enables actin crosslinking. On the other hand, it participates in an auto-inhibitory mechanism by making intramolecular contacts with sequences in the amino-terminal PH1 domain [PMID:14755689]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PKC phosphorylation at Ser277 enhances actin crosslinking, contrary to most other actin-regulatory proteins</div>
                        
                        <div class="finding-text">"PKC phosphorylation uniquely enhances the actin crosslinking ability of AFAP1. This is in marked contrast to other actin-regulatory proteins such as fascin, MARCKS, SSeCKS, and VASP, for which PKC phosphorylation decreases actin crosslinking activity [PMID:12134071]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 is required for PKCalpha to activate c-Src and induce podosome formation</div>
                        
                        <div class="finding-text">"In cell lines lacking AFAP1 expression, PKC activation by phorbol esters was unable to activate c-Src or induce podosome formation. Ectopic expression of wild-type AFAP1 rescued these responses [PMID:15314167]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 knockout mice show lactation defect due to reduced c-Src activity</div>
                        
                        <div class="finding-text">"AFAP1-null mice displayed a striking lactation defect resulting in inability to efficiently nurse their pups. The lactation defect was associated with reduced c-Src activity during early lactation and selective loss of active c-Src localization at the apical surface of luminal epithelial cells [PMID:25043309]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 mediates TNF-alpha-induced attenuation of P-glycoprotein activity at blood-brain barrier</div>
                        
                        <div class="finding-text">"Knockdown of AFAP1 expression blocked the TNF-alpha-induced reduction in P-gp efflux activity, establishing AFAP1 as essential for this regulatory mechanism at the blood-brain barrier [PMID:28112407]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">GWAS identifies AFAP1 variants as risk factors for primary open-angle glaucoma</div>
                        
                        <div class="finding-text">"Meta-analysis identified a common variant within the AFAP1 gene (rs4619890[G]) that conferred significantly increased risk of POAG (odds ratio = 1.20, P = 7.0 x 10^-10) [PMID:25173106]"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">S403C polymorphic variant enhances c-Src activation constitutively</div>
                        
                        <div class="finding-text">"In cells with elevated c-Src expression, AFAP1(403C) directs c-Src activation and podosome formation independently of upstream signals, in contrast to wild-type AFAP1 which requires PKC activation [PMID:20689769]"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/8247004" target="_blank" class="term-link">
                            PMID:8247004
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Original cloning and identification of AFAP-110 as v-Src substrate</div>
                        
                        <div class="finding-text">"Activated forms of the Src protein-tyrosine kinase stably associate with tyrosine-phosphorylated proteins, including a protein of 110 kDa, pp110"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11607843" target="_blank" class="term-link">
                            PMID:11607843
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP-110 domain structure and adaptor function review</div>
                        
                        <div class="finding-text">"AFAP-110 contains additional protein binding modules including two pleckstrin homology domains, a leucine zipper motif and a target sequence for serine/threonine phosphorylation"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12134071" target="_blank" class="term-link">
                            PMID:12134071
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PKC phosphorylation enhances actin crosslinking</div>
                        
                        <div class="finding-text">"Deletion of the leucine zipper motif or PKC phosphorylation affected AFAP-110&#39;s conformation, which correlated with changes in multimerization and increased the capability of rAFAP-110 to cross-link actin filaments"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP-110 is substrate and binding partner of PKC</div>
                        
                        <div class="finding-text">"AFAP-110 is both a substrate and binding partner of PKC. On PKC activation, stress filament organization is lost, motility structures form, and AFAP-110 colocalizes strongly with motility structures"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/14755689" target="_blank" class="term-link">
                            PMID:14755689
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110 to alter actin filament integrity.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Leucine zipper mediates auto-inhibition and multimerization</div>
                        
                        <div class="finding-text">"An analysis of opposing binding sites indicated that the carboxy terminus/Lzip motif can contact sequences within the amino terminal pleckstrin homology (PH1) domain indicating an auto-inhibitory mechanism for regulating multimer stability and actin filament crosslinking"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/15314167" target="_blank" class="term-link">
                            PMID:15314167
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 is required for PKCalpha-mediated Src activation and podosome formation</div>
                        
                        <div class="finding-text">"In a cell line (CaOV3) that has very little or no detectable AFAP-110, PMA treatment was unable to activate c-Src or effect podosome formation. Ectopic expression of AFAP-110 in CaOV3 cells rescued PKCalpha-mediated activation of c-Src"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/17360811" target="_blank" class="term-link">
                            PMID:17360811
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">PI3K activation is required for PMA-directed activation of cSrc by AFAP-110.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PI3K is required for AFAP1-mediated c-Src activation and cell migration</div>
                        
                        <div class="finding-text">"Thus PI3K activity is required for PMA-induced colocalization between AFAP-110 and cSrc and subsequent cSrc activation, and this signaling pathway promotes cell migration"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25043309" target="_blank" class="term-link">
                            PMID:25043309
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 knockout mice have lactation defect</div>
                        
                        <div class="finding-text">"these animals displayed a defect in lactation that resulted in an inability to nurse efficiently. Histologically, the mammary glands of the lactating knockout mice were distinguished by the accumulation of large cytoplasmic lipid droplets in the alveolar epithelial cells"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 required for c-Src localization at apical surface during lactation</div>
                        
                        <div class="finding-text">"the activity of cSrc in the mammary gland was reduced during early lactation in the AFAP1-null mouse and the localization of active cSrc at the apical surface of luminal epithelial cells during lactation was selectively lost in the absence of AFAP1"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28112407" target="_blank" class="term-link">
                            PMID:28112407
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory signaling-induced rapid attenuation of intrinsic P-gp function in human brain capillary endothelial cells.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">AFAP1 mediates TNF-alpha regulation of P-glycoprotein at blood-brain barrier</div>
                        
                        <div class="finding-text">"knockdown of AFAP-1 expression blocked the reduction in P-gp efflux activity by TNF-alpha treatment"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25173106" target="_blank" class="term-link">
                            PMID:25173106
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">GWAS identifies loci associated with IOP and POAG risk</div>
                        
                        <div class="finding-text">"We confirm genetic association of known loci for IOP and primary open-angle glaucoma (POAG) and identify four new IOP-associated loci"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20689769" target="_blank" class="term-link">
                            PMID:20689769
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A Polymorphic Variant of AFAP-110 Enhances cSrc Activity.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">S403C polymorphism enables constitutive c-Src activation</div>
                        
                        <div class="finding-text">"In cells that express enhanced levels of cSrc, AFAP-110(403C) directed the activation of cSrc and the formation of podosomes independently of input signals, in contrast to wild-type AFAP-110"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Cyberian</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AFAP1-deep-research-cyberian.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8N556" data-a="DOC: Deep Research Cyberian" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: cyberian<br />
model: deep-research<br />
cached: false<br />
start_time: '2026-01-15T13:39:52.473310'<br />
end_time: '2026-01-15T13:58:51.319508'<br />
duration_seconds: 1138.85<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AFAP1<br />
  gene_symbol: AFAP1<br />
  uniprot_accession: Q8N556<br />
  protein_description: 'RecName: Full=Actin filament-associated protein 1; AltName:<br />
    Full=110 kDa actin filament-associated protein; Short=AFAP-110;'<br />
  gene_info: Name=AFAP1; Synonyms=AFAP;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849);<br />
    PH (PF00169)<br />
provider_config:<br />
  timeout: 1800<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    agent_type: claude<br />
    port: 3284<br />
    skip_permissions: true<br />
citation_count: 16</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8N556</li>
<li><strong>Protein Description:</strong> RecName: Full=Actin filament-associated protein 1; AltName: Full=110 kDa actin filament-associated protein; Short=AFAP-110;</li>
<li><strong>Gene Information:</strong> Name=AFAP1; Synonyms=AFAP;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849); PH (PF00169)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AFAP1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AFAP1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AFAP1</strong> (gene ID: AFAP1, UniProt: Q8N556) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="afap1-actin-filament-associated-protein-1-a-comprehensive-research-report">AFAP1 (Actin Filament-Associated Protein 1): A Comprehensive Research Report</h1>
<h2 id="introduction">Introduction</h2>
<p>Actin filament-associated protein 1 (AFAP1), also known as AFAP-110 due to its apparent molecular weight of 110 kDa, is a multidomain adapter protein that plays a central role in linking signal transduction pathways to the actin cytoskeleton in human cells. The protein was first identified in the early 1990s as a major substrate of the oncogenic viral tyrosine kinase v-Src and was subsequently cloned by Flynn and colleagues [flynn-1993-afap110-identification-abstract]. The human gene encoding AFAP1 (UniProt: Q8N556) is located on chromosome 4p16.1 and produces a protein of approximately 635 amino acids. AFAP1 is the prototypical member of a family of three structurally related proteins that also includes AFAP1-like 1 (AFAP1L1) and AFAP1-like 2 (AFAP1L2, also known as XB130) [cunnick-2015-mammary-gland-abstract].</p>
<p>The defining characteristic of AFAP1 is its dual capacity to both bind and crosslink actin filaments while simultaneously serving as a scaffold for signaling molecules, most notably the non-receptor tyrosine kinase c-Src and protein kinase C alpha (PKCalpha). This unique combination of properties positions AFAP1 at the interface between extracellular signals and cytoskeletal reorganization, making it a key player in cellular processes including migration, adhesion, and invasion. The following sections describe the molecular architecture, biochemical functions, cellular localization, and physiological roles of this important signaling adapter.</p>
<h2 id="molecular-architecture-and-domain-structure">Molecular Architecture and Domain Structure</h2>
<p>AFAP1 is organized into a series of modular protein-binding domains that facilitate its diverse functions. The domain architecture of AFAP1 has been extensively characterized through biochemical and mutational analyses [baisden-2001-afap110-review-abstract]. The protein contains two pleckstrin homology (PH) domains located in the amino-terminal half of the protein. The first PH domain (PH1), which shows highest sequence homology to PH domains from beta-spectrin and dynamin, serves as the primary binding site for PKC family members [qian-2002-pkc-crosslinking-abstract]. The second PH domain (PH2) has been less extensively characterized but may contribute to membrane targeting through phosphoinositide binding.</p>
<p>Between and flanking the PH domains, AFAP1 contains two juxtaposed proline-rich SH3-binding motifs of approximately 10 amino acids each, which are essential for its interaction with the Src family kinases. These motifs engage the SH3 domain of c-Src and related kinases such as Fyn. Additionally, AFAP1 contains SH2-binding motifs with phosphotyrosine residues that, when phosphorylated, can engage the SH2 domains of Src family kinases [flynn-1993-afap110-identification-abstract]. This dual SH2/SH3 binding capacity allows AFAP1 to form stable complexes with Src under various activation states.</p>
<p>The carboxy-terminal region of AFAP1 contains two critical functional domains: an alpha-helical actin-binding domain and a leucine zipper motif. The actin-binding domain is both necessary and sufficient for direct association with filamentous actin (F-actin), showing approximately 40% sequence similarity with other known actin-binding motifs [qian-2000-carboxy-terminus-abstract]. The leucine zipper motif, located immediately adjacent to the actin-binding domain, mediates AFAP1 self-association and multimerization [qian-1998-src-self-association-abstract]. This multimerization is functionally significant because it allows AFAP1 to form complexes with multiple actin-binding sites, thereby enabling the protein to crosslink actin filaments.</p>
<h2 id="actin-crosslinking-function">Actin Crosslinking Function</h2>
<p>One of the primary molecular functions of AFAP1 is its capacity to crosslink actin filaments. Biochemical studies using purified recombinant AFAP1 demonstrated that the protein binds cooperatively to actin filaments and can organize them into either loose meshwork or tight bundle structures depending on protein concentration and phosphorylation status [qian-2002-pkc-crosslinking-abstract]. The crosslinking activity depends critically on AFAP1's ability to multimerize through its leucine zipper domain, which allows the formation of complexes containing multiple actin-binding sites.</p>
<p>The leucine zipper motif serves a dual regulatory role in AFAP1 function. On one hand, it facilitates multimerization and thus enables actin crosslinking. On the other hand, it participates in an auto-inhibitory mechanism by making intramolecular contacts with sequences in the amino-terminal PH1 domain [qian-2004-leucine-zipper-abstract]. This auto-inhibitory configuration maintains AFAP1 in a relatively inactive conformation under basal conditions. Disruption of the leucine zipper, either through deletion mutagenesis or through phosphorylation-induced conformational changes, releases this auto-inhibition and dramatically increases the actin crosslinking capability of AFAP1. Notably, deletion of the leucine zipper motif causes AFAP1 to alter actin filament integrity and induce the formation of lamellipodia in untransformed cells, mimicking the effects of Src transformation [qian-2000-carboxy-terminus-abstract].</p>
<p>Size exclusion chromatography analyses have revealed that AFAP1 can exist in multiple oligomeric states in cells, ranging from monomers to tetramers in vivo and potentially higher-order multimers (up to nonamers) in vitro [qian-2004-leucine-zipper-abstract]. The transition between these oligomeric states is regulated by signaling inputs, particularly from Src and PKC.</p>
<h2 id="regulation-by-protein-kinase-c">Regulation by Protein Kinase C</h2>
<p>AFAP1 is a direct substrate of protein kinase C alpha (PKCalpha) and this phosphorylation plays a key regulatory role in AFAP1 function. PKCalpha binds to AFAP1 through the amino-terminal PH1 domain, and this interaction results in phosphorylation of AFAP1 on serine residues [qian-2002-pkc-crosslinking-abstract]. Mutational analysis identified Ser277 as a critical PKC phosphorylation site in AFAP1. Upon treatment with phorbol esters such as phorbol 12-myristate 13-acetate (PMA) or phorbol 12,13-dibutyrate (PDBu), which activate PKC, AFAP1 becomes phosphorylated on Ser277 and undergoes conformational changes that alter its multimerization state [qian-2002-pkc-crosslinking-abstract].</p>
<p>PKC phosphorylation uniquely enhances the actin crosslinking ability of AFAP1. This is in marked contrast to other actin-regulatory proteins such as fascin, MARCKS, SSeCKS, and VASP, for which PKC phosphorylation decreases actin crosslinking activity. The mechanism appears to involve reduction in AFAP1 self-association, which paradoxically increases crosslinking activity, possibly by generating a population of smaller oligomers that are more effective at bridging between filaments [qian-2002-pkc-crosslinking-abstract].</p>
<p>Phosphorylation of Ser277 also regulates podosome dynamics. Studies in vascular smooth muscle A7r5 cells demonstrated that expression of a non-phosphorylatable AFAP1 mutant (S277A) resulted in an increased number of long-lived podosomes, suggesting that phosphorylation and dephosphorylation at this site regulate podosome turnover and stability [dorfleutner-2008-podosome-lifespan, from Journal of Cell Science 121:2394-2405]. The Ser277 site is conserved between human, chicken, rat, and mouse AFAP1, indicating evolutionary conservation of this regulatory mechanism.</p>
<h2 id="src-kinase-activation-and-signaling">Src Kinase Activation and Signaling</h2>
<p>A defining feature of AFAP1 is its capacity to activate c-Src tyrosine kinase. AFAP1 was originally identified as an SH2/SH3 binding partner of Src, and subsequent studies have established that AFAP1 can function as an activator of Src family kinases in response to upstream signals [baisden-2001-afap110-review-abstract]. The mechanism involves phosphorylation-induced conformational changes in AFAP1 that relieve auto-inhibitory intramolecular interactions and expose the SH3-binding motifs, enabling engagement with the Src SH3 domain.</p>
<p>The intrinsic connection between AFAP1's ability to alter actin filament integrity and its capacity to activate tyrosine kinases was demonstrated through studies of the leucine zipper deletion mutant (AFAP1-ŒîLzip) [baisden-2001-intrinsic-ability-abstract]. Unlike wild-type AFAP1, the ŒîLzip mutant is capable of activating cellular tyrosine kinases, including Src family members, and is itself hyperphosphorylated on tyrosine residues. Critically, a point mutation that disrupts the SH3-binding motif of AFAP1-ŒîLzip prevents it from activating tyrosine kinases and altering actin filament integrity. These findings demonstrate that conformational changes in AFAP1, whether induced by leucine zipper deletion or by physiological signals, enable it to activate cellular kinases through a mechanism requiring functional SH3-binding motifs. Furthermore, the downstream effects on actin filaments were shown to require RhoA activity, placing AFAP1-mediated Src activation upstream of Rho GTPase signaling in the cytoskeletal reorganization pathway.</p>
<p>The seminal study by Gatesman and colleagues demonstrated that AFAP1 is required for PKCalpha to activate c-Src and induce podosome formation [gatesman-2004-pkc-src-podosome-abstract]. In cell lines lacking AFAP1 expression, PKC activation by phorbol esters was unable to activate c-Src or induce podosome formation. Ectopic expression of wild-type AFAP1 rescued these responses, while mutant forms of AFAP1 that cannot bind or colocalize with c-Src were unable to do so. The data establish a linear signaling pathway in which PKCalpha phosphorylation of AFAP1 leads to AFAP1-mediated activation of c-Src, which in turn drives cytoskeletal reorganization and podosome formation.</p>
<p>Further studies identified an additional requirement for PI3K (phosphoinositide 3-kinase) signaling in this pathway [walker-2007-pi3k-csrc-abstract]. PI3K activity is required for PMA-induced colocalization between AFAP1 and c-Src and for subsequent c-Src activation. Cells lacking the p85 regulatory subunits of PI3K or treated with PI3K inhibitors showed defects in this signaling axis, resulting in impaired cell migration.</p>
<h2 id="tissue-expression-and-distribution">Tissue Expression and Distribution</h2>
<p>AFAP1 exhibits broad but heterogeneous expression across human tissues. According to data from the Human Protein Atlas, AFAP1 shows ubiquitous cytoplasmic expression with a granular pattern in multiple tissues. The protein is expressed in diverse cell types including stromal cells of the endometrium, cortical neurons, peripheral nerve tissue, and over 120 other cell types and tissues. Notably, AFAP1 shows relatively high expression in peripheral blood mononuclear cells and breast tissue.</p>
<p>The expression pattern of AFAP1 in breast tissue is of particular interest in the context of cancer biology. While normal breast epithelial cell lines such as MCF-10A show low AFAP1 expression, and tumorigenic but less invasive breast cancer cell lines (MCF-7, T-47D, ZR-75-1) also exhibit low levels, highly invasive breast cancer cell lines MDA-MB-231 and MDA-MB-435 show markedly elevated AFAP1 expression [dorfleutner-2007-breast-cancer-abstract]. This expression pattern suggests that AFAP1 may be particularly important for the invasive phenotype rather than for proliferation per se.</p>
<p>AFAP1 is also expressed in ocular tissues including the retina, optic nerve, trabecular meshwork, and retinal ganglion cells [gharahkhani-2014-glaucoma-gwas-abstract]. This expression pattern has become significant in light of genome-wide association studies linking AFAP1 variants to glaucoma risk (discussed below).</p>
<h2 id="cellular-localization">Cellular Localization</h2>
<p>AFAP1 displays a characteristic localization pattern that reflects its association with actin structures and its regulation by signaling pathways. In quiescent, untransformed cells, AFAP1 colocalizes with actin stress fibers and the cortical actin network along the cell membrane [flynn-1993-afap110-identification-abstract]. This localization depends on the carboxy-terminal actin-binding domain and positions AFAP1 to respond to signals that regulate the actin cytoskeleton.</p>
<p>Upon activation of PKC or transformation by Src, AFAP1 redistributes from stress fibers to specialized actin-rich adhesion structures called podosomes [gatesman-2004-pkc-src-podosome-abstract]. Podosomes are highly dynamic structures consisting of an F-actin-rich core surrounded by a ring of focal adhesion components. They are found on the ventral membrane of cells and are involved in cell adhesion and extracellular matrix degradation. AFAP1 consistently colocalizes with podosomes and has been established as a reliable molecular marker for these structures, along with cortactin and Tks5 [dorfleutner-2008-podosome-lifespan].</p>
<p>In cancer cells, AFAP1 also localizes to invadopodia, which are related structures that mediate invasive behavior. AFAP1 is recruited to invadopodia along with other components including Arp2/3, cortactin, and Tks5. The phosphorylation status of AFAP1 affects the dynamics of both podosomes and invadopodia, with serine phosphorylation promoting structure turnover [dorfleutner-2007-breast-cancer-abstract].</p>
<p>AFAP1 is also found at focal adhesions, which are larger, more stable adhesion structures that connect the actin cytoskeleton to the extracellular matrix. Studies in prostate cancer cells and breast cancer cells have demonstrated that AFAP1 is required for proper focal adhesion formation and function, with knockdown of AFAP1 resulting in disrupted focal contacts and decreased cell adhesion [zhang-2007-prostate-cancer-abstract; dorfleutner-2007-breast-cancer-abstract].</p>
<h2 id="role-in-cell-adhesion-and-migration">Role in Cell Adhesion and Migration</h2>
<p>AFAP1 plays an essential role in cell adhesion and migration through its effects on the actin cytoskeleton and focal adhesion structures. Studies in MDA-MB-231 breast cancer cells demonstrated that knockdown of AFAP1 expression resulted in loss of actin stress fiber crosslinking and decreased adhesion to fibronectin [dorfleutner-2007-breast-cancer-abstract]. Although AFAP1 knockdown did not affect cell proliferation, it prevented the formation of focal contacts even when cells were treated with lysophosphatidic acid (LPA), a known stimulator of stress fiber formation and adhesion. This suggests that AFAP1 provides cytoskeletal tension through stress fiber crosslinking that is required for focal adhesion assembly.</p>
<p>The role of AFAP1 in cell migration was established through wound healing assays using mouse embryo fibroblasts [walker-2007-pi3k-csrc-abstract]. Cells expressing dominant-negative AFAP1 or lacking c-Src showed significantly reduced migration rates. Similarly, cells lacking the p85 regulatory subunits of PI3K showed migration defects, establishing that the PI3K-AFAP1-cSrc signaling axis is required for efficient cell migration.</p>
<p>In prostate cancer cells, AFAP1 knockdown reduced cell migration and invasion while disrupting focal adhesion organization [zhang-2007-prostate-cancer-abstract]. The effects were dependent on the PKC-binding capacity of AFAP1, as re-expression of wild-type AFAP1 but not a PKC-binding-deficient mutant restored normal phenotypes.</p>
<h2 id="role-in-blood-brain-barrier-function">Role in Blood-Brain Barrier Function</h2>
<p>A novel function for AFAP1 was identified in the regulation of P-glycoprotein (P-gp) activity at the blood-brain barrier [hoshi-2017-pgp-bbb-abstract]. P-glycoprotein is a critical efflux transporter that protects the brain from potentially harmful substances and affects drug delivery to the central nervous system. Using phosphoproteomic analysis in human brain capillary endothelial cells, researchers discovered that inflammatory mediators such as TNF-alpha rapidly attenuate P-gp efflux activity without changing P-gp protein expression levels. AFAP1 was identified as a key mediator of this inflammatory signaling pathway. Knockdown of AFAP1 expression blocked the TNF-alpha-induced reduction in P-gp efflux activity, establishing AFAP1 as essential for this regulatory mechanism. This finding suggests that AFAP1 plays a role in the dynamic regulation of blood-brain barrier function during inflammation, potentially through its effects on cytoskeletal organization and membrane protein function in brain endothelial cells.</p>
<h2 id="physiological-function-lactation">Physiological Function: Lactation</h2>
<p>A major physiological function of AFAP1 was revealed through the generation of AFAP1 knockout mice [cunnick-2015-mammary-gland-abstract]. These mice displayed a striking lactation defect resulting in inability to efficiently nurse their pups. Histological analysis of mammary glands from lactating AFAP1-null mice revealed accumulation of large cytoplasmic lipid droplets in alveolar epithelial cells, along with reduced lipid synthesis and expression of lipogenic genes. Importantly, protein secretion (as assessed by beta-casein production) was not affected, indicating a specific defect in lipid secretion rather than a general secretory failure.</p>
<p>The lactation defect in AFAP1-null mice was associated with reduced c-Src activity during early lactation and selective loss of active c-Src localization at the apical surface of luminal epithelial cells. AFAP1 was found to respond to prolactin, a key lactogenic hormone, by forming a complex with c-Src and becoming tyrosine phosphorylated. These findings established that AFAP1 is required for the spatial and temporal regulation of c-Src activity in the normal mammary gland, specifically for milk production [cunnick-2015-mammary-gland-abstract].</p>
<h2 id="role-in-cancer">Role in Cancer</h2>
<p>AFAP1 has been implicated in cancer progression, particularly in prostate cancer. Immunohistochemical analysis of human tissue arrays revealed that AFAP1 is absent or expressed at very low levels in normal prostatic epithelium and benign prostatic hyperplasia, but is significantly overexpressed in prostate carcinomas [zhang-2007-prostate-cancer-abstract]. The level of AFAP1 expression correlated with Gleason scores, indicating association with disease aggressiveness.</p>
<p>Functional studies demonstrated that knockdown of AFAP1 in prostate cancer cell lines inhibited cell proliferation, tumor growth in xenograft models, cell adhesion, and migration. Re-expression of wild-type AFAP1 rescued these phenotypes, but a mutant lacking PKC-binding capacity did not, indicating that the tumorigenic effects of AFAP1 depend on its interaction with PKC and downstream signaling [zhang-2007-prostate-cancer-abstract].</p>
<p>Similarly, AFAP1 is overexpressed in breast cancer cell lines MDA-MB-231 and MDA-MB-435, where it contributes to stress fiber formation and adhesion [dorfleutner-2007-breast-cancer-abstract]. The capacity of AFAP1 to activate c-Src and promote podosome/invadopodia formation suggests a role in cancer cell invasion.</p>
<p>A significant finding in the cancer biology of AFAP1 was the identification of a naturally occurring polymorphic variant that enhances c-Src activation [clump-2010-polymorphic-variant-abstract]. Analysis of the AFAP1 coding sequence revealed a nonsynonymous single-nucleotide polymorphism resulting in a serine-to-cysteine substitution at position 403 (S403C). This variant, designated AFAP1(403C), is present in approximately one-quarter of the general population. Importantly, in cells with elevated c-Src expression, AFAP1(403C) directs c-Src activation and podosome formation independently of upstream signals, in contrast to wild-type AFAP1 which requires PKC activation. In an analysis of ovarian cancer samples, AFAP1 and c-Src were found to be overexpressed in 30 and 32 of 33 samples, respectively. These findings suggest that individuals carrying the 403C polymorphism may be at increased risk for cancer progression when c-Src is overexpressed, providing a mechanism by which inherited genetic variation could influence cancer biology.</p>
<h2 id="genetic-association-with-glaucoma">Genetic Association with Glaucoma</h2>
<p>A surprising connection between AFAP1 and eye disease emerged from genome-wide association studies (GWAS) of primary open-angle glaucoma (POAG), the most common form of glaucoma and a leading cause of irreversible blindness worldwide. In a landmark study published in Nature Genetics, Gharahkhani and colleagues performed a GWAS in an Australian discovery cohort of 1,155 POAG cases and 1,992 controls, with replication in additional Australian and US cohorts [gharahkhani-2014-glaucoma-gwas-abstract]. Meta-analysis identified a common variant within the AFAP1 gene (rs4619890[G]) that conferred significantly increased risk of POAG (odds ratio = 1.20, P = 7.0 √ó 10^-10).</p>
<p>The mechanistic connection between AFAP1 and glaucoma pathophysiology remains to be fully elucidated. AFAP1 is expressed in key ocular tissues including the trabecular meshwork (which regulates aqueous humor outflow and thus intraocular pressure), the optic nerve, retina, and retinal ganglion cells (whose death underlies vision loss in glaucoma). The extracellular matrix remodeling functions suggested for AFAP1, potentially through its regulation of cytoskeletal dynamics and cell-matrix adhesions, may be relevant to trabecular meshwork function. Subsequent GWAS meta-analyses have confirmed the association of AFAP1 variants with both POAG and elevated intraocular pressure across diverse ancestral populations, establishing AFAP1 as one of the most robust genetic risk factors for this disease. Fine-mapping studies incorporating data from multiple ancestries have improved the localization of the likely causal variant at this locus.</p>
<h2 id="afap1-as1-an-antisense-long-non-coding-rna">AFAP1-AS1: An Antisense Long Non-coding RNA</h2>
<p>An antisense long non-coding RNA (lncRNA), designated AFAP1-AS1, is transcribed from the AFAP1 locus in the opposite direction. AFAP1-AS1 has emerged as a topic of considerable research interest in cancer biology, independent of AFAP1 protein function. This lncRNA is overexpressed in multiple cancer types including gastric cancer, breast cancer, lung cancer, and others, and its elevated expression generally correlates with poor prognosis. AFAP1-AS1 functions through multiple mechanisms including sequestration of microRNAs (acting as a "sponge") and direct effects on signaling pathways involved in cancer progression. While AFAP1-AS1 can influence AFAP1 protein expression in some contexts, it also has AFAP1-independent functions. The existence of this cancer-associated lncRNA at the AFAP1 locus adds another layer of complexity to understanding the biology of this genomic region, though the functional relationship between AFAP1-AS1 and AFAP1 protein remains an area of active investigation.</p>
<h2 id="the-afap-protein-family">The AFAP Protein Family</h2>
<p>AFAP1 is the founding member of a three-protein family that also includes AFAP1L1 and AFAP1L2/XB130. All three proteins share a similar modular domain structure with two PH domains flanking a serine/threonine-rich region, SH2-binding motifs, and SH3-binding motifs. Cladistic analysis indicates that AFAP1 and AFAP1L1 are more closely related to each other than to AFAP1L2/XB130.</p>
<p>A major structural difference between the family members lies in the carboxy terminus. AFAP1 and AFAP1L1 contain a leucine zipper and actin-binding domain, enabling direct F-actin binding and crosslinking. In contrast, AFAP1L2/XB130 contains a related coiled-coil but lacks an actin-binding motif and does not bind efficiently to actin filaments. Consequently, AFAP1L2/XB130 appears to have distinct functions, acting as an intermediary between the RET/PTC kinase and PI3K pathway in the thyroid rather than primarily regulating actin dynamics.</p>
<p>AFAP1L1 shares many functional properties with AFAP1, including the ability to associate with actin filaments, localize to invadosomes, and induce podosomes upon overexpression. However, the tissue distribution patterns differ, with AFAP1L1 showing unique localization to muscle tissue and the dentate nucleus of the brain where AFAP1 is not detectable.</p>
<h2 id="open-questions">Open Questions</h2>
<p>Despite the substantial body of research on AFAP1, several important questions remain unresolved:</p>
<ol>
<li>
<p><strong>Structural basis of function:</strong> No experimentally determined high-resolution crystal or cryo-EM structure of AFAP1 or its domains is currently available. However, an AlphaFold-predicted structure is available through the AlphaFold Protein Structure Database (entry Q8N556), which may provide insights into domain organization and the auto-inhibitory mechanism. Experimental validation of the predicted structure and its conformational dynamics would greatly enhance understanding of AFAP1 function.</p>
</li>
<li>
<p><strong>Regulation of multimerization:</strong> While it is clear that AFAP1 exists in multiple oligomeric states and that transitions between these states are regulated, the precise structural changes and the upstream signals that control them remain incompletely defined.</p>
</li>
<li>
<p><strong>Tissue-specific functions:</strong> The lactation defect in AFAP1 knockout mice suggests tissue-specific functions, but the roles of AFAP1 in other tissues have not been systematically investigated.</p>
</li>
<li>
<p><strong>Relationship to metastasis:</strong> Although AFAP1 is overexpressed in prostate and breast cancers and contributes to migration and invasion, its precise contribution to metastatic dissemination in vivo remains to be determined.</p>
</li>
<li>
<p><strong>Therapeutic targeting:</strong> Given its overexpression in certain cancers and its role in promoting tumorigenic phenotypes, AFAP1 might represent a therapeutic target, but no small-molecule inhibitors or other targeting strategies have been developed.</p>
</li>
<li>
<p><strong>Coordination with other actin-binding proteins:</strong> How AFAP1 coordinates with other actin-binding and crosslinking proteins in cells to produce coherent cytoskeletal responses to signals is not well understood.</p>
</li>
<li>
<p><strong>Non-canonical functions:</strong> Whether AFAP1 has signaling functions independent of its actin-binding and Src-activation roles remains an open question.</p>
</li>
<li>
<p><strong>Mechanism of glaucoma association:</strong> The GWAS association between AFAP1 variants and primary open-angle glaucoma is robust, but the mechanistic basis for this association remains unknown. Does AFAP1 play a direct role in trabecular meshwork function, retinal ganglion cell survival, or optic nerve health? Is the risk variant a gain- or loss-of-function allele?</p>
</li>
<li>
<p><strong>Functional consequences of the S403C polymorphism:</strong> The polymorphic variant AFAP1(403C) appears to constitutively activate c-Src, but the structural basis for this gain-of-function, and whether it contributes to cancer risk in the general population, requires further investigation.</p>
</li>
<li>
<p><strong>Role in neuronal function:</strong> AFAP1 is expressed in neuronal tissues but its specific functions in neurons have not been characterized. Given the involvement of cytoskeletal dynamics in neuronal processes such as axon guidance and synaptic plasticity, AFAP1 may have important neurological functions.</p>
</li>
</ol>
<h2 id="references">References</h2>
<ul>
<li>
<p>[flynn-1993-afap110-identification-abstract] Flynn DC, Leu TH, Reynolds AB, Parsons JT. Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate. Mol Cell Biol. 1993;13(12):7892-7900. PMID: 8247004. DOI: 10.1128/mcb.13.12.7892-7900.1993</p>
</li>
<li>
<p>[baisden-2001-afap110-review-abstract] Baisden JM, Qian Y, Zot HM, Flynn DC. The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity. Oncogene. 2001;20(44):6435-6447. PMID: 11607843. DOI: 10.1038/sj.onc.1204784</p>
</li>
<li>
<p>[qian-2002-pkc-crosslinking-abstract] Qian Y, Baisden JM, Cherezova L, Summy JM, Guappone-Koay A, Shi X, Mast T, Pustula J, Zot HG, Mazloum N, Lee MY, Flynn DC. PKC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments. Mol Biol Cell. 2002;13(7):2311-2322. PMID: 12134071. DOI: 10.1091/mbc.e01-12-0148</p>
</li>
<li>
<p>[qian-2000-carboxy-terminus-abstract] Qian Y, Baisden JM, Zot HG, Van Winkle WB, Flynn DC. The carboxy terminus of AFAP-110 modulates direct interactions with actin filaments and regulates its ability to alter actin filament integrity and induce lamellipodia formation. Exp Cell Res. 2000;255(1):102-113. PMID: 10666339. DOI: 10.1006/excr.1999.4795</p>
</li>
<li>
<p>[qian-1998-src-self-association-abstract] Qian Y, Baisden JM, Westin EH, Guappone AC, Koay TC, Flynn DC. Src can regulate carboxy terminal interactions with AFAP-110, which influence self-association, cell localization and actin filament integrity. Oncogene. 1998;16(17):2185-2195. PMID: 9619827. DOI: 10.1038/sj.onc.1201753</p>
</li>
<li>
<p>[qian-2004-leucine-zipper-abstract] Qian Y, Gatesman AS, Baisden JM, Zot HG, Cherezova L, Qazi I, Mazloum N, Lee MY, Guappone-Koay A, Flynn DC. Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110 to alter actin filament integrity. J Cell Biochem. 2004;91(3):602-620. PMID: 14755689. DOI: 10.1002/jcb.10725</p>
</li>
<li>
<p>[gatesman-2004-pkc-src-podosome-abstract] Gatesman A, Walker VG, Baisden JM, Weed SA, Flynn DC. Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110. Mol Cell Biol. 2004;24(17):7578-7597. PMID: 15314167. DOI: 10.1128/MCB.24.17.7578-7597.2004</p>
</li>
<li>
<p>[walker-2007-pi3k-csrc-abstract] Walker VG, Ammer A, Cao Z, Clump AC, Jiang BH, Kelley LC, Weed SA, Zot H, Flynn DC. PI3K activation is required for PMA-directed activation of cSrc by AFAP-110. Am J Physiol Cell Physiol. 2007;293(1):C119-132. PMID: 17360811. DOI: 10.1152/ajpcell.00525.2006</p>
</li>
<li>
<p>[zhang-2007-prostate-cancer-abstract] Zhang J, Park SI, Artime MC, Summy JM, Shah AN, Bomser JA, Dorfleutner A, Flynn DC, Gallick GE. AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts. J Clin Invest. 2007;117(10):2962-2973. PMID: 17885682. DOI: 10.1172/JCI30710</p>
</li>
<li>
<p>[dorfleutner-2007-breast-cancer-abstract] Dorfleutner A, Stehlik C, Zhang J, Gallick GE, Flynn DC. AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells. J Cell Physiol. 2007;213(3):740-749. PMID: 17520695. DOI: 10.1002/jcp.21143</p>
</li>
<li>
<p>[cunnick-2015-mammary-gland-abstract] Cunnick JM, Kim S, Hadsell J, Collins S, Cerra C, Reiser P, Flynn DC, Cho Y. Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland. Oncogene. 2015;34(20):2640-2649. PMID: 25043309. DOI: 10.1038/onc.2014.205</p>
</li>
<li>
<p>[baisden-2001-intrinsic-ability-abstract] Baisden JM, Gatesman AS, Cherezova L, Jiang BH, Flynn DC. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases. Oncogene. 2001;20(45):6607-6616. PMID: 11641786. DOI: 10.1038/sj.onc.1204802</p>
</li>
<li>
<p>[clump-2010-polymorphic-variant-abstract] Clump DA, Yu JJ, Cho Y, Gao R, Jett J, Zot H, Cunnick JM, Snyder B, Clump AC, Dodrill M, Gannett P, Coad JE, Shurina R, Figg WD, Reed E, Flynn DC. A polymorphic variant of AFAP-110 enhances cSrc activity. Transl Oncol. 2010;3(4):276-285. PMID: 20689769. DOI: 10.1593/tlo.10106</p>
</li>
<li>
<p>[gharahkhani-2014-glaucoma-gwas-abstract] Gharahkhani P, Burdon KP, Fogarty R, Sharma S, Hewitt AW, Martin S, Law MH, Cremin K, Bailey JNC, Loomis SJ, et al. Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma. Nat Genet. 2014;46:1120-1125. PMID: 25173106. DOI: 10.1038/ng.3079</p>
</li>
<li>
<p>[dorfleutner-2008-podosome-lifespan-abstract] Dorfleutner A, Cho Y, Vincent D, Cunnick J, Lin H, Weed SA, Stehlik C, Flynn DC. Phosphorylation of AFAP-110 affects podosome lifespan in A7r5 cells. J Cell Sci. 2008;121(14):2394-2405. PMID: 18577569. DOI: 10.1242/jcs.024943</p>
</li>
<li>
<p>[hoshi-2017-pgp-bbb-abstract] Hoshi Y, Uchida Y, Tachikawa M, Ohtsuki S, Terasaki T. Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory signaling-induced rapid attenuation of intrinsic P-gp function in human brain capillary endothelial cells. J Neurochem. 2017;141(2):247-262. PMID: 28112407. DOI: 10.1111/jnc.13960</p>
</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>baisden-2001-afap110-review-abstract.md</li>
<li>baisden-2001-intrinsic-ability-abstract.md</li>
<li>clump-2010-polymorphic-variant-abstract.md</li>
<li>cunnick-2015-mammary-gland-abstract.md</li>
<li>dorfleutner-2007-breast-cancer-abstract.md</li>
<li>dorfleutner-2008-podosome-lifespan-abstract.md</li>
<li>flynn-1993-afap110-identification-abstract.md</li>
<li>gatesman-2004-pkc-src-podosome-abstract.md</li>
<li>gharahkhani-2014-glaucoma-gwas-abstract.md</li>
<li>hoshi-2017-pgp-bbb-abstract.md</li>
<li>qian-1998-src-self-association-abstract.md</li>
<li>qian-2000-carboxy-terminus-abstract.md</li>
<li>qian-2002-pkc-crosslinking-abstract.md</li>
<li>qian-2004-leucine-zipper-abstract.md</li>
<li>walker-2007-pi3k-csrc-abstract.md</li>
<li>zhang-2007-prostate-cancer-abstract.md</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AFAP1-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8N556" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-27T10:15:36.423430'<br />
end_time: '2025-12-27T10:21:48.198683'<br />
duration_seconds: 371.78<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AFAP1<br />
  gene_symbol: AFAP1<br />
  uniprot_accession: Q8N556<br />
  protein_description: 'RecName: Full=Actin filament-associated protein 1; AltName:<br />
    Full=110 kDa actin filament-associated protein; Short=AFAP-110;'<br />
  gene_info: Name=AFAP1; Synonyms=AFAP;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849);<br />
    PH (PF00169)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 17</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8N556</li>
<li><strong>Protein Description:</strong> RecName: Full=Actin filament-associated protein 1; AltName: Full=110 kDa actin filament-associated protein; Short=AFAP-110;</li>
<li><strong>Gene Information:</strong> Name=AFAP1; Synonyms=AFAP;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849); PH (PF00169)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AFAP1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AFAP1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AFAP1</strong> (gene ID: AFAP1, UniProt: Q8N556) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8N556</li>
<li><strong>Protein Description:</strong> RecName: Full=Actin filament-associated protein 1; AltName: Full=110 kDa actin filament-associated protein; Short=AFAP-110;</li>
<li><strong>Gene Information:</strong> Name=AFAP1; Synonyms=AFAP;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849); PH (PF00169)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AFAP1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AFAP1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AFAP1</strong> (gene ID: AFAP1, UniProt: Q8N556) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Research plan overview<br />
We verified AFAP1 identity, curated recent (2023‚Äì2024) primary literature, and synthesized domain architecture, mechanisms, localization, signaling pathways, physiological roles, disease links, and quantitative data where available. We prioritized human AFAP1 (AFAP-110; UniProt Q8N556) and avoided conflation with AFAP1L1/AFAP1L2 and AFAP1-AS1.</p>
<table>
<thead>
<tr>
<th>Aspect</th>
<th>Key details (mechanistic)</th>
<th style="text-align: right;">Experimental / Model context</th>
<th>Source (DOI URL and year)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Identity &amp; family distinction vs AFAP1L1/AFAP1L2</td>
<td>AFAP1 (AFAP-110) is the prototypic AFAP family member; AFAP1L1 and AFAP1L2 share high sequence similarity (AFAP1L1 ~71%, AFAP1L2 ~64%) with conserved PH domains but divergent C-terminal motifs that confer distinct interactions.</td>
<td style="text-align: right;">Sequence comparisons, domain mapping and family phylogeny from thesis/database analyses.</td>
<td>Snyder 2011 ‚Äî https://doi.org/10.33915/etd.3379 (2011) (snyder2011anewmember pages 26-30, snyder2011anewmember pages 30-34)</td>
</tr>
<tr>
<td>Domain architecture</td>
<td>Two pleckstrin homology (PH) domains (PH1 binds PKCŒ±), N-terminal proline-rich SH3-binding motifs and SH2-binding motifs, central leucine-zipper/coiled-coil for multimerization, C-terminal actin-binding domain (ABD) with mapped ABD motifs (~residues 593‚Äì637).</td>
<td style="text-align: right;">Epitope mapping, domain deletion constructs, monoclonal antibody mapping, biochemical fractionation.</td>
<td>Qian et al. 1999 ‚Äî https://doi.org/10.1089/hyb.1999.18.167 (1999); Xiao et al. 2012 ‚Äî https://doi.org/10.1007/s00018-011-0812-5 (2012) (qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4)</td>
</tr>
<tr>
<td>Actin binding, crosslinking &amp; multimerization</td>
<td>C-terminal ABD mediates F-actin binding; AFAP1 multimerizes (coiled-coil/leucine zipper) enabling actin cross-linking similar to Œ±-actinin; multimerization required for crosslink function and is PKC-regulated.</td>
<td style="text-align: right;">In vitro actin co-sedimentation, cross-linking assays, FPLC/blue-native PAGE, mutant (Œîlzip/ŒîABD) phenotypes.</td>
<td>Rubacha 2010 (2010) (no DOI available) ; Qian et al. 1999 ‚Äî https://doi.org/10.1089/hyb.1999.18.167 (1999); Xiao et al. 2012 ‚Äî https://doi.org/10.1007/s00018-011-0812-5 (2012) (rubacha2010xb130insilicob pages 24-28, qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4)</td>
</tr>
<tr>
<td>Src binding &amp; activation; PKC regulation</td>
<td>AFAP1 binds c-Src via proline-rich SH3-binding motifs and can promote Src activation; PKCŒ± binds PH1 and phosphorylates AFAP1 (e.g., Ser277), altering conformation/multimerization and promoting relocalization to podosomes and increased Src activity.</td>
<td style="text-align: right;">Biochemical binding assays, PKC activation (PMA), phosphorylation mapping, cell imaging of podosome formation; cancer cell lines (MDA-MB-231, PC3).</td>
<td>Snyder 2011 ‚Äî https://doi.org/10.33915/etd.3379 (2011); Rubacha 2010 (2010); Cunnick et al. 2015 ‚Äî https://doi.org/10.1038/onc.2014.205 (2015) (snyder2011anewmember pages 30-34, rubacha2010xb130insilicob pages 24-28, cunnick2015actinfilamentassociatedprotein pages 1-3)</td>
</tr>
<tr>
<td>Subcellular localization</td>
<td>Localizes to F-actin stress fibers and focal adhesions in resting cells; relocates to podosomes/invadopodia and lamellipodia upon PKC/Src activation or transformation; in vivo AFAP1 required for apical localization of active c-Src in lactating mammary epithelium.</td>
<td style="text-align: right;">Immunofluorescence, fractionation, AFAP1 knockout mice (mammary gland), cancer cell imaging.</td>
<td>Cunnick et al. 2015 ‚Äî https://doi.org/10.1038/onc.2014.205 (2015); Xiao et al. 2012 ‚Äî https://doi.org/10.1007/s00018-011-0812-5 (2012) (cunnick2015actinfilamentassociatedprotein pages 1-3, xiao2012theactinbindingdomain pages 2-4)</td>
</tr>
<tr>
<td>Signaling pathways</td>
<td>Key axes: PKC ‚Üí AFAP1 ‚Üí Src (AFAP1 as adaptor/activator of Src); reported role downstream of TGF-Œ≤ to facilitate Src-dependent CCN2 induction in osteoblast models (AFAP1 required for Src activation in growth factor signaling).</td>
<td style="text-align: right;">Cell-based signaling assays, primary osteoblasts and siRNA, promoter assays and biochemical readouts of Src/CCN2.</td>
<td>Cunnick et al. 2015 ‚Äî https://doi.org/10.1038/onc.2014.205 (2015); supporting mechanistic literature and reviews (cunnick2015actinfilamentassociatedprotein pages 1-3, snyder2011anewmember pages 30-34)</td>
</tr>
<tr>
<td>Physiologic role</td>
<td>Required for proper c-Src activity spatially/temporally during lactation: AFAP1 knockout mice show defective secretory activation (large cytoplasmic lipid droplets), reduced c-Src activity and impaired nursing.</td>
<td style="text-align: right;">AFAP1-null mouse model, histology, biochemical assays of c-Src activity.</td>
<td>Cunnick et al. 2015 ‚Äî https://doi.org/10.1038/onc.2014.205 (2015) (cunnick2015actinfilamentassociatedprotein pages 1-3)</td>
</tr>
<tr>
<td>2023‚Äì2024 development (regulation &amp; antiviral link)</td>
<td>Matsumoto et al. (2023) identified CSNK2B (CK2Œ≤) as an IRF1 co-regulator: CSNK2B modulates IRF1 chromatin binding and locus-specific control of AFAP1 transcription; CSNK2B also mediates phosphorylation-dependent activation of AFAP1‚ÄìSrc signaling linked to antiviral effects.</td>
<td style="text-align: right;">Proteomics, CUT&amp;RUN genome-wide IRF1 binding, phosphorylation assays, antiviral functional assays.</td>
<td>Matsumoto et al. 2023 ‚Äî https://doi.org/10.1093/nar/gkad298 (2023) (matsumoto2023csnk2bmodulatesirf1 pages 1-2)</td>
</tr>
<tr>
<td>Disease associations (cancer invasion/metastasis)</td>
<td>AFAP1 promotes cytoskeletal remodeling, invadopodia/podosome formation, adhesion and invasion in cancer cells; AFAP1 expression and function linked experimentally to increased invasive phenotypes and observed upregulation in some tumors (e.g., prostate, breast models).</td>
<td style="text-align: right;">Cancer cell lines (invasion/matrix degradation assays), xenograft/RNAi studies, database/expression surveys.</td>
<td>Snyder 2011 ‚Äî https://doi.org/10.33915/etd.3379 (2011); Rubacha 2010 (2010); Qian et al. 1999 ‚Äî https://doi.org/10.1089/hyb.1999.18.167 (1999) (snyder2011anewmember pages 39-43, rubacha2010xb130insilicob pages 24-28, qian1999monoclonalantibodiesdirected pages 1-5)</td>
</tr>
</tbody>
</table>
<p><em>Table: Concise table summarizing AFAP1/AFAP-110 domains, mechanistic functions, localization, signaling roles, physiologic effects and recent (2023) regulatory findings with primary-source DOIs and contextual citations for each entry.</em></p>
<p>1) Key concepts and definitions with current understanding<br />
- Identity and nomenclature. AFAP1 (actin filament-associated protein 1), also known as AFAP-110, is a human adaptor/scaffold that binds F-actin and regulates Src-family kinase signaling. It is the prototypic member of the AFAP family (AFAP1, AFAP1L1, AFAP1L2). AFAP1 is distinct from AFAP1L1 and AFAP1L2 (XB130/PI3KAP) despite sequence conservation in PH domains; AFAP1 harbors SH3-binding proline-rich motifs that engage Src, a leucine-zipper/coiled-coil for multimerization, and a C-terminal actin-binding domain that mediates actin crosslinking (snyder2011anewmember pages 26-30, snyder2011anewmember pages 30-34, qian1999monoclonalantibodiesdirected pages 1-5).<br />
- Domain architecture. AFAP1 contains two pleckstrin homology (PH) domains (PH1 binds PKCŒ±), multiple SH2- and SH3-binding motifs (including two N‚Äëterminal proline-rich SH3 ligands), a central leucine-zipper/coiled-coil that mediates multimerization and conformational regulation, and a C-terminal actin-binding domain (ABD) with mapped actin-binding sequences around residues ~593‚Äì637 (qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4, snyder2011anewmember pages 30-34).<br />
- Primary biochemical functions. AFAP1 binds F‚Äëactin directly and forms multimers that crosslink actin filaments; it also binds and can activate c‚ÄëSrc, positioning AFAP1 as a mechanistic link between the actin cytoskeleton and Src-family kinase signaling (qian1999monoclonalantibodiesdirected pages 1-5, rubacha2010xb130insilicob pages 24-28, snyder2011anewmember pages 30-34).</p>
<p>2) Recent developments and latest research (2023‚Äì2024 prioritized)<br />
- CSNK2B‚ÄìIRF1 regulation of AFAP1 and antiviral signaling (2023). Matsumoto et al. demonstrated that CSNK2B (CK2Œ≤) interacts with IRF1 to modulate genome-wide chromatin binding; CSNK2B depletion causes an abnormal accumulation of IRF1 at AFAP1 loci and downregulates AFAP1 transcription. CSNK2B further mediates phosphorylation-dependent activation of AFAP1‚ÄìSrc signaling and contributes to antiviral effects against flaviviruses, identifying AFAP1 as an IRF1/CK2Œ≤‚Äëresponsive effector that connects cytoskeletal signaling to innate immunity (Nucleic Acids Research, 2023; doi:10.1093/nar/gkad298) (matsumoto2023csnk2bmodulatesirf1 pages 1-2).<br />
- Context from established AFAP1 mechanistic literature supports and frames the 2023 finding: AFAP1‚Äôs ability to activate Src and remodel actin provides biological plausibility for antiviral phenotypes when AFAP1‚ÄìSrc signaling is modulated (snyder2011anewmember pages 30-34, rubacha2010xb130insilicob pages 24-28, xiao2012theactinbindingdomain pages 1-2).</p>
<p>3) Current applications and real-world implementations<br />
- Physiological model and in vivo application (mammary gland). AFAP1 knockout in mice revealed a requirement for AFAP1 in secretory activation during lactation: AFAP1 forms a prolactin-induced complex with c‚ÄëSrc, becomes tyrosine‚Äëphosphorylated, and is necessary for spatial and temporal regulation of c‚ÄëSrc activity at the apical surface of luminal epithelial cells; AFAP1 loss reduces c‚ÄëSrc activity and impairs milk production (Oncogene, 2015; doi:10.1038/onc.2014.205) (cunnick2015actinfilamentassociatedprotein pages 1-3).<br />
- Cell biology tools/assays. AFAP1 domain mutants (ŒîABD, Œîleucine zipper) are used to dissect actin-binding vs. multimerization functions, assess stress fiber formation, focal adhesion maturation, podosome/invadopodia dynamics, and matrix degradation in multiple cell models; these reagents are widely used to probe cytoskeletal signaling and Src activation in vitro (Cell Mol Life Sci, 2012; doi:10.1007/s00018-011-0812-5) (xiao2012theactinbindingdomain pages 2-4).<br />
- Emerging virology application. The 2023 IRF1‚ÄìCSNK2B study links AFAP1 to host antiviral responses, suggesting AFAP1‚ÄìSrc signaling as a cellular effector that can be leveraged or modulated in antiviral strategies (Nucleic Acids Research, 2023; doi:10.1093/nar/gkad298) (matsumoto2023csnk2bmodulatesirf1 pages 1-2).</p>
<p>4) Expert opinions and analysis from authoritative sources<br />
- AFAP1 as Src activator and actin crosslinker. Foundational analyses describe AFAP1 as a c‚ÄëSrc activator and actin crosslinking protein that is essential for stress fiber formation and focal adhesion maturation, and that re-localizes to podosomes/invadopodia upon transformation or PKC activation. These mechanistic insights underpin consensus views of AFAP1 as a cytoskeleton‚ÄìSrc adaptor (thesis and review-style syntheses with primary data and citations) (snyder2011anewmember pages 30-34, snyder2011anewmember pages 39-43).<br />
- Domain-function relationships. Detailed mapping shows that PH1 mediates PKCŒ± interaction and phosphorylation (e.g., Ser277), the leucine-zipper/coiled-coil supports multimerization and autoinhibitory contacts, and the C‚Äëterminal ABD is necessary for stable F‚Äëactin association‚Äîconsistent with an autoinhibited scaffold that is activated by PKC and engages Src (snyder2011anewmember pages 30-34, qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4).</p>
<p>5) Relevant statistics and data from recent studies<br />
- 2023 IRF1‚ÄìCSNK2B study. Genome-wide CUT&amp;RUN and functional assays showed that CSNK2B depletion produces locus-specific shifts in IRF1 binding with down-regulation of AFAP1 and phosphorylation-dependent activation of AFAP1‚ÄìSrc signaling, contributing to antiviral responses; while the study highlights mechanistic outcomes and specific loci, quantitative parameters most relevant here are the directional regulatory effects at AFAP1 and the functional linkage to antiviral phenotypes (Nucleic Acids Research, 2023; doi:10.1093/nar/gkad298) (matsumoto2023csnk2bmodulatesirf1 pages 1-2).<br />
- In vivo lactation phenotype. AFAP1-null mice demonstrated reduced c‚ÄëSrc activity during early lactation and loss of apical active c‚ÄëSrc localization; histology showed large cytoplasmic lipid droplets in alveolar epithelia indicating defective secretory activation (Oncogene, 2015; doi:10.1038/onc.2014.205) (cunnick2015actinfilamentassociatedprotein pages 1-3).<br />
- Actin-binding requirement. Deletion of the ABD shifts AFAP1 from the Triton-insoluble cytoskeletal fraction to the soluble fraction, with concomitant disruption of stress fibers and altered matrix degradation in podosome-like structures, indicating a quantitative redistribution of AFAP1 upon loss of ABD and a functional dependence of cytoskeletal association on the ABD (Cell Mol Life Sci, 2012; doi:10.1007/s00018-011-0812-5) (xiao2012theactinbindingdomain pages 2-4).</p>
<p>Functional role, pathways, and localization<br />
- Primary function. AFAP1 is a modular actin-binding adaptor that crosslinks F‚Äëactin via multimerization and couples cytoskeletal dynamics to Src-family kinase activation. It binds c‚ÄëSrc through proline-rich SH3 ligands and SH2 motifs and can increase Src activity; PKCŒ± phosphorylates AFAP1 (PH1 interaction), transitioning AFAP1 from an autoinhibited state to an active scaffold that promotes Src activation and cytoskeletal remodeling (qian1999monoclonalantibodiesdirected pages 1-5, snyder2011anewmember pages 30-34, rubacha2010xb130insilicob pages 24-28).<br />
- Localization. AFAP1 localizes to stress fibers and focal adhesions under basal conditions. Upon PKC/Src activation or oncogenic transformation, AFAP1 relocates to podosomes/invadopodia and lamellipodia; in mammary epithelium, AFAP1 is required for the apical localization of active Src during lactation (xiao2012theactinbindingdomain pages 2-4, cunnick2015actinfilamentassociatedprotein pages 1-3, snyder2011anewmember pages 30-34).<br />
- Pathways. Key axes include PKC‚ÜíAFAP1‚ÜíSrc (PKCŒ± binding to PH1 and Ser277 phosphorylation facilitate Src activation and podosome formation) and TGF‚ÄëŒ≤‚ÜíAFAP1‚ÜíSrc‚ÜíCCN2 induction in osteoblasts (AFAP1 required for Src activation and CCN2 promoter activity in response to TGF‚ÄëŒ≤) (snyder2011anewmember pages 30-34, cunnick2015actinfilamentassociatedprotein pages 1-3).</p>
<p>Disease and translational relevance<br />
- Cancer cell invasion and adhesion. AFAP1 supports stress fiber formation, focal adhesion maturation, and invadopodia/podosome dynamics. RNAi or loss-of-function reduces adhesion/migration/invasion phenotypes in breast and prostate cancer models, and AFAP1 upregulation has been reported in certain tumors, consistent with a role in invasive behavior (snyder2011anewmember pages 30-34, snyder2011anewmember pages 39-43, rubacha2010xb130insilicob pages 24-28).<br />
- Host defense. 2023 data integrate AFAP1 into IRF1/CK2Œ≤‚Äëcontrolled antiviral signaling, linking a cytoskeletal‚ÄìSrc adaptor to innate immune regulation and suggesting potential for therapeutic modulation (matsumoto2023csnk2bmodulatesirf1 pages 1-2).</p>
<p>Mandatory verification of identity<br />
- Gene symbol and protein description match: AFAP1 encodes actin filament-associated protein 1 (AFAP‚Äë110), as specified; features and functions summarized above align with this identity (qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4).<br />
- Organism is human: all core mechanistic evidence cited includes human protein context and mammalian models, consistent with Homo sapiens AFAP1 (qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4, cunnick2015actinfilamentassociatedprotein pages 1-3).<br />
- Domains/family alignment: two PH domains, SH3-binding proline-rich motifs, SH2-binding motifs, leucine-zipper/coiled-coil, and C‚Äëterminal ABD are repeatedly validated in the literature for AFAP1 (qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4, snyder2011anewmember pages 30-34). We explicitly avoid conflation with AFAP1L1 (cortactin‚Äëinteracting) and AFAP1L2/XB130 (PI3KAP), which have overlapping but distinct C‚Äëterminal features (snyder2011anewmember pages 26-30, snyder2011anewmember pages 39-43).</p>
<p>Notes on AFAP1-AS1<br />
- The lncRNA AFAP1‚ÄëAS1 is frequently studied in cancer and shows disease associations; however, those statistics and mechanisms correspond to the antisense noncoding RNA, not the AFAP1 protein, and are therefore not used here to infer AFAP1 protein function (xiao2012theactinbindingdomain pages 1-2).</p>
<p>Selected source details with URLs and dates<br />
- Matsumoto et al., 2023, Nucleic Acids Research 51:4451‚Äì4466. CSNK2B‚ÄìIRF1 regulation of AFAP1, antiviral effects; doi:10.1093/nar/gkad298; published April 2023 (matsumoto2023csnk2bmodulatesirf1 pages 1-2).<br />
- Cunnick et al., 2015, Oncogene 34:2640‚Äì2649. AFAP1 knockout mouse reveals role in lactation and c‚ÄëSrc activity/localization; doi:10.1038/onc.2014.205; online May 14, 2015 (cunnick2015actinfilamentassociatedprotein pages 1-3).<br />
- Xiao et al., 2012, Cell Mol Life Sci 69:1137‚Äì1151. AFAP ABD requirement for cytoskeletal association and podosome-related function; doi:10.1007/s00018-011-0812-5; October 2012 (xiao2012theactinbindingdomain pages 2-4).<br />
- Qian et al., 1999, Hybridoma 18:167‚Äì175. AFAP-110 domain mapping, multimerization, actin binding; doi:10.1089/hyb.1999.18.167; April 1999 (qian1999monoclonalantibodiesdirected pages 1-5).<br />
- Mechanistic syntheses with primary data: Snyder, 2011 (AFAP1 domains, Src activation, PKC regulation, family distinctions), ArXiv DOI 10.33915/etd.3379; 2011 (snyder2011anewmember pages 26-30, snyder2011anewmember pages 30-34, snyder2011anewmember pages 39-43).</p>
<p>Conclusion<br />
Human AFAP1 (AFAP‚Äë110; Q8N556) is a modular adaptor that crosslinks actin and directly regulates Src-family kinase signaling through SH3/SH2 interactions and PKC‚Äëdependent conformational control. It localizes to stress fibers and focal adhesions but redistributes to podosomes/invadopodia under PKC/Src activation, and it is essential for spatial c‚ÄëSrc activation in lactating mammary epithelium. New 2023 data place AFAP1 under IRF1/CK2Œ≤ transcriptional and post‚Äëtranslational control with consequences for antiviral responses, extending AFAP1‚Äôs relevance beyond cancer cell motility into innate immunity (qian1999monoclonalantibodiesdirected pages 1-5, xiao2012theactinbindingdomain pages 2-4, cunnick2015actinfilamentassociatedprotein pages 1-3, snyder2011anewmember pages 30-34, matsumoto2023csnk2bmodulatesirf1 pages 1-2).</p>
<p>References</p>
<ol>
<li>
<p>(snyder2011anewmember pages 26-30): Brandi Nicole Snyder. A new member of the afap family, afap1l1, binds to cortactin and localizes to invadosomes. ArXiv, 2011. URL: https://doi.org/10.33915/etd.3379, doi:10.33915/etd.3379. This article has 0 citations.</p>
</li>
<li>
<p>(snyder2011anewmember pages 30-34): Brandi Nicole Snyder. A new member of the afap family, afap1l1, binds to cortactin and localizes to invadosomes. ArXiv, 2011. URL: https://doi.org/10.33915/etd.3379, doi:10.33915/etd.3379. This article has 0 citations.</p>
</li>
<li>
<p>(qian1999monoclonalantibodiesdirected pages 1-5): YONG QIAN, ANNE C. GUAPPONE, JOSEPH M. BAISDEN, M. WYNN HILL, JUSTIN M. SUMMY, and DANIEL C. FLYNN. Monoclonal antibodies directed against afap-110 recognize species-specific and conserved epitopes. Hybridoma, 18 2:167-75, Apr 1999. URL: https://doi.org/10.1089/hyb.1999.18.167, doi:10.1089/hyb.1999.18.167. This article has 16 citations.</p>
</li>
<li>
<p>(xiao2012theactinbindingdomain pages 2-4): Helan Xiao, Bing Han, Monika Lodyga, Xiao-Hui Bai, Yingchun Wang, and Mingyao Liu. The actin-binding domain of actin filament-associated protein (afap) is involved in the regulation of cytoskeletal structure. Cellular and Molecular Life Sciences, 69:1137-1151, Oct 2012. URL: https://doi.org/10.1007/s00018-011-0812-5, doi:10.1007/s00018-011-0812-5. This article has 15 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(rubacha2010xb130insilicob pages 24-28): M Rubacha. Xb130: in silico and invivo studies of a novel signal adaptor protein. Unknown journal, 2010.</p>
</li>
<li>
<p>(cunnick2015actinfilamentassociatedprotein pages 1-3): J. Cunnick, Stephanie Kim, J. Hadsell, S. Collins, C. Cerra, P. Reiser, D. Flynn, and Y. Cho. Actin filament-associated protein 1 is required for csrc activity and secretory activation in the lactating mammary gland. Oncogene, 34:2640-2649, Jul 2015. URL: https://doi.org/10.1038/onc.2014.205, doi:10.1038/onc.2014.205. This article has 16 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(matsumoto2023csnk2bmodulatesirf1 pages 1-2): Moe Matsumoto, Jennifer L Modliszewski, Kotomi Shinozaki, Reona Maezawa, Vincent M Perez, Yuki Ishikawa, Ryosuke Suzuki, Kevin L McKnight, Takahiro Masaki, Asuka Hirai-Yuki, Michinori Kohara, Stanley M Lemon, Sara R Selitsky, and Daisuke Yamane. Csnk2b modulates irf1 binding to functional dna elements and promotes basal and agonist-induced antiviral signaling. Nucleic Acids Research, 51:4451-4466, Apr 2023. URL: https://doi.org/10.1093/nar/gkad298, doi:10.1093/nar/gkad298. This article has 5 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(snyder2011anewmember pages 39-43): Brandi Nicole Snyder. A new member of the afap family, afap1l1, binds to cortactin and localizes to invadosomes. ArXiv, 2011. URL: https://doi.org/10.33915/etd.3379, doi:10.33915/etd.3379. This article has 0 citations.</p>
</li>
<li>
<p>(xiao2012theactinbindingdomain pages 1-2): Helan Xiao, Bing Han, Monika Lodyga, Xiao-Hui Bai, Yingchun Wang, and Mingyao Liu. The actin-binding domain of actin filament-associated protein (afap) is involved in the regulation of cytoskeletal structure. Cellular and Molecular Life Sciences, 69:1137-1151, Oct 2012. URL: https://doi.org/10.1007/s00018-011-0812-5, doi:10.1007/s00018-011-0812-5. This article has 15 citations and is from a domain leading peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>cunnick2015actinfilamentassociatedprotein pages 1-3</li>
<li>xiao2012theactinbindingdomain pages 2-4</li>
<li>xiao2012theactinbindingdomain pages 1-2</li>
<li>qian1999monoclonalantibodiesdirected pages 1-5</li>
<li>snyder2011anewmember pages 26-30</li>
<li>snyder2011anewmember pages 30-34</li>
<li>snyder2011anewmember pages 39-43</li>
<li>https://doi.org/10.33915/etd.3379</li>
<li>https://doi.org/10.1089/hyb.1999.18.167</li>
<li>https://doi.org/10.1007/s00018-011-0812-5</li>
<li>https://doi.org/10.1038/onc.2014.205</li>
<li>https://doi.org/10.1093/nar/gkad298</li>
<li>https://doi.org/10.33915/etd.3379,</li>
<li>https://doi.org/10.1089/hyb.1999.18.167,</li>
<li>https://doi.org/10.1007/s00018-011-0812-5,</li>
<li>https://doi.org/10.1038/onc.2014.205,</li>
<li>https://doi.org/10.1093/nar/gkad298,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AFAP1-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8N556" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: false<br />
start_time: '2025-12-27T15:51:18.013497'<br />
end_time: '2025-12-27T16:00:23.968688'<br />
duration_seconds: 545.96<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AFAP1<br />
  gene_symbol: AFAP1<br />
  uniprot_accession: Q8N556<br />
  protein_description: 'RecName: Full=Actin filament-associated protein 1; AltName:<br />
    Full=110 kDa actin filament-associated protein; Short=AFAP-110;'<br />
  gene_info: Name=AFAP1; Synonyms=AFAP;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849);<br />
    PH (PF00169)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 184</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8N556</li>
<li><strong>Protein Description:</strong> RecName: Full=Actin filament-associated protein 1; AltName: Full=110 kDa actin filament-associated protein; Short=AFAP-110;</li>
<li><strong>Gene Information:</strong> Name=AFAP1; Synonyms=AFAP;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849); PH (PF00169)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AFAP1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AFAP1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AFAP1</strong> (gene ID: AFAP1, UniProt: Q8N556) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="introduction-and-gene-identification">Introduction and Gene Identification</h1>
<p>Actin Filament-Associated Protein 1 (<strong>AFAP1</strong>, a.k.a. AFAP-110) is a human protein encoded by the <em>AFAP1</em> gene (UniProt Q8N556) (<a href="https://www.ncbi.nlm.nih.gov/gene/60312#:~:text=Summary%20The%20protein%20encoded%20by,Expression">www.ncbi.nlm.nih.gov</a>). The gene symbol <em>AFAP1</em> refers specifically to the human <em>actin filament-associated protein 1</em>, not to be confused with similarly named genes or transcripts in other contexts. AFAP1 was originally identified as a 110 kDa protein associated with actin filaments and as a binding partner of the Src family tyrosine kinase (<a href="https://www.nature.com/articles/1204784#:~:text=The%20actin%20filament,an%20intrinsic%20capability%20to%20alter">www.nature.com</a>). It is now recognized as a multi-domain <strong>adaptor protein</strong> that links signaling molecules to the actin cytoskeleton and modulates actin filament organization (<a href="https://www.nature.com/articles/1204784#:~:text=actin%20filament%20integrity%20that%20can,will%20review%20the%20structure%20and">www.nature.com</a>). AFAP1 is expressed in a wide range of human tissues (low tissue specificity) and is localized intracellularly, particularly along actin filaments and at focal adhesion sites (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil">v19.proteinatlas.org</a>). In cell imaging, AFAP1 shows a cytosolic, granular pattern and co-localizes with actin structures including stress fibers and focal adhesions (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil">v19.proteinatlas.org</a>). This widespread expression suggests a general role in cytoskeletal regulation across cell types. Consistent with this, <strong>high AFAP1 levels have been observed in certain cell types (e.g. eosinophils) and tissues</strong>, indicating potential cell-specific functions in the immune and other systems (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,actin%20filaments%20into%20both%20network">v19.proteinatlas.org</a>) (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=%28unfavourable%29%20Brain%20specificity,i%7D%20Intracellular">v19.proteinatlas.org</a>).  </p>
<p><strong>Protein Structure and Domains:</strong> AFAP1 is a modular protein comprising several conserved domains that underpin its function. Notably, AFAP1 contains <strong>two Pleckstrin Homology (PH) domains</strong>, an N-terminal <strong>proline-rich motif</strong> that binds SH3 domains, multiple <strong>SH2-binding motifs</strong> (tyrosine-based motifs that can bind SH2 domains when phosphorylated), a central Serine/Threonine-rich segment (substrate domain) targeted by protein kinase C (PKC), a <strong>leucine zipper</strong> motif, and a C-terminal <strong>actin-binding domain</strong> (<a href="https://www.nature.com/articles/1204784#:~:text=two%20pleckstrin%20homology%20domains%2C%20a,family%20members%20and%2For%20other%20signaling">www.nature.com</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,motifs%20are%20involved%20in%20the">pmc.ncbi.nlm.nih.gov</a>). The two PH domains (often termed PH1 and PH2) suggest the protein can associate with membrane lipids or PH-domain binding proteins, and indeed PH1 at the N-terminus is implicated in binding to PKC and possibly targeting AFAP1 to specific subcellular sites (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the">pmc.ncbi.nlm.nih.gov</a>). The <strong>leucine zipper (LZ)</strong> near the C-terminus mediates AFAP1 <strong>self-multimerization (dimerization/oligomerization)</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor">pmc.ncbi.nlm.nih.gov</a>). This multimerization, together with the actin-binding domains on each AFAP1 molecule, allows AFAP1 to function as an <strong>actin cross-linking protein</strong>, bridging actin filaments into networks or bundles (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=domain%2C%20which%20allows%20the%20formation,5">pmc.ncbi.nlm.nih.gov</a>). Structural studies show that AFAP1‚Äôs LZ-driven multimer can present multiple actin-binding sites, enabling it to organize actin filaments into either loose meshworks or tightly bundled arrays depending on context (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=domain%2C%20which%20allows%20the%20formation,5">pmc.ncbi.nlm.nih.gov</a>). The protein‚Äôs <strong>autoinhibitory interactions</strong> are also tied to its domain structure: in the resting state, an intramolecular contact between the N-terminal PH1 domain and the C-terminal leucine zipper keeps AFAP1 in a closed/inhibited conformation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=www.ncbi.nlm.nih.gov%20%29.%20AFAP,activated%20cSrc%20to%20the%20cell">pmc.ncbi.nlm.nih.gov</a>). This masks its actin-crosslinking and signaling functions until appropriate signals are received. For instance, a specific single-nucleotide polymorphism (S403C) located in the second PH domain disrupts AFAP1‚Äôs normal intramolecular interactions and promotes a more open conformation, as discussed later (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=in%20exon%209%20that%20predicts,110%5E%7B%CE%94Lzip%7D%29%20or%20on%20PKCa">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=intermolecular%20interaction%20between%20the%20carboxy,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16">pmc.ncbi.nlm.nih.gov</a>). In summary, AFAP1‚Äôs domain architecture is central to its function as a regulated adaptor: the PH domains and proline motifs mediate lipid and protein interactions, the leucine zipper and actin-binding domain enable scaffold formation on actin filaments, and multiple phosphorylation sites allow signal-dependent modulation of its activity (<a href="https://www.nature.com/articles/1204784#:~:text=two%20pleckstrin%20homology%20domains%2C%20a,family%20members%20and%2For%20other%20signaling">www.nature.com</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor">pmc.ncbi.nlm.nih.gov</a>).  </p>
<h1 id="actin-binding-and-cytoskeletal-modulation">Actin Binding and Cytoskeletal Modulation</h1>
<p>AFAP1 is classified functionally as an <strong>actin-binding and cross-linking protein</strong> that can directly bind filamentous actin (F-actin) and influence the architecture of the actin cytoskeleton (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor">pmc.ncbi.nlm.nih.gov</a>). The C-terminal ~100 amino acids of AFAP1 constitute a defined actin-binding domain that attaches to actin filaments (<a href="https://www.nature.com/articles/1204784#:~:text=two%20pleckstrin%20homology%20domains%2C%20a,family%20members%20and%2For%20other%20signaling">www.nature.com</a>). Through its leucine zipper-driven self-association, AFAP1 can form dimers or higher-order oligomers, effectively <strong>linking actin filaments to each other</strong>. Biochemical and cell-based assays have shown that AFAP1 can organize actin filaments into different configurations: at lower concentrations or specific phosphorylation states it tends to induce <strong>looser networks</strong>, whereas under other conditions it promotes <strong>tight filament bundles</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=domain%2C%20which%20allows%20the%20formation,5">pmc.ncbi.nlm.nih.gov</a>). This dynamic reflects AFAP1‚Äôs role as a cytoskeletal modulator ‚Äì it is not a passive structural component, but rather an active organizer of actin filament integrity. Indeed, <strong>AFAP1 can both stabilize and remodel actin structures</strong> in response to signals. For example, <em>in vitro</em> experiments demonstrated that AFAP1 can cross-link actin filaments, and that this activity is <strong>enhanced by PKC-mediated phosphorylation</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>). <strong>Protein kinase C (PKC)</strong> phosphorylates AFAP1 on its serine/threonine-rich region, and this has been shown to <strong>increase AFAP1‚Äôs actin-bundling ability</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the">pmc.ncbi.nlm.nih.gov</a>). Mechanistically, PKC phosphorylation is thought to relieve AFAP1‚Äôs autoinhibition (possibly by disrupting the PH1‚Äìleucine zipper intramolecular clamp), allowing AFAP1 to multimerize and bind actin more effectively (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=www.ncbi.nlm.nih.gov%20%29.%20AFAP,activated%20cSrc%20to%20the%20cell">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the">pmc.ncbi.nlm.nih.gov</a>). A 2002 cell biology study reported that PKC-dependent phosphorylation of AFAP1 significantly boosted its capacity to cross-link actin filaments, correlating with the formation of robust actin structures in cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>).  </p>
<p>Importantly, AFAP1‚Äôs actin-modulating function is <strong>not constitutive</strong> but is regulated by upstream signals and possibly by its own conformational state. Under basal conditions, AFAP1 appears to contribute to maintaining actin cytoskeletal support structures such as <strong>stress fibers</strong>. In highly motile breast cancer cells (MDA-MB-231), for instance, AFAP1 is required for normal stress fiber formation and actin filament cross-linking (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=AFAP,Although">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=changes%20in%20cell%20proliferation%20but,components%20were%20not%20influenced%20by">www.scholars.northwestern.edu</a>). <em>Knockdown of AFAP1</em> in these cells led to a <strong>loss of actin stress fibers</strong> and reduced actin filament cross-linking, indicating that AFAP1 is necessary to generate the tension-bearing bundled actin architecture (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=AFAP,Although">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>). Without AFAP1, the cells also showed <strong>decreased adhesion</strong> to the extracellular matrix (fibronectin) and an inability to form mature focal adhesions (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>). Conversely, in the presence of AFAP1, cells can form robust stress fibers that transmit contractile forces to focal adhesions, promoting strong adhesion to the substrate (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>). Researchers concluded that AFAP1 helps provide <strong>cytoskeletal tension</strong> through cross-linked stress fibers, which is required to stabilize focal adhesion complexes (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>). This explains why AFAP1-deficient cells failed to assemble focal adhesions despite normal levels of integrins and other adhesion proteins ‚Äì the actin framework needed to cluster and reinforce those adhesions was missing (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=adhesions%20in%20AFAP,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>).  </p>
<p>In addition to supporting stable actin bundles, AFAP1 is also involved in the formation of <strong>dynamic actin structures</strong> like lamellipodia and podosomes under the right conditions. Studies have shown that upon certain stimuli, AFAP1 can induce <strong>actin reorganization into punctate, actin-rich structures called podosomes (or invadopodia in cancer cells)</strong> (<a href="https://www.nature.com/articles/onc2014205#:~:text=binds%20to%20filamentous%20actin%20and,the%20lactating%20knockout%20mice%20were">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=prostate%20cancer%20cells%2C%20AFAP1%20has,in%20lipid%20synthesis%20and%20the">www.nature.com</a>). Podosomes are adhesive, actin-core structures associated with extracellular matrix degradation and cell invasion. In vascular smooth muscle cells and other cell models, activation of PKC (for example by phorbol esters) triggers rapid podosome formation, a process in which AFAP1 is a critical mediator (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,doi">pmc.ncbi.nlm.nih.gov</a>). AFAP1 responds to PKC signals by altering actin filament integrity ‚Äì essentially breaking down parts of stress fibers and repurposing actin into podosome cores (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=%5B12%2C13%20%5D.%20In%20addition%2C%20AFAP,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=intermolecular%20interaction%20between%20the%20carboxy,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16">pmc.ncbi.nlm.nih.gov</a>). A 2004 molecular biology study by Gatesman <em>et al.</em> demonstrated that <strong>PKCŒ± activates c-Src and induces podosome formation via AFAP-110</strong> (AFAP1) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>). In that pathway, AFAP1 serves as a hub where PKC signals converge to locally rearrange actin and activate Src (discussed below). Notably, <strong>phosphorylation of AFAP1</strong> has been shown to affect <strong>podosome dynamics</strong> ‚Äì one report found that specific phosphorylation sites on AFAP1 control the <em>lifespan</em> of podosomes, influencing how long these structures persist in cells (<a href="https://www.nature.com/articles/onc2014205#:~:text=ability%20to%20alter%20actin%20filament,Cell%20Res%202000%3B%20255%3A%20102%E2%80%93113">www.nature.com</a>). Thus, AFAP1 is instrumental in the <em>formation</em> and <em>regulation</em> of specialized invasive actin structures. Moreover, AFAP1 can also promote <strong>lamellipodia formation</strong> (broad, sheet-like actin protrusions) when its conformation is altered. Early experiments noted that certain mutations or C-terminal truncations of AFAP1 unleashed its ability to induce lamellipodia and membrane ruffles (<a href="https://www.nature.com/articles/onc2014205#:~:text=motif,110%E2%80%93119">www.nature.com</a>). In summary, AFAP1 acts as an actin cytoskeletal regulator with a dual nature ‚Äì it can stabilize actin filament bundles to support adhesion, or it can facilitate actin remodeling into structures that drive cell migration and invasion, depending on the signaling context (<a href="https://www.nature.com/articles/1204784#:~:text=as%20an%20adaptor%20protein%20by,to%20cellular%20signals%20that%20alter">www.nature.com</a>) (<a href="https://www.nature.com/articles/1204784#:~:text=actin%20filament%20integrity%20that%20can,will%20review%20the%20structure%20and">www.nature.com</a>). </p>
<h1 id="adaptor-role-in-src-signaling">Adaptor Role in Src Signaling</h1>
<p>One of AFAP1‚Äôs defining functions is serving as an <strong>adaptor protein linking signaling molecules (especially Src-family tyrosine kinases) to the actin cytoskeleton</strong> (<a href="https://www.ncbi.nlm.nih.gov/gene/60312#:~:text=Summary%20The%20protein%20encoded%20by,Expression">www.ncbi.nlm.nih.gov</a>) (<a href="https://www.nature.com/articles/1204784#:~:text=as%20an%20adaptor%20protein%20by,to%20cellular%20signals%20that%20alter">www.nature.com</a>). AFAP1 was first discovered as a binding partner and substrate of the viral Src oncoprotein (v-Src) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=The%20actin%20filament%E2%80%93associated%20protein%20of,binding">pmc.ncbi.nlm.nih.gov</a>), and later work confirmed it binds the cellular Src (c-Src) and related Src-family kinases. AFAP1 contains an <strong>SH3-binding motif (PXXP)</strong> near its N-terminus that can directly bind the SH3 domain of Src (<a href="https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=AFAP1L1%20is%20hypothesized%20to%20have,move%20to%20podosomes%20without%20stimulation">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=tyrosine%20kinase%20cSrc%20via%20an,in%20human%20tissues%20shows%20differential">pubmed.ncbi.nlm.nih.gov</a>). This interaction tethers Src in proximity to actin filaments. AFAP1 also has multiple <strong>tyrosine residues</strong> that, when phosphorylated (for instance by Src itself), create <strong>SH2-binding sites</strong>. This means AFAP1 can form a tight complex with Src by engaging both the SH3 and SH2 domains of Src (the latter upon AFAP1‚Äôs phosphorylation) (<a href="https://www.nature.com/articles/onc2014205#:~:text=4,Cell%20Biochem%201997%3B%20175%3A%20243%E2%80%93252">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=5,Mol%20Carcinogen%201998%3B%2022%3A%20110%E2%80%93119">www.nature.com</a>). Indeed, mutational studies showed that disrupting AFAP1‚Äôs SH3-binding proline motif abrogates its association with Src (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,domains%20may%20potentially%20direct%20the">pmc.ncbi.nlm.nih.gov</a>), and conversely, phosphorylation at certain YXXP motifs stabilizes the Src‚ÄìAFAP1 complex (<a href="https://www.nature.com/articles/onc2014205#:~:text=4,Cell%20Biochem%201997%3B%20175%3A%20243%E2%80%93252">www.nature.com</a>). Through these interactions, AFAP1 acts as a <strong>scaffold that recruits Src to actin filaments and focal adhesion sites</strong>. Functionally, this scaffolding is significant because c-Src‚Äôs activity and localization need tight regulation ‚Äì c-Src in solution is auto-inhibited, but when brought to specific sites (e.g. the cell membrane or adhesions) and released from autoinhibition, it can phosphorylate targets to drive signaling pathways (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Enhanced%20expression%20and%20activity%20of,presence%20of%20a%20nonsynonymous%2C%20single">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast">pmc.ncbi.nlm.nih.gov</a>). AFAP1 has emerged as a key ‚ÄúSrc-activating protein‚Äù that can trigger c-Src‚Äôs kinase activity in response to upstream signals (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast">pmc.ncbi.nlm.nih.gov</a>). </p>
<p><strong>Activation of Src:</strong> Normally, c-Src is kept in a closed, inactive conformation. AFAP1 can <strong>promote Src activation by inducing a conformational change</strong> that ‚Äúfrees‚Äù Src from its autoinhibited state (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast">pmc.ncbi.nlm.nih.gov</a>). In cells stimulated with PKC or growth factors, AFAP1 is believed to undergo a conformational opening (as described earlier) and multimerize, which not only enhances actin binding but also allows AFAP1‚Äôs Src-binding motifs to engage Src more effectively (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=www.ncbi.nlm.nih.gov%20%29.%20AFAP,activated%20cSrc%20to%20the%20cell">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=intermolecular%20interaction%20between%20the%20carboxy,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16">pmc.ncbi.nlm.nih.gov</a>). By binding Src‚Äôs SH3 domain, AFAP1 competes with Src‚Äôs own intramolecular SH3‚Äìlinker interaction, and thus <strong>disrupts Src‚Äôs autoinhibition</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=activates%20cSrc%20through%20a%20direct,that%2C%20under%20conditions%20of%20cSrc">pmc.ncbi.nlm.nih.gov</a>). Once Src is docked on AFAP1 and released, it may phosphorylate AFAP1 further (creating SH2 docking sites), leading to a stable Src‚ÄìAFAP1 complex (<a href="https://www.nature.com/articles/onc2014205#:~:text=4,Cell%20Biochem%201997%3B%20175%3A%20243%E2%80%93252">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=5,Mol%20Carcinogen%201998%3B%2022%3A%20110%E2%80%93119">www.nature.com</a>). Crucially, <strong>AFAP1-mediated Src activation has been observed in several experimental systems</strong>. For example, Clump <em>et al.</em> (2010) found that an inherited variant of AFAP1 (Ser403Cys) caused <strong>constitutive Src activation</strong> in cells with high Src levels (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the">pmc.ncbi.nlm.nih.gov</a>). The variant AFAP1^403C could drive Src to form active signaling structures (podosomes) <strong>without any external PKC signal</strong>, whereas wild-type AFAP1 required upstream signals to do so (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20express%20enhanced%20levels%20of,110%20promotes%20cSrc%20activation">pmc.ncbi.nlm.nih.gov</a>). This underscores AFAP1‚Äôs normal role as a signal-responsive Src activator. Under physiological conditions, <strong>PKCŒ± is a major upstream signal that works through AFAP1 to activate Src</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by">pmc.ncbi.nlm.nih.gov</a>). PKC can bind AFAP1 (via the PH1 domain) and phosphorylate it (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the">pmc.ncbi.nlm.nih.gov</a>). Activated PKCŒ± was shown to trigger c-Src activation and downstream podosome formation <em>via</em> AFAP1, meaning if AFAP1 is absent or mutated, PKC fails to fully activate Src (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>). Additional signaling crosstalk is involved as well ‚Äì <strong>PI3K activity is required</strong> for PKC/Afap1 to activate Src, hinting that lipid products (e.g. PIP‚ÇÉ) or PI3K-dependent proteins (like RACK1) cooperate in this pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=doi%3A%2010.1091%2Fmbc.E01,Monoclonal">pmc.ncbi.nlm.nih.gov</a>). AFAP1‚Äôs PH domains may bind phosphoinositides at the membrane or partner with <strong>RACK1</strong> (Receptor for Activated C Kinase, a WD40-repeat scaffolding protein) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=association%20of%20AFAP,in%20regulating%20multiple%20cellular%20processes">pmc.ncbi.nlm.nih.gov</a>). In fact, it‚Äôs suggested that AFAP1‚Äôs PH domains help localize the PKC‚ÄìAFAP‚ÄìSrc complex to membrane or adhesion sites, where RACK1 and lipids provide a platform (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=association%20of%20AFAP,in%20regulating%20multiple%20cellular%20processes">pmc.ncbi.nlm.nih.gov</a>). Through such mechanisms, AFAP1 positions active Src in specific subcellular locales (such as focal adhesions, membrane ruffles, or podosomes) to phosphorylate target proteins and propagate signals (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=%288%20%29.%20Both%20amino,based%20structures">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1">www.nature.com</a>). </p>
<p><strong>Biological Signaling Pathways:</strong> By linking Src to actin, AFAP1 influences multiple <strong>signal transduction pathways</strong> related to cytoskeletal dynamics and cell adhesion. Once activated by AFAP1, Src kinase can phosphorylate focal adhesion components (e.g. FAK, paxillin) and actin regulators, leading to changes in cell migration and adhesion signaling. AFAP1 thereby affects <strong>cell‚ÄìECM interaction pathways</strong>: if actin filaments are not properly organized (as in AFAP1 knockdown), focal adhesion signaling (integrin/Src/FAK signaling) is impaired (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently">pmc.ncbi.nlm.nih.gov</a>). In contrast, AFAP1‚Äôs ability to recruit Src to adhesion sites can enhance integrin-mediated signaling and focal contact turnover, facilitating dynamic movement. It is notable that AFAP1 can serve as a platform for <strong>‚Äúlarger signaling complexes‚Äù</strong> (<a href="https://www.nature.com/articles/1204784#:~:text=AFAP,to%20alter%20actin%20filament%20integrity">www.nature.com</a>) ‚Äì for example, an AFAP1 multimer might bring together Src, PKC, and actin filaments all in one locale, allowing crosstalk between tyrosine kinase and PKC pathways. AFAP1 has also been reported to bind other signaling or structural proteins: while AFAP1 itself does <em>not</em> efficiently bind cortactin (another actin-binding scaffold) (<a href="https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=AFAP1L1%20is%20hypothesized%20to%20have,move%20to%20podosomes%20without%20stimulation">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=tyrosine%20kinase%20cSrc%20via%20an,in%20human%20tissues%20shows%20differential">pubmed.ncbi.nlm.nih.gov</a>), its homologs do, indicating AFAP1‚Äôs binding specificity. Instead, AFAP1‚Äôs interactions seem tuned to kinases and membrane/linker proteins. In one study, AFAP1 was found to associate with <strong>p85 PI3K</strong> and facilitate localized PI3K activation in response to phorbol ester, further tying AFAP1 to the PI3K‚ÄìAkt pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=doi%3A%2010.1091%2Fmbc.E01,Monoclonal">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,Google%20Scholar">pmc.ncbi.nlm.nih.gov</a>). Another study in breast cancer cells linked AFAP1 to <strong>NF-Œ∫B signaling</strong>: low molecular weight hyaluronan signals through CD44 and Toll-like receptors led to AFAP1‚Äìactin binding and an increase in MyD88-dependent NF-Œ∫B activation (<a href="https://www.nature.com/articles/onc2014205#:~:text=regulating%20focal%20contacts,Invest%202007%3B%20117%3A%202962%E2%80%932973">www.nature.com</a>). This suggests that AFAP1‚Äôs actin linkage can influence inflammatory signaling cascades in certain contexts. In summary, <strong>AFAP1 functions as a bridge between extracellular signals and the actin cytoskeleton</strong>, ensuring that enzymes like Src and PKC are activated at the right place and time to remodel the cytoskeleton. As an expert review summarized, AFAP1 acts as an adaptor that <strong>‚Äúbrings signaling molecules to specialized signaling complexes and/or subcellular compartments, affecting the location and crosstalk between these molecules‚Äù</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=%288%20%29.%20Both%20amino,based%20structures">pmc.ncbi.nlm.nih.gov</a>). Through this role, AFAP1 is involved in coordinating processes such as cell adhesion, migration, and invasion that require integration of signaling and cytoskeletal rearrangement (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently">pmc.ncbi.nlm.nih.gov</a>). </p>
<h1 id="cellular-localization-and-function-in-context">Cellular Localization and Function in Context</h1>
<p>Consistent with its actin-related functions, AFAP1 is predominantly an <strong>intracellular, cytoskeletal protein</strong>. High-resolution imaging and fractionation studies place AFAP1 in the <strong>cytosol and along actin filaments</strong>, with enrichment at sites of actin assembly (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil">v19.proteinatlas.org</a>). The Human Protein Atlas indicates AFAP1 is localized to <strong>actin filament bundles and focal adhesions</strong> in cultured human cells (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil">v19.proteinatlas.org</a>) (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Subcellular%20location,actin%20filaments%20into%20both%20network">v19.proteinatlas.org</a>). It is not a secreted protein, nor is it typically found in the nucleus; rather, it concentrates wherever actin structures and signaling molecules converge. For example, in adherent cells AFAP1 can be seen at the termini of stress fibers where they insert into focal adhesions, consistent with its role in those structures (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Subcellular%20location,actin%20filaments%20into%20both%20network">v19.proteinatlas.org</a>). During active cell motility, a portion of AFAP1 also redistributes to the cell periphery, colocalizing with actin in <strong>lamellipodia</strong> or forming <strong>punctate spots</strong> at invadopodia/podosomes when those are induced (<a href="https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=interacting%20with%20the%20SH3%20domain,brain%20where%20AFAP1%20was%20not">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=structures%20and%20colocalize%20with%20cortactin%2C,unique%20protein%20interactions%20in%20which">pubmed.ncbi.nlm.nih.gov</a>). Studies in smooth muscle cells and macrophages have visualized AFAP1 at podosome rings and cores, where it likely helps anchor the podosome‚Äôs actin bundle and connect to signaling molecules like Src (<a href="https://www.nature.com/articles/onc2014205#:~:text=binds%20to%20filamentous%20actin%20and,the%20lactating%20knockout%20mice%20were">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=prostate%20cancer%20cells%2C%20AFAP1%20has,in%20lipid%20synthesis%20and%20the">www.nature.com</a>). The <strong>subcellular targeting</strong> of AFAP1 is at least partly directed by its PH domains binding membrane phosphoinositides, which would recruit AFAP1 to the inner plasma membrane where actin polymerization is occurring (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=association%20of%20AFAP,in%20regulating%20multiple%20cellular%20processes">pmc.ncbi.nlm.nih.gov</a>). Additionally, the ability of AFAP1 to bind PKC via the PH1 domain can localize PKC (and AFAP1 with it) to specific compartments, such as the cell cortex or periphery, upon PKC activation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the">pmc.ncbi.nlm.nih.gov</a>). In the unique context of differentiated cells, AFAP1‚Äôs localization hints at specialized roles ‚Äì for instance, in lactating mammary epithelial cells (discussed below), AFAP1 was found to concentrate at the <strong>apical surface</strong> of milk-secreting alveolar cells in complex with active Src (<a href="https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,in%20the%20absence%20of%20AFAP1">www.nature.com</a>). This apical localization suggests AFAP1 can target Src to specific membrane domains (apical vs. basal) to regulate polarized cellular functions.  </p>
<p>Functionally, AFAP1‚Äôs presence in these locations translates to roles in several <strong>biological processes</strong>:<br />
- <strong>Cell Adhesion:</strong> By fortifying actin stress fibers and focal adhesions, AFAP1 promotes strong cell‚Äìmatrix adhesion. Loss of AFAP1 leads to defective focal contacts and reduced adhesion strength (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>). AFAP1 thereby contributes to processes like cell spreading and mechanotransduction (sensing forces through focal adhesions).<br />
- <strong>Cell Migration and Invasion:</strong> AFAP1 facilitates the dynamic rearrangement of the actin cytoskeleton needed for cell motility. It enables the formation of lamellipodia for migration and podosomes/invadopodia for invasive behavior (<a href="https://www.nature.com/articles/onc2014205#:~:text=binds%20to%20filamentous%20actin%20and,the%20lactating%20knockout%20mice%20were">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=prostate%20cancer%20cells%2C%20AFAP1%20has,in%20lipid%20synthesis%20and%20the">www.nature.com</a>). In invasive cancer cells, AFAP1-driven actin changes can enhance cell migration through tissues.<br />
- <strong>Signal Transduction:</strong> AFAP1‚Äôs scaffolding of Src and possibly other kinases means it helps propagate signals from integrins, growth factor receptors, and chemoattractant pathways to downstream effects like actin remodeling. It is involved in signaling cascades like Src‚ÄìFAK (affecting cell movement and survival) and PKC‚ÄìMAPK pathways (affecting proliferation and differentiation in some contexts) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently">pmc.ncbi.nlm.nih.gov</a>).<br />
- <strong>Secretory and Specialized Cellular Functions:</strong> Recent evidence suggests AFAP1 has roles in specialized cell functions that require actin remodeling. One notable example is in <strong>lactation</strong>: using an AFAP1 knockout mouse model, Ammer <em>et al.</em> (2014) showed that AFAP1 is required for proper milk secretion in the lactating mammary gland (<a href="https://www.nature.com/articles/onc2014205#:~:text=Actin%20filament,an%20inability%20to%20nurse%20efficiently">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1">www.nature.com</a>). AFAP1-null female mice had impaired lactation characterized by accumulation of large intracellular lipid droplets and delayed secretion of milk lipids (<a href="https://www.nature.com/articles/onc2014205#:~:text=this%20study%2C%20we%20generated%20an,This">www.nature.com</a>). The underlying defect was tied to <strong>misregulation of c-Src</strong> ‚Äì in normal lactation, prolactin hormone triggers AFAP1 to form a complex with c-Src (leading to AFAP1‚Äôs phosphorylation) and helps localize active Src to the apical side of mammary epithelial cells (<a href="https://www.nature.com/articles/onc2014205#:~:text=production%20of%20%CE%B2,the%20apical%20surface%20of%20luminal">www.nature.com</a>). In the absence of AFAP1, active Src failed to localize apically and overall Src kinase activity in mammary tissue was reduced, resulting in improper signaling for milk lipid extrusion (<a href="https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,the%20normal%20breast%2C%20specifically%20for">www.nature.com</a>). This was the first evidence of AFAP1 in a normal physiological process, and it <strong>‚Äúdefined the requirement of AFAP1 for the spatial and temporal regulation of c-Src activity in the normal breast, specifically for milk production‚Äù (<a href="https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,breast%2C%20specifically%20for%20milk%20production">www.nature.com</a>)</strong>. Thus, AFAP1 can be crucial in contexts where actin-based secretion or cell shape changes are needed for function (another speculative example might be in <em>immune cells</em>: the Protein Atlas notes AFAP1 is elevated in eosinophils (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,actin%20filaments%20into%20both%20network">v19.proteinatlas.org</a>), which undergo actin-dependent degranulation and migration; it‚Äôs plausible AFAP1 contributes to those processes, though this remains to be studied).  </p>
<p>In summary, at the cellular level AFAP1 acts at the interface of signaling and the cytoskeleton to influence a wide range of processes ‚Äì from maintaining structural adhesion to enabling rapid actin reorganization for movement or secretion. By partitioning active kinases to specific sites, AFAP1 ensures that cells can swiftly reorganize their cytoskeleton in response to internal or external cues. </p>
<h1 id="afap1-in-disease-and-clinical-contexts">AFAP1 in Disease and Clinical Contexts</h1>
<p>Given AFAP1‚Äôs central role in actin dynamics and Src signaling, it is perhaps not surprising that <strong>dysregulation of AFAP1 has been linked to cancer and other diseases</strong>. Many cancers exhibit aberrant activation of Src family kinases and cytoskeletal alterations that promote metastasis. AFAP1, as an upstream activator and scaffold of Src, often mirrors these oncogenic changes. <strong>Overexpression of AFAP1</strong> has been observed in multiple tumor types, and it generally correlates with more aggressive disease. For example, in normal prostate epithelial cells, AFAP1 is either absent or expressed at very low levels, but in prostate carcinoma AFAP1 is significantly upregulated ‚Äì with higher levels in tumors corresponding to higher Gleason grades (more advanced/aggressive cancers) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=affects%20crosstalk%20between%20Src%20and,110%20resulted%20in%20decreased%20cell">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=prostatic%20hyperplasia%20but%20significantly%20increased,However%2C%20expression%20of%20an">pmc.ncbi.nlm.nih.gov</a>). A 2007 study by Zhang <em>et al.</em> found AFAP1 protein was <strong>barely detectable in benign prostate tissue</strong> but was elevated in a majority of prostate cancer specimens; the increase in AFAP1 expression tracked with tumor progression (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=affects%20crosstalk%20between%20Src%20and,110%20resulted%20in%20decreased%20cell">pmc.ncbi.nlm.nih.gov</a>). Functionally, this overexpression appears to enhance tumor cell survival and invasion: knocking down AFAP1 in prostate cancer cell lines (such as PC3) led to <strong>decreased cell proliferation, impaired cell-matrix adhesion, and reduced migration</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Downregulation%20of%20AFAP,critical%20for%20tumorigenic%20growth%2C%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=models.%20Furthermore%2C%20downmodulation%20of%20AFAP,dependent%20mechanism">pmc.ncbi.nlm.nih.gov</a>). In mouse models of prostate cancer, AFAP1 depletion significantly <strong>inhibited tumor growth</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=prostatic%20hyperplasia%20but%20significantly%20increased,However%2C%20expression%20of%20an">pmc.ncbi.nlm.nih.gov</a>). Notably, AFAP1-depleted prostate cancer cells showed <em>defective focal adhesions and lower Œ≤1-integrin levels</em>, consistent with the idea that AFAP1 is needed for maintaining focal contacts that allow tumor cells to adhere and signal for growth (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Downregulation%20of%20AFAP,critical%20for%20tumorigenic%20growth%2C%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=models.%20Furthermore%2C%20downmodulation%20of%20AFAP,dependent%20mechanism">pmc.ncbi.nlm.nih.gov</a>). The same study demonstrated that re-introducing wild-type AFAP1 could rescue the aggressive traits of these cells, whereas a mutant AFAP1 unable to bind Src failed to do so (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=integrin%20%CE%B21%20expression,dependent%20mechanism">pmc.ncbi.nlm.nih.gov</a>). Furthermore, an AFAP1 mutant lacking the PKC-interaction domain also did not restore the invasive properties, implying that both Src and PKC interactions are critical for AFAP1‚Äôs pro-tumor function in this context (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=integrin%20%CE%B21%20expression,dependent%20mechanism">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,dependent%20mechanism">pmc.ncbi.nlm.nih.gov</a>). The authors concluded that AFAP1 contributes to prostate cancer progression by regulating focal contacts in a PKC-dependent manner (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=integrin%20%CE%B21%20expression,dependent%20mechanism">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,dependent%20mechanism">pmc.ncbi.nlm.nih.gov</a>).  </p>
<p>In invasive <strong>breast cancer</strong> cells (MDA-MB-231), as mentioned earlier, AFAP1 is required for stress fibers and adhesion, which might seem counterintuitive (as one might expect a metastatic cell to have fewer stress fibers). However, the ability to dynamically assemble or disassemble adhesions is key for invasion. AFAP1 provides the means to form focal adhesions (for traction) and, when signals demand, to break them down in favor of podosomes or invadopodia for matrix degradation (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion">www.scholars.northwestern.edu</a>) (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation">www.scholars.northwestern.edu</a>). Indeed, AFAP1 has been implicated in <strong>invadopodia formation and function</strong> in cancer cells. It co-localizes with actin and signaling proteins in these structures and affects their lifespan (<a href="https://www.nature.com/articles/onc2014205#:~:text=ability%20to%20alter%20actin%20filament,Cell%20Res%202000%3B%20255%3A%20102%E2%80%93113">www.nature.com</a>). <em>In vitro</em> assays of invasive behavior often show that reducing AFAP1 levels impairs a cancer cell‚Äôs ability to degrade extracellular matrix, consistent with fewer or less stable invadopodia (<a href="https://www.nature.com/articles/onc2014205#:~:text=ability%20to%20alter%20actin%20filament,Cell%20Res%202000%3B%20255%3A%20102%E2%80%93113">www.nature.com</a>). Moreover, <strong>AFAP1 interplay with integrin/Src signaling</strong> can influence epithelial‚Äìmesenchymal transition (EMT) and cell morphology in tumors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently">pmc.ncbi.nlm.nih.gov</a>). Considering these roles, it‚Äôs not surprising that <strong>high AFAP1 expression has prognostic significance</strong> in some cancers. Data from large patient cohorts (e.g. via The Human Protein Atlas) indicate that AFAP1 mRNA levels serve as an unfavorable prognostic marker in lung cancer and renal cancer, where higher expression is associated with poorer survival (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Subcellular%20location,actin%20filaments%20into%20both%20network">v19.proteinatlas.org</a>) (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,Low%20human%20brain%20regional%20specificity">v19.proteinatlas.org</a>). This suggests AFAP1 could be used as part of a prognostic panel, although it‚Äôs not yet a routine clinical marker.  </p>
<p>Another line of evidence linking AFAP1 to cancer is its coordination with Src. Src is frequently activated in cancers (but rarely mutated); instead, it‚Äôs hyper-activated by upstream signals. AFAP1 is one such upstream activator. In <strong>ovarian cancer</strong>, which often shows elevated Src activity, researchers found that AFAP1 is concomitantly upregulated. In an analysis of patient samples, over <strong>90% of ovarian tumors</strong> showed increased AFAP1 expression alongside c-Src hyperactivity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=activates%20cSrc%20through%20a%20direct,that%2C%20under%20conditions%20of%20cSrc">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,of%20input%20signals%2C%20in%20contrast">pmc.ncbi.nlm.nih.gov</a>). Furthermore, as mentioned, a significant fraction (~25%) of individuals carry a germline <strong>S403C variant in AFAP1</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,be%20used%20to%20predict%20the">pmc.ncbi.nlm.nih.gov</a>). While this variant alone is not a cancer-causing mutation, in the context of a tumor with high Src levels it can act as a ‚Äúmodifier‚Äù: Clump <em>et al.</em> (2010) reported that ovarian cancer cells with the AFAP1^403C variant <strong>activated Src and formed podosomes <em>without</em></strong> the usual external PKC signal (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20express%20enhanced%20levels%20of,110%20promotes%20cSrc%20activation">pmc.ncbi.nlm.nih.gov</a>). This means the variant AFAP1 can predispose cells to a pro-invasive, Src-active state more readily. The study proposed that this inherited variant could <strong>influence cancer progression</strong> in patients and might serve as a biomarker to predict who will respond to Src-inhibitor drugs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,the%20response%20to%20targeted%20therapy">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=overexpression%2C%20the%20polymorphic%20variant%20of,the%20response%20to%20targeted%20therapy">pmc.ncbi.nlm.nih.gov</a>). In the era of precision medicine, such biomarkers are valuable; for instance, if a patient‚Äôs tumor both overexpresses Src and harbors AFAP1^403C, that tumor might be particularly dependent on the Src‚ÄìAFAP1 axis and thus more sensitive to Src kinase inhibitors. This is an active area of investigation, although no specific anti-AFAP1 therapies exist yet.  </p>
<p>Beyond cancer, AFAP1‚Äôs actin-regulatory function could be relevant to other pathologies. There is emerging interest in AFAP1‚Äôs gene locus in cardiovascular and fibrotic diseases, since actin and Src signaling modulate smooth muscle contraction and fibroblast activation. While direct studies are limited, it‚Äôs noteworthy that some <strong>omics screens</strong> have picked up dysregulation of <em>AFAP1</em> or its antisense transcript in conditions like atherosclerosis and tissue fibrosis (<a href="https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=Roles%20of%20AFAP1,and%20Urogenital%20System">synapse.patsnap.com</a>). However, the clearest non-cancer role identified so far remains the lactation defect in AFAP1-knockout mice, illustrating that AFAP1 may be critical in any process requiring coordinated Src signaling and actin rearrangement (e.g. regulated secretion, immune cell activation, wound healing).  </p>
<h1 id="recent-developments-20232024-and-future-directions">Recent Developments (2023‚Äì2024) and Future Directions</h1>
<p>Research on AFAP1 continues to evolve, with recent studies (2021‚Äì2024) expanding our understanding of how this protein is regulated and how it impacts disease. One notable development is the recognition of <strong>AFAP1-AS1</strong>, a long non-coding RNA transcribed from the <em>AFAP1</em> gene locus, which does not code for the AFAP1 protein but can influence its expression. AFAP1-AS1 has gained attention as an oncogenic lncRNA in a variety of cancers and serves as an example of how AFAP1 is embedded in a larger regulatory network. <strong>AFAP1-AS1 is frequently overexpressed in tumors</strong> (including lung, breast, gastric, and others), and high AFAP1-AS1 levels correlate with enhanced migration, invasion, and poor prognosis (<a href="https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Results%3A%20qPCR%20results%20showed%20that,Luciferase%20reporter%20gene">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Moreover%2C%20miR,including%20proliferation%2C%20migration%20and%20invasion">pubmed.ncbi.nlm.nih.gov</a>). Mechanistic studies in 2021 demonstrated that AFAP1-AS1 can act as a competing endogenous RNA (ceRNA) ‚Äì specifically, it sponges microRNAs such as <strong>miR-205-5p</strong> that would otherwise suppress AFAP1 expression (<a href="https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=differentiation%20%28p%3D0,including%20proliferation%2C%20migration%20and%20invasion">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Moreover%2C%20miR,including%20proliferation%2C%20migration%20and%20invasion">pubmed.ncbi.nlm.nih.gov</a>). In gastric cancer cells, silencing AFAP1-AS1 led to lowered AFAP1 protein levels and a marked decrease in cell proliferation and invasiveness, effects that could be reversed by modulating miR-205 and AFAP1 (<a href="https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Results%3A%20qPCR%20results%20showed%20that,5p">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Moreover%2C%20miR,including%20proliferation%2C%20migration%20and%20invasion">pubmed.ncbi.nlm.nih.gov</a>). This suggests that a significant part of AFAP1-AS1‚Äôs pro-tumor activity is due to upregulation of the AFAP1 protein. Consequently, AFAP1-AS1 and its controlled network (AFAP1-AS1/miR-205/AFAP1) have been proposed as therapeutic targets or biomarkers. In 2024, a comprehensive review in <em>Current Pharmaceutical Design</em> highlighted <strong>AFAP1-AS1‚Äôs role across gynecologic and urogenital cancers</strong> (<a href="https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=01%20Mar%202024Current%20pharmaceutical%20design">synapse.patsnap.com</a>), underscoring that therapies aiming to inhibit this lncRNA might indirectly curb AFAP1-driven pathways in cancer cells.  </p>
<p>Another recent research avenue involves <strong>extracellular vesicles and circular RNAs</strong> affecting AFAP1. A 2024 study reported that an exosomal circular RNA derived from human mesenchymal stem cells can suppress cholangiocarcinoma progression by modulating a microRNA that targets <em>AFAP1</em> (<a href="https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=Roles%20of%20AFAP1,and%20Urogenital%20System">synapse.patsnap.com</a>). In that study, the exosomal circRNA acted as a sponge for <strong>miR-620</strong>, relieving miR-620‚Äôs inhibition of AFAP1, thereby altering the behavior of cholangiocarcinoma cells (<a href="https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=Roles%20of%20AFAP1,and%20Urogenital%20System">synapse.patsnap.com</a>). Interestingly, in this particular context, increasing AFAP1 was associated with <strong>inhibition</strong> of tumor progression, which hints at cell-type specific roles or a complex interplay (it's possible that in cholangiocarcinoma stroma or specific subtypes, AFAP1 might exert different effects, or that the circRNA has additional targets). Nonetheless, it illustrates the current interest in the <em>AFAP1 axis</em> in cancer: researchers are looking not just at the protein itself, but at upstream regulators (lncRNAs, circRNAs, miRNAs) that fine-tune AFAP1 expression in disease states. These findings open the door to novel therapeutic strategies ‚Äì for instance, delivering a competing oligonucleotide to soak up AFAP1-AS1, or using exosome-mediated transfer of circRNAs or miRNA mimics/inhibitors to modulate AFAP1 levels in tumors.  </p>
<p>On the <strong>clinical research front</strong>, efforts are being made to translate knowledge of AFAP1 into clinical markers. Large-scale genomic studies in 2023 have started to identify rare variants in <em>AFAP1</em> that might contribute to disease beyond cancer. For example, a 2024 precision oncology study investigating unexplained cases of familial adenomatous polyposis (FAP) ‚Äì a hereditary colon cancer syndrome ‚Äì utilized DNA/RNA sequencing to uncover non-APC gene contributors (<a href="https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=01%20May%202024JCO%20precision%20oncology">synapse.patsnap.com</a>). Intriguingly, that study (JCO Precision Oncology, May 2024) identified anomalies in <em>AFAP1</em> transcripts in certain patients, suggesting that cryptic alterations in AFAP1 could underlie some cancer-predisposition in the colon (this is still a developing area, and the term ‚ÄúAFAP‚Äù in gastroenterology also refers to an attenuated form of polyposis, so follow-up work is needed to confirm AFAP1‚Äôs role). Nonetheless, the inclusion of AFAP1 in such cutting-edge diagnostics underscores its growing recognition.  </p>
<p>From a therapeutic perspective, AFAP1 is not an enzyme and thus not a classic drug target, but its position at a convergence of PKC and Src pathways makes it attractive to consider in combination therapies. Src kinase inhibitors (like dasatinib) have had mixed success in solid tumors; one hypothesis is that <strong>patient stratification based on AFAP1 activity or expression</strong> could improve their efficacy. For instance, tumors with high AFAP1 (or the AFAP1^403C variant) might rely heavily on the Src-AFAP1 axis and thus be more vulnerable to Src inhibition (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,the%20response%20to%20targeted%20therapy">pmc.ncbi.nlm.nih.gov</a>). Conversely, if AFAP1 is low, Src might be less critical or activated through alternate routes. As research moves forward, <strong>AFAP1 levels or genotype could become part of a biomarker panel</strong> to guide the use of Src inhibitors or perhaps PKC modulators. Additionally, disrupting the AFAP1‚ÄìSrc interaction is a conceivable strategy; some researchers have suggested designing peptides or small molecules that mask AFAP1‚Äôs SH3-binding motif or phospho-tyrosine motifs, thereby preventing it from activating Src. While still in preclinical stages, such interventions could potentially block invasive behavior in metastatic cancers with fewer side effects than broad kinase inhibitors.  </p>
<p>In conclusion, AFAP1 (Actin Filament-Associated Protein 1) is a versatile actin-binding adaptor that plays a crucial role in connecting signal transduction to cytoskeletal remodeling. <strong>Key concepts</strong> include its domain-mediated regulation (PH domains, leucine zipper, etc.), its ability to cross-link actin filaments, and its function in activating and localizing Src family kinases. <strong>Current understanding</strong> solidifies AFAP1 as both a stabilizer of actin structures and a facilitator of dynamic actin reorganization in response to signals. <strong>Recent research (2021‚Äì2024)</strong> has shed light on the gene‚Äôs regulation by non-coding RNAs and hinted at clinical relevance in prognostics and personalized therapy. <strong>Real-world implementations</strong> are on the horizon: for example, AFAP1 is already noted as an unfavorable prognostic marker in certain cancers (<a href="https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,actin%20filaments%20into%20both%20network">v19.proteinatlas.org</a>), and its genetic variants may inform treatment choices (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,the%20response%20to%20targeted%20therapy">pmc.ncbi.nlm.nih.gov</a>). <strong>Expert analyses</strong> from leading studies describe AFAP1 as an essential mediator that ‚Äúaffects crosstalk between Src and PKC‚Äù and coordinates the assembly/disassembly of actin networks (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=first%20identified%20as%20a%20substrate,prostate%20cancer%20cells%20inhibited%20cell">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,as%20phospholipids%20at%20the%20cellular">pmc.ncbi.nlm.nih.gov</a>). As such, AFAP1 is an important node in cell biology, and continuing to unravel its interactions and regulation holds promise for understanding diseases driven by cytoskeletal dysfunction and dysregulated signaling. </p>
<p><strong>References:</strong> Publications cited above include foundational studies such as Flynn <em>et al.</em> 1993 (AFAP1 discovery), Baisden <em>et al.</em> 2001 (<a href="https://www.nature.com/articles/1204784#:~:text=AFAP,to%20alter%20actin%20filament%20integrity">www.nature.com</a>), which first articulated AFAP1‚Äôs adaptor role and structure; Qian <em>et al.</em> 2002 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by">pmc.ncbi.nlm.nih.gov</a>) on PKC phosphorylation effects; Gatesman <em>et al.</em> 2004 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>) on PKC‚ÄìSrc‚Äìpodosome signaling; Dorfleutner <em>et al.</em> 2007 (<a href="https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=AFAP,Although">www.scholars.northwestern.edu</a>) on AFAP1 in adhesion; Zhang <em>et al.</em> 2007 (J Clin Invest) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,motifs%20are%20involved%20in%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor">pmc.ncbi.nlm.nih.gov</a>) on AFAP1 in prostate cancer; Clump <em>et al.</em> 2010 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=activates%20cSrc%20through%20a%20direct,that%2C%20under%20conditions%20of%20cSrc">pmc.ncbi.nlm.nih.gov</a>) on the AFAP1^403C variant; and Ammer <em>et al.</em> 2014 (<a href="https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1">www.nature.com</a>) (<a href="https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,the%20normal%20breast%2C%20specifically%20for">www.nature.com</a>) demonstrating AFAP1‚Äôs physiological role in mammary gland function, among others. These and more recent sources (Dang <em>et al.</em> 2021 (<a href="https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=differentiation%20%28p%3D0,including%20proliferation%2C%20migration%20and%20invasion">pubmed.ncbi.nlm.nih.gov</a>), Wen <em>et al.</em> 2024, etc.) collectively provide a comprehensive view of AFAP1 as a critical link between cellular signals and the actin cytoskeleton, with significant implications for health and disease.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=293, start_index=170, title='AFAP1 actin filament associated protein 1 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/60312#:~:text=Summary%20The%20protein%20encoded%20by,Expression')</li>
<li>AnnotationURLCitation(end_index=746, start_index=615, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=The%20actin%20filament,an%20intrinsic%20capability%20to%20alter')</li>
<li>AnnotationURLCitation(end_index=1053, start_index=906, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=actin%20filament%20integrity%20that%20can,will%20review%20the%20structure%20and')</li>
<li>AnnotationURLCitation(end_index=1411, start_index=1229, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil')</li>
<li>AnnotationURLCitation(end_index=1737, start_index=1555, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil')</li>
<li>AnnotationURLCitation(end_index=2208, start_index=2030, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,actin%20filaments%20into%20both%20network')</li>
<li>AnnotationURLCitation(end_index=2355, start_index=2209, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=%28unfavourable%29%20Brain%20specificity,i%7D%20Intracellular')</li>
<li>AnnotationURLCitation(end_index=3042, start_index=2882, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=two%20pleckstrin%20homology%20domains%2C%20a,family%20members%20and%2For%20other%20signaling')</li>
<li>AnnotationURLCitation(end_index=3166, start_index=3043, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,motifs%20are%20involved%20in%20the')</li>
<li>AnnotationURLCitation(end_index=3603, start_index=3424, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the')</li>
<li>AnnotationURLCitation(end_index=3849, start_index=3724, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16')</li>
<li>AnnotationURLCitation(end_index=3979, start_index=3850, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor')</li>
<li>AnnotationURLCitation(end_index=4306, start_index=4181, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16')</li>
<li>AnnotationURLCitation(end_index=4437, start_index=4307, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=domain%2C%20which%20allows%20the%20formation,5')</li>
<li>AnnotationURLCitation(end_index=4777, start_index=4652, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16')</li>
<li>AnnotationURLCitation(end_index=4908, start_index=4778, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=domain%2C%20which%20allows%20the%20formation,5')</li>
<li>AnnotationURLCitation(end_index=5311, start_index=5158, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=www.ncbi.nlm.nih.gov%20%29.%20AFAP,activated%20cSrc%20to%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=5775, start_index=5617, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=in%20exon%209%20that%20predicts,110%5E%7B%CE%94Lzip%7D%29%20or%20on%20PKCa')</li>
<li>AnnotationURLCitation(end_index=5974, start_index=5776, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=intermolecular%20interaction%20between%20the%20carboxy,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16')</li>
<li>AnnotationURLCitation(end_index=6476, start_index=6316, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=two%20pleckstrin%20homology%20domains%2C%20a,family%20members%20and%2For%20other%20signaling')</li>
<li>AnnotationURLCitation(end_index=6606, start_index=6477, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor')</li>
<li>AnnotationURLCitation(end_index=6973, start_index=6848, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16')</li>
<li>AnnotationURLCitation(end_index=7103, start_index=6974, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor')</li>
<li>AnnotationURLCitation(end_index=7381, start_index=7221, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=two%20pleckstrin%20homology%20domains%2C%20a,family%20members%20and%2For%20other%20signaling')</li>
<li>AnnotationURLCitation(end_index=7949, start_index=7824, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=contains%20a%20carboxyterminal%20actin,16')</li>
<li>AnnotationURLCitation(end_index=8080, start_index=7950, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=domain%2C%20which%20allows%20the%20formation,5')</li>
<li>AnnotationURLCitation(end_index=8662, start_index=8502, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by')</li>
<li>AnnotationURLCitation(end_index=8799, start_index=8663, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=9117, start_index=8957, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by')</li>
<li>AnnotationURLCitation(end_index=9297, start_index=9118, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the')</li>
<li>AnnotationURLCitation(end_index=9666, start_index=9513, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=www.ncbi.nlm.nih.gov%20%29.%20AFAP,activated%20cSrc%20to%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=9846, start_index=9667, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the')</li>
<li>AnnotationURLCitation(end_index=10220, start_index=10060, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by')</li>
<li>AnnotationURLCitation(end_index=10357, start_index=10221, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=10975, start_index=10798, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=AFAP,Although')</li>
<li>AnnotationURLCitation(end_index=11223, start_index=10976, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=changes%20in%20cell%20proliferation%20but,components%20were%20not%20influenced%20by')</li>
<li>AnnotationURLCitation(end_index=11615, start_index=11438, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=AFAP,Although')</li>
<li>AnnotationURLCitation(end_index=11876, start_index=11616, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=12264, start_index=12028, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion')</li>
<li>AnnotationURLCitation(end_index=12525, start_index=12265, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=12933, start_index=12697, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion')</li>
<li>AnnotationURLCitation(end_index=13194, start_index=12934, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=13596, start_index=13360, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion')</li>
<li>AnnotationURLCitation(end_index=13857, start_index=13597, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=14339, start_index=14079, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=14572, start_index=14340, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=adhesions%20in%20AFAP,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=15082, start_index=14932, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=binds%20to%20filamentous%20actin%20and,the%20lactating%20knockout%20mice%20were')</li>
<li>AnnotationURLCitation(end_index=15231, start_index=15083, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=prostate%20cancer%20cells%2C%20AFAP1%20has,in%20lipid%20synthesis%20and%20the')</li>
<li>AnnotationURLCitation(end_index=15663, start_index=15535, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=15789, start_index=15664, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,doi')</li>
<li>AnnotationURLCitation(end_index=16138, start_index=15951, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=%5B12%2C13%20%5D.%20In%20addition%2C%20AFAP,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16')</li>
<li>AnnotationURLCitation(end_index=16337, start_index=16139, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=intermolecular%20interaction%20between%20the%20carboxy,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16')</li>
<li>AnnotationURLCitation(end_index=16614, start_index=16486, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=16751, start_index=16615, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=17281, start_index=17123, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=ability%20to%20alter%20actin%20filament,Cell%20Res%202000%3B%20255%3A%20102%E2%80%93113')</li>
<li>AnnotationURLCitation(end_index=17761, start_index=17669, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=motif,110%E2%80%93119')</li>
<li>AnnotationURLCitation(end_index=18171, start_index=18032, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=as%20an%20adaptor%20protein%20by,to%20cellular%20signals%20that%20alter')</li>
<li>AnnotationURLCitation(end_index=18319, start_index=18172, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=actin%20filament%20integrity%20that%20can,will%20review%20the%20structure%20and')</li>
<li>AnnotationURLCitation(end_index=18646, start_index=18523, title='AFAP1 actin filament associated protein 1 [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/60312#:~:text=Summary%20The%20protein%20encoded%20by,Expression')</li>
<li>AnnotationURLCitation(end_index=18786, start_index=18647, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=as%20an%20adaptor%20protein%20by,to%20cellular%20signals%20that%20alter')</li>
<li>AnnotationURLCitation(end_index=19035, start_index=18887, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=The%20actin%20filament%E2%80%93associated%20protein%20of,binding')</li>
<li>AnnotationURLCitation(end_index=19404, start_index=19240, title='AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=AFAP1L1%20is%20hypothesized%20to%20have,move%20to%20podosomes%20without%20stimulation')</li>
<li>AnnotationURLCitation(end_index=19563, start_index=19405, title='AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=tyrosine%20kinase%20cSrc%20via%20an,in%20human%20tissues%20shows%20differential')</li>
<li>AnnotationURLCitation(end_index=20024, start_index=19900, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=4,Cell%20Biochem%201997%3B%20175%3A%20243%E2%80%93252')</li>
<li>AnnotationURLCitation(end_index=20150, start_index=20025, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=5,Mol%20Carcinogen%201998%3B%2022%3A%20110%E2%80%93119')</li>
<li>AnnotationURLCitation(end_index=20400, start_index=20271, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor')</li>
<li>AnnotationURLCitation(end_index=20532, start_index=20401, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,domains%20may%20potentially%20direct%20the')</li>
<li>AnnotationURLCitation(end_index=20746, start_index=20622, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=4,Cell%20Biochem%201997%3B%20175%3A%20243%E2%80%93252')</li>
<li>AnnotationURLCitation(end_index=21354, start_index=21181, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Enhanced%20expression%20and%20activity%20of,presence%20of%20a%20nonsynonymous%2C%20single')</li>
<li>AnnotationURLCitation(end_index=21517, start_index=21355, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast')</li>
<li>AnnotationURLCitation(end_index=21806, start_index=21644, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast')</li>
<li>AnnotationURLCitation(end_index=22174, start_index=22012, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast')</li>
<li>AnnotationURLCitation(end_index=22583, start_index=22430, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=www.ncbi.nlm.nih.gov%20%29.%20AFAP,activated%20cSrc%20to%20the%20cell')</li>
<li>AnnotationURLCitation(end_index=22782, start_index=22584, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=intermolecular%20interaction%20between%20the%20carboxy,rich%20invasive%20structures%E2%80%94podosomes%20%5B14%2C16')</li>
<li>AnnotationURLCitation(end_index=23087, start_index=22925, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast')</li>
<li>AnnotationURLCitation(end_index=23252, start_index=23088, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=activates%20cSrc%20through%20a%20direct,that%2C%20under%20conditions%20of%20cSrc')</li>
<li>AnnotationURLCitation(end_index=23523, start_index=23399, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=4,Cell%20Biochem%201997%3B%20175%3A%20243%E2%80%93252')</li>
<li>AnnotationURLCitation(end_index=23649, start_index=23524, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=5,Mol%20Carcinogen%201998%3B%2022%3A%20110%E2%80%93119')</li>
<li>AnnotationURLCitation(end_index=24066, start_index=23904, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20releases%20its%20autoinhibition,of%20input%20signals%2C%20in%20contrast')</li>
<li>AnnotationURLCitation(end_index=24202, start_index=24067, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the')</li>
<li>AnnotationURLCitation(end_index=24522, start_index=24387, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the')</li>
<li>AnnotationURLCitation(end_index=24681, start_index=24523, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20express%20enhanced%20levels%20of,110%20promotes%20cSrc%20activation')</li>
<li>AnnotationURLCitation(end_index=24995, start_index=24867, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=25156, start_index=24996, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by')</li>
<li>AnnotationURLCitation(end_index=25398, start_index=25219, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the')</li>
<li>AnnotationURLCitation(end_index=25699, start_index=25571, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=25836, start_index=25700, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=T%2C%20Pustula%20J%2C%20Zot%20HG%2C,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=26179, start_index=26058, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=doi%3A%2010.1091%2Fmbc.E01,Monoclonal')</li>
<li>AnnotationURLCitation(end_index=26495, start_index=26338, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=association%20of%20AFAP,in%20regulating%20multiple%20cellular%20processes')</li>
<li>AnnotationURLCitation(end_index=26814, start_index=26657, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=association%20of%20AFAP,in%20regulating%20multiple%20cellular%20processes')</li>
<li>AnnotationURLCitation(end_index=27142, start_index=27013, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=%288%20%29.%20Both%20amino,based%20structures')</li>
<li>AnnotationURLCitation(end_index=27288, start_index=27143, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1')</li>
<li>AnnotationURLCitation(end_index=28031, start_index=27841, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles')</li>
<li>AnnotationURLCitation(end_index=28194, start_index=28032, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently')</li>
<li>AnnotationURLCitation(end_index=28557, start_index=28443, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=AFAP,to%20alter%20actin%20filament%20integrity')</li>
<li>AnnotationURLCitation(end_index=29053, start_index=28889, title='AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=AFAP1L1%20is%20hypothesized%20to%20have,move%20to%20podosomes%20without%20stimulation')</li>
<li>AnnotationURLCitation(end_index=29212, start_index=29054, title='AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=tyrosine%20kinase%20cSrc%20via%20an,in%20human%20tissues%20shows%20differential')</li>
<li>AnnotationURLCitation(end_index=29650, start_index=29529, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=doi%3A%2010.1091%2Fmbc.E01,Monoclonal')</li>
<li>AnnotationURLCitation(end_index=29752, start_index=29651, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,Google%20Scholar')</li>
<li>AnnotationURLCitation(end_index=30130, start_index=29984, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=regulating%20focal%20contacts,Invest%202007%3B%20117%3A%202962%E2%80%932973')</li>
<li>AnnotationURLCitation(end_index=30805, start_index=30676, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=%288%20%29.%20Both%20amino,based%20structures')</li>
<li>AnnotationURLCitation(end_index=31176, start_index=30986, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles')</li>
<li>AnnotationURLCitation(end_index=31339, start_index=31177, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently')</li>
<li>AnnotationURLCitation(end_index=31838, start_index=31656, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil')</li>
<li>AnnotationURLCitation(end_index=32149, start_index=31967, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Gene%20name%5E%7Bi%7D%20AFAP1%20%28AFAP%2C%20AFAP,i%7D%20Immune%20cell%20enhanced%20%28eosinophil')</li>
<li>AnnotationURLCitation(end_index=32299, start_index=32150, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Subcellular%20location,actin%20filaments%20into%20both%20network')</li>
<li>AnnotationURLCitation(end_index=32772, start_index=32623, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Subcellular%20location,actin%20filaments%20into%20both%20network')</li>
<li>AnnotationURLCitation(end_index=33138, start_index=32986, title='AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=interacting%20with%20the%20SH3%20domain,brain%20where%20AFAP1%20was%20not')</li>
<li>AnnotationURLCitation(end_index=33314, start_index=33139, title='AFAP1L1 is a novel adaptor protein of the AFAP family that interacts with cortactin and localizes to invadosomes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/21333378/#:~:text=structures%20and%20colocalize%20with%20cortactin%2C,unique%20protein%20interactions%20in%20which')</li>
<li>AnnotationURLCitation(end_index=33665, start_index=33515, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=binds%20to%20filamentous%20actin%20and,the%20lactating%20knockout%20mice%20were')</li>
<li>AnnotationURLCitation(end_index=33814, start_index=33666, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=prostate%20cancer%20cells%2C%20AFAP1%20has,in%20lipid%20synthesis%20and%20the')</li>
<li>AnnotationURLCitation(end_index=34189, start_index=34032, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=association%20of%20AFAP,in%20regulating%20multiple%20cellular%20processes')</li>
<li>AnnotationURLCitation(end_index=34557, start_index=34378, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=functional%20domains%2C%20including%202%20pleckstrin,domains%20may%20potentially%20direct%20the')</li>
<li>AnnotationURLCitation(end_index=34989, start_index=34844, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1')</li>
<li>AnnotationURLCitation(end_index=35132, start_index=34990, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,in%20the%20absence%20of%20AFAP1')</li>
<li>AnnotationURLCitation(end_index=35825, start_index=35589, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion')</li>
<li>AnnotationURLCitation(end_index=36086, start_index=35826, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=36599, start_index=36449, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=binds%20to%20filamentous%20actin%20and,the%20lactating%20knockout%20mice%20were')</li>
<li>AnnotationURLCitation(end_index=36748, start_index=36600, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=prostate%20cancer%20cells%2C%20AFAP1%20has,in%20lipid%20synthesis%20and%20the')</li>
<li>AnnotationURLCitation(end_index=37442, start_index=37252, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles')</li>
<li>AnnotationURLCitation(end_index=37605, start_index=37443, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently')</li>
<li>AnnotationURLCitation(end_index=38079, start_index=37950, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=Actin%20filament,an%20inability%20to%20nurse%20efficiently')</li>
<li>AnnotationURLCitation(end_index=38225, start_index=38080, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1')</li>
<li>AnnotationURLCitation(end_index=38491, start_index=38378, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=this%20study%2C%20we%20generated%20an,This')</li>
<li>AnnotationURLCitation(end_index=38886, start_index=38753, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=production%20of%20%CE%B2,the%20apical%20surface%20of%20luminal')</li>
<li>AnnotationURLCitation(end_index=39217, start_index=39072, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1')</li>
<li>AnnotationURLCitation(end_index=39374, start_index=39218, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,the%20normal%20breast%2C%20specifically%20for')</li>
<li>AnnotationURLCitation(end_index=39766, start_index=39605, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,breast%2C%20specifically%20for%20milk%20production')</li>
<li>AnnotationURLCitation(end_index=40175, start_index=39997, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,actin%20filaments%20into%20both%20network')</li>
<li>AnnotationURLCitation(end_index=41717, start_index=41553, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=affects%20crosstalk%20between%20Src%20and,110%20resulted%20in%20decreased%20cell')</li>
<li>AnnotationURLCitation(end_index=41893, start_index=41718, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=prostatic%20hyperplasia%20but%20significantly%20increased,However%2C%20expression%20of%20an')</li>
<li>AnnotationURLCitation(end_index=42287, start_index=42123, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=affects%20crosstalk%20between%20Src%20and,110%20resulted%20in%20decreased%20cell')</li>
<li>AnnotationURLCitation(end_index=42690, start_index=42534, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Downregulation%20of%20AFAP,critical%20for%20tumorigenic%20growth%2C%20in')</li>
<li>AnnotationURLCitation(end_index=42850, start_index=42691, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=models.%20Furthermore%2C%20downmodulation%20of%20AFAP,dependent%20mechanism')</li>
<li>AnnotationURLCitation(end_index=43120, start_index=42945, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=prostatic%20hyperplasia%20but%20significantly%20increased,However%2C%20expression%20of%20an')</li>
<li>AnnotationURLCitation(end_index=43521, start_index=43365, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Downregulation%20of%20AFAP,critical%20for%20tumorigenic%20growth%2C%20in')</li>
<li>AnnotationURLCitation(end_index=43681, start_index=43522, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=models.%20Furthermore%2C%20downmodulation%20of%20AFAP,dependent%20mechanism')</li>
<li>AnnotationURLCitation(end_index=43993, start_index=43856, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=integrin%20%CE%B21%20expression,dependent%20mechanism')</li>
<li>AnnotationURLCitation(end_index=44346, start_index=44209, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=integrin%20%CE%B21%20expression,dependent%20mechanism')</li>
<li>AnnotationURLCitation(end_index=44457, start_index=44347, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,dependent%20mechanism')</li>
<li>AnnotationURLCitation(end_index=44727, start_index=44590, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=integrin%20%CE%B21%20expression,dependent%20mechanism')</li>
<li>AnnotationURLCitation(end_index=44838, start_index=44728, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,dependent%20mechanism')</li>
<li>AnnotationURLCitation(end_index=45564, start_index=45328, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=approach%20confirms%20that%20MDA,231%20breast%20cancer%20cell%20adhesion')</li>
<li>AnnotationURLCitation(end_index=45825, start_index=45565, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=cytoskeletal%20tension%20through%20stress%20fiber,would%20promote%20focal%20adhesion%20formation')</li>
<li>AnnotationURLCitation(end_index=46175, start_index=46017, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=ability%20to%20alter%20actin%20filament,Cell%20Res%202000%3B%20255%3A%20102%E2%80%93113')</li>
<li>AnnotationURLCitation(end_index=46526, start_index=46368, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=ability%20to%20alter%20actin%20filament,Cell%20Res%202000%3B%20255%3A%20102%E2%80%93113')</li>
<li>AnnotationURLCitation(end_index=46860, start_index=46670, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=Disruption%20of%20actin%20organization%20abrogates,evidence%20demonstrates%20the%20multifunctional%20roles')</li>
<li>AnnotationURLCitation(end_index=47023, start_index=46861, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=structures%20and%20disturbs%20integrin,bundling%20protein%2C%20is%20frequently')</li>
<li>AnnotationURLCitation(end_index=47528, start_index=47379, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Subcellular%20location,actin%20filaments%20into%20both%20network')</li>
<li>AnnotationURLCitation(end_index=47710, start_index=47529, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,Low%20human%20brain%20regional%20specificity')</li>
<li>AnnotationURLCitation(end_index=48475, start_index=48311, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=activates%20cSrc%20through%20a%20direct,that%2C%20under%20conditions%20of%20cSrc')</li>
<li>AnnotationURLCitation(end_index=48620, start_index=48476, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,of%20input%20signals%2C%20in%20contrast')</li>
<li>AnnotationURLCitation(end_index=48873, start_index=48738, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the')</li>
<li>AnnotationURLCitation(end_index=49022, start_index=48874, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,be%20used%20to%20predict%20the')</li>
<li>AnnotationURLCitation(end_index=49457, start_index=49322, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=increase%20of%20AFAP,be%20used%20to%20predict%20the')</li>
<li>AnnotationURLCitation(end_index=49616, start_index=49458, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=that%20express%20enhanced%20levels%20of,110%20promotes%20cSrc%20activation')</li>
<li>AnnotationURLCitation(end_index=50056, start_index=49898, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,the%20response%20to%20targeted%20therapy')</li>
<li>AnnotationURLCitation(end_index=50234, start_index=50057, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=overexpression%2C%20the%20polymorphic%20variant%20of,the%20response%20to%20targeted%20therapy')</li>
<li>AnnotationURLCitation(end_index=51211, start_index=51066, title='AFAP1 - Drugs, Indications, Patents - Synapse', type='url_citation', url='https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=Roles%20of%20AFAP1,and%20Urogenital%20System')</li>
<li>AnnotationURLCitation(end_index=52425, start_index=52274, title='LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Results%3A%20qPCR%20results%20showed%20that,Luciferase%20reporter%20gene')</li>
<li>AnnotationURLCitation(end_index=52580, start_index=52426, title='LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Moreover%2C%20miR,including%20proliferation%2C%20migration%20and%20invasion')</li>
<li>AnnotationURLCitation(end_index=52954, start_index=52791, title='LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=differentiation%20%28p%3D0,including%20proliferation%2C%20migration%20and%20invasion')</li>
<li>AnnotationURLCitation(end_index=53109, start_index=52955, title='LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Moreover%2C%20miR,including%20proliferation%2C%20migration%20and%20invasion')</li>
<li>AnnotationURLCitation(end_index=53442, start_index=53317, title='LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Results%3A%20qPCR%20results%20showed%20that,5p')</li>
<li>AnnotationURLCitation(end_index=53597, start_index=53443, title='LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=Moreover%2C%20miR,including%20proliferation%2C%20migration%20and%20invasion')</li>
<li>AnnotationURLCitation(end_index=54141, start_index=53992, title='AFAP1 - Drugs, Indications, Patents - Synapse', type='url_citation', url='https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=01%20Mar%202024Current%20pharmaceutical%20design')</li>
<li>AnnotationURLCitation(end_index=54696, start_index=54551, title='AFAP1 - Drugs, Indications, Patents - Synapse', type='url_citation', url='https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=Roles%20of%20AFAP1,and%20Urogenital%20System')</li>
<li>AnnotationURLCitation(end_index=55013, start_index=54868, title='AFAP1 - Drugs, Indications, Patents - Synapse', type='url_citation', url='https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=Roles%20of%20AFAP1,and%20Urogenital%20System')</li>
<li>AnnotationURLCitation(end_index=56452, start_index=56310, title='AFAP1 - Drugs, Indications, Patents - Synapse', type='url_citation', url='https://synapse.patsnap.com/target/d0c14faf9cd134bcb3492bb97550290f#:~:text=01%20May%202024JCO%20precision%20oncology')</li>
<li>AnnotationURLCitation(end_index=57678, start_index=57520, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,the%20response%20to%20targeted%20therapy')</li>
<li>AnnotationURLCitation(end_index=59390, start_index=59212, title='AFAP1 protein expression summary - The Human Protein Atlas', type='url_citation', url='https://v19.proteinatlas.org/ENSG00000196526-AFAP1#:~:text=Cancer%20prognostic%20summary%20Prognostic%20marker,actin%20filaments%20into%20both%20network')</li>
<li>AnnotationURLCitation(end_index=59604, start_index=59446, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=cSrc%20and%20the%20formation%20of,the%20response%20to%20targeted%20therapy')</li>
<li>AnnotationURLCitation(end_index=59959, start_index=59791, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=first%20identified%20as%20a%20substrate,prostate%20cancer%20cells%20inhibited%20cell')</li>
<li>AnnotationURLCitation(end_index=60089, start_index=59960, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,as%20phospholipids%20at%20the%20cellular')</li>
<li>AnnotationURLCitation(end_index=60561, start_index=60447, title='The actin filament-associated protein AFAP-110 is an adaptor protein that modulates changes in actin filament integrity | Oncogene', type='url_citation', url='https://www.nature.com/articles/1204784#:~:text=AFAP,to%20alter%20actin%20filament%20integrity')</li>
<li>AnnotationURLCitation(end_index=60802, start_index=60642, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=Scholar%20scholar.google.com%20%5D%20,directed%20activation%20of%20cSrc%20by')</li>
<li>AnnotationURLCitation(end_index=60986, start_index=60858, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=,0148.%20%5BDOI%5D%20%5BPMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=61221, start_index=61044, title='AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells - Northwestern Scholars', type='url_citation', url='https://www.scholars.northwestern.edu/en/publications/afap-110-is-required-for-actin-stress-fiber-formation-and-cell-ad/#:~:text=AFAP,Although')</li>
<li>AnnotationURLCitation(end_index=61403, start_index=61280, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,motifs%20are%20involved%20in%20the')</li>
<li>AnnotationURLCitation(end_index=61533, start_index=61404, title='AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1978423/#:~:text=AFAP,proteins%2C%20such%20as%20the%20receptor')</li>
<li>AnnotationURLCitation(end_index=61747, start_index=61583, title='A Polymorphic Variant of AFAP-110 Enhances cSrc Activity - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2915419/#:~:text=activates%20cSrc%20through%20a%20direct,that%2C%20under%20conditions%20of%20cSrc')</li>
<li>AnnotationURLCitation(end_index=61944, start_index=61799, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=study%20also%20demonstrated%20that%20AFAP1,in%20the%20absence%20of%20AFAP1')</li>
<li>AnnotationURLCitation(end_index=62101, start_index=61945, title='Actin filament-associated protein 1 is required for cSrc activity and secretory activation in the lactating mammary gland | Oncogene', type='url_citation', url='https://www.nature.com/articles/onc2014205#:~:text=activation%20in%20the%20cSrc%20knockout,the%20normal%20breast%2C%20specifically%20for')</li>
<li>AnnotationURLCitation(end_index=62397, start_index=62234, title='LncRNA AFAP1-AS1 Modulates the Proliferation and Invasion of Gastric Cancer Cells by Regulating AFAP1 via miR-205-5p - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34234560/#:~:text=differentiation%20%28p%3D0,including%20proliferation%2C%20migration%20and%20invasion')</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(AFAP1-deep-research-perplexity.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q8N556" data-a="DOC: Deep Research Perplexity" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-deep-research<br />
cached: false<br />
start_time: '2025-12-27T16:18:31.049377'<br />
end_time: '2025-12-27T16:20:35.359525'<br />
duration_seconds: 124.31<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: AFAP1<br />
  gene_symbol: AFAP1<br />
  uniprot_accession: Q8N556<br />
  protein_description: 'RecName: Full=Actin filament-associated protein 1; AltName:<br />
    Full=110 kDa actin filament-associated protein; Short=AFAP-110;'<br />
  gene_info: Name=AFAP1; Synonyms=AFAP;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849);<br />
    PH (PF00169)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: medium<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 41</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q8N556</li>
<li><strong>Protein Description:</strong> RecName: Full=Actin filament-associated protein 1; AltName: Full=110 kDa actin filament-associated protein; Short=AFAP-110;</li>
<li><strong>Gene Information:</strong> Name=AFAP1; Synonyms=AFAP;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> AFAP. (IPR030113); PH-like_dom_sf. (IPR011993); PH_domain. (IPR001849); PH (PF00169)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "AFAP1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'AFAP1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>AFAP1</strong> (gene ID: AFAP1, UniProt: Q8N556) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p><think><br />
Let me analyze the search results provided to create a comprehensive research report on AFAP1 (Actin filament-associated protein 1).</p>
<p>First, let me verify I have the correct gene/protein:<br />
- UniProt Accession: Q8N556<br />
- Protein Description: Actin filament-associated protein 1<br />
- Gene: AFAP1<br />
- Organism: Homo sapiens (Human)<br />
- Domains: PH domain, actin filament associated protein family</p>
<p>Looking at the search results, I have extensive information about AFAP1 and related proteins. The search results include:<br />
1. Basic gene information (Wikipedia, NCBI, UniProt)<br />
2. Information about AFAP1-AS (a long noncoding RNA derived from the AFAP1 gene)<br />
3. Structural and functional information about AFAP1 protein<br />
4. Cancer-related research<br />
5. Information about related proteins like AFAP1L1<br />
6. Mechanistic studies on AFAP1 function</p>
<p>Now I need to organize this into a comprehensive research report covering:<br />
1. Introduction and key findings<br />
2. Protein structure and domains<br />
3. Molecular interactions (Src binding, actin binding)<br />
4. Cellular localization<br />
5. Signaling pathways and mechanisms<br />
6. Biological functions (adhesion, migration, invasion)<br />
7. Role in podosomes and invadopodia<br />
8. Cancer-related functions<br />
9. The AFAP1-AS1 lncRNA (as an important regulatory element)<br />
10. Physiological roles<br />
11. Conclusion</p>
<p>I need to write at least 10,000 words following the format guidelines with proper citations.<br />
</think></p>
<h1 id="actin-filament-associated-protein-1-afap1-structure-function-and-cellular-mechanisms">Actin Filament-Associated Protein 1 (AFAP1): Structure, Function, and Cellular Mechanisms</h1>
<p>AFAP1 (actin filament-associated protein 1), also known as AFAP-110, is a multifunctional adapter protein that plays critical roles in regulating cytoskeletal dynamics and cellular signaling, particularly through its interactions with the Src family tyrosine kinases and filamentous actin structures[1][4]. Recent research has revealed that AFAP1 functions as a dual-role regulator, operating both as a direct mediator of signal transduction at the protein level and indirectly through its associated antisense long noncoding RNA (AFAP1-AS1), which modulates oncogenic processes in various cancer types[9][14]. The protein is primarily localized to actin filaments, focal adhesions, and specialized membrane structures called podosomes and invadopodia, where it coordinates the assembly and remodeling of actin-rich structures essential for cell adhesion, migration, and invasion[1][12][19]. This comprehensive report examines the molecular architecture, biochemical functions, cellular mechanisms, and biological significance of AFAP1, synthesizing current knowledge from structural biology, cell biology, and cancer research to provide an integrated understanding of this important regulatory protein.</p>
<h2 id="molecular-architecture-and-domain-organization">Molecular Architecture and Domain Organization</h2>
<p>AFAP1 possesses a highly specialized modular architecture that enables its diverse cellular functions through multiple protein-protein interaction domains. The protein structure includes two <strong>Pleckstrin Homology (PH) domains</strong>, which are characteristic features of the broader AFAP family of proteins and serve as recognition modules for phosphorylated lipids and protein interaction surfaces[54][55]. One of these PH domains contains a binding site for protein kinase C (PKC), specifically PKCŒ±, which phosphorylates serine residue 277 and plays a critical role in regulating AFAP1's ability to modulate podosome formation and stability[49][52][54]. Beyond the PH domains, AFAP1 contains N-terminal <strong>SH2 and SH3 binding motifs</strong> that specifically interact with the SH3 and SH2 domains of the nonreceptor tyrosine kinase c-Src, enabling tight coupling of AFAP1 to Src family kinase signaling[6][10][54]. These SH3 binding motifs are structurally conserved and essential for stable complex formation with Src and subsequent tyrosine phosphorylation of AFAP1[50]. The C-terminal region of the protein harbors <strong>actin-binding domains</strong> that mediate direct interactions with filamentous actin (F-actin) and likely involve AFAP1 multimeric assemblies, allowing the protein to cross-link actin filaments into both network and bundle structures[1][40][54][55]. The N-terminal SH3 binding motif is absolutely critical for AFAP1 function, as mutations or deletions of this motif completely abolish both Src binding and the ability of AFAP1 to regulate downstream cellular processes[1][6][10].</p>
<p>The protein exists in at least two isoforms, the neuronal cell-specific A isoform and the ubiquitously expressed B isoform, suggesting specialized functions in different cellular contexts[33]. Multiple transcript variants have been identified that encode different AFAP1 isoforms, providing additional regulatory flexibility through alternative splicing[1][4][8]. The overall design of AFAP1's domain organization‚Äîcombining PKC regulatory sites, Src interaction motifs, and actin-binding capability‚Äîpositions it as an ideal scaffold protein capable of integrating multiple signaling inputs to coordinate actin cytoskeletal responses. This architecture is shared to varying degrees by other family members such as AFAP1L1 and AFAP1L2 (also known as XB130), though subtle differences in domain structure and amino acid sequences lead to different subcellular localizations and binding affinities for specific interaction partners[57].</p>
<h2 id="protein-protein-interactions-and-src-kinase-coupling">Protein-Protein Interactions and Src Kinase Coupling</h2>
<p>The interaction between AFAP1 and the proto-oncogene tyrosine-protein kinase Src (c-Src) represents one of the most fundamental and well-characterized aspects of AFAP1 biology, as this coupling directly translates extracellular signals into cytoskeletal reorganization. AFAP1 binds to c-Src through its N-terminal SH3 binding motif, which interacts with the SH3 domain of Src, and this interaction is further strengthened by phosphorylation-dependent binding of the Src SH2 domain to tyrosine-phosphorylated residues on AFAP1[6][22][51]. Upon phosphorylation by activated Src (or by PKCŒ±), AFAP1 undergoes conformational changes that expose additional interaction surfaces, allowing the SRC SH2 domain to bind phosphorylated tyrosine residues on AFAP1, thereby stabilizing and potentially increasing the catalytic efficiency of the AFAP1-Src complex[22][47][51]. This phosphorylation-dependent interaction is particularly important for the localization of Src to actin filaments, as AFAP1 serves as a bridging molecule that brings activated Src into proximity with its substrate targets in the actin cytoskeleton[22][47][51]. AFAP1 is itself a substrate for both PKCŒ± and Src family kinases (c-Src and Fyn), creating a regulatory feedback loop in which AFAP1 phosphorylation enhances Src activation and vice versa[13][54][37]. In response to stimuli such as prolactin in mammary gland tissue, AFAP1 becomes tyrosine phosphorylated and forms a stable complex with c-Src, facilitating normal spatial and temporal Src activity[54].</p>
<p>The relationship between AFAP1 and Src extends beyond simple binding, as AFAP1 can directly activate c-Src through interactions with both the SH3 and SH2 domains, suggesting that AFAP1 acts as a nucleation factor or scaffold that promotes Src autophosphorylation and activation[7][16]. Mechanistic studies indicate that AFAP1 can facilitate c-Src activation through binding-induced conformational changes that relieve autoinhibition of the kinase[7][16]. The C-terminal actin-binding capability of AFAP1 means that once activated, the AFAP1-Src complex is simultaneously positioned on actin filaments where Src can phosphorylate additional substrates involved in cytoskeletal organization[40][54]. This spatial organization is crucial because Src phosphorylates numerous substrates beyond AFAP1, including cortactin and other actin regulatory proteins, all of which need to be coordinated to produce coherent changes in cytoskeletal architecture[22][47]. Interestingly, AFAP1 appears to show substrate specificity or preference in terms of which Src family kinases it interacts with most efficiently‚Äîwhile it binds strongly to c-Src via its SH3 binding motif, AFAP1L1, a family member, shows reduced affinity for Src but instead preferentially associates with cortactin, indicating functional diversification within the AFAP family[45][57].</p>
<h2 id="cellular-localization-and-subcellular-distribution">Cellular Localization and Subcellular Distribution</h2>
<p>AFAP1 exhibits a highly dynamic and stimulus-dependent pattern of subcellular localization that reflects its functional role in organizing actin-based cellular structures. In unstimulated cells, AFAP1 localizes prominently to actin filaments and focal adhesion sites, where it remains available to respond to cellular signals[23][59]. The protein is primarily distributed along the cytoskeleton, localizing to the cell cortex and to the ventral surface of cells where focal adhesions and podosomes form[1][59]. Upon stimulation with activators of PKC or in response to growth factors, AFAP1 rapidly translocates to newly forming podosomes and invadopodia, specialized actin-rich membrane protrusions that are sites of intense cytoskeletal remodeling[17][54][56]. In the lactating mammary gland, AFAP1 shows a striking pattern of localization at the apical surface of luminal epithelial cells, where it colocalizes with active c-Src, particularly during early lactation when elevated Src activity is required for proper milk protein secretion[54]. The protein outlines the cellular cortex with equal distribution on basolateral and apical sides of cells, localized exterior to cytokeratin staining, suggesting its role in organizing cortical actin structures that are fundamental to epithelial cell architecture and function[54].</p>
<p>AFAP1's ability to respond dynamically to signals is reflected in its redistribution to sites of active actin remodeling. Upon c-Src binding and activation, AFAP1 and c-Src move together to podosomes, which are adhesion structures found on the ventral membrane of cells containing an F-actin-rich core surrounded by adhesion proteins[17][56]. This coordinated localization is essential for AFAP1's function in regulating podosome assembly and stability, as the protein must be present at the site of actin dynamics to exert its mechanical effects on filament organization[16][37]. In specialized cell types such as retinal ganglion cells, AFAP1 is expressed and likely plays roles in ocular physiology, with expression variants suggesting involvement in tissue-specific functions[33][36]. The dynamic nature of AFAP1 localization‚Äîshifting from baseline distribution on focal adhesions and actin filaments to concentrated accumulation at podosomes and invadopodia in response to specific signals‚Äîdemonstrates that AFAP1 functions as a signal-responsive organizer of cytoskeletal structures rather than as a static structural component.</p>
<h2 id="regulation-of-actin-filament-structure-and-mechanical-properties">Regulation of Actin Filament Structure and Mechanical Properties</h2>
<p>At the molecular level, AFAP1 directly modulates the physical properties of the actin cytoskeleton through its dual capacity to bind both Src kinase and F-actin, creating what is essentially a mechanochemical coupling system. AFAP1 can cross-link actin filaments into both network and bundle structures, a function that requires both its actin-binding domain and potentially its capacity for self-association through multimerization[55][58]. The actin-binding domain of AFAP1, located at the C-terminus, is critical for regulating actin filament structure, and overexpression of deletion mutants lacking the actin-binding domain (AFAPŒîABD) results in disrupted regulation of actin organization[43]. Phosphorylation of serine 277 by PKCŒ± increases the ability of AFAP1 to cross-link actin filaments, suggesting that post-translational modification directly enhances the mechanical interaction between AFAP1 and the actin cytoskeleton[49][54]. The mechanism by which AFAP1 affects actin filament integrity appears to involve not merely passive cross-linking, but also active regulation of actin filament dynamics, as AFAP1 can modulate the responsiveness of actin networks to external mechanical forces and cellular signaling inputs[43].</p>
<p>The functional significance of AFAP1's actin-binding activity is particularly evident in its role in actin stress fiber formation and maintenance. AFAP1 plays an important role in breast cancer cell adhesion, possibly by regulating stress filament cross-linking, which would promote focal adhesion maturation and mechanotransduction signaling[41]. Loss or reduction of AFAP1 expression results in decreased actin stress fiber formation and loss of cell stress filament integrity, indicating that AFAP1 is a critical positive regulator of stress fiber assembly[21][38]. In nasopharyngeal carcinoma cells, loss of lncRNA AFAP1-AS1 (which is transcribed from the antisense strand and acts partly through AFAP1-independent mechanisms) results in loss of stress fiber formation via effects on F-actin polymerization, though the exact relationship to AFAP1 protein levels remains to be clarified[42][60]. The mechanism appears to involve AFAP1's ability to stabilize actin filament bundles through cross-linking and possibly through recruitment of additional actin regulatory proteins via its interaction with c-Src and other signaling molecules. AFAP1 may thus represent a key node in the complex regulatory network that balances actin polymerization with filament stabilization and organization into higher-order structures.</p>
<h2 id="podosomes-formation-regulation-and-function">Podosomes: Formation, Regulation, and Function</h2>
<p>Podosomes represent specialized actin-based cellular structures where AFAP1 plays a particularly prominent role in orchestrating assembly and regulating the maturation and turnover of these dynamic organelles. Podosomes are adhesion structures found on the ventral membrane of cells and consist of a core of cross-linked F-actin surrounded by a ring of adhesion-related proteins including vinculin, paxillin, and talin[1][17][26][29]. AFAP1 is absolutely required to mediate PKCŒ±-induced activation of the tyrosine kinase c-Src and the subsequent formation of podosomes, as demonstrated through studies showing that AFAP1 null cells fail to form podosomes in response to PKC activation[16][37]. The mechanism involves PKCŒ± phosphorylation of AFAP1 at serine 277, which enhances AFAP1's ability to activate c-Src, and the resulting activated AFAP1-Src complex localizes to sites of incipient podosome formation where it phosphorylates downstream substrates[16][49][54].</p>
<p>The formation of podosomes occurs in a stepwise manner, with the first visible stage being the formation of actin puncta, small accumulations of branched actin filaments at specific locations[26][29]. AFAP1 appears to be involved in the early stages of this process through its interaction with c-Src and actin filaments, likely helping to stabilize initial actin accumulations and recruit additional proteins required for podosome maturation[17][26]. Following formation of the actin puncta, adhesion proteins including vinculin and paxillin are recruited to form a ring-like structure surrounding the actin core[26][29]. The adhesion ring that forms around podosomes represents a specialized focal adhesion-like structure that serves to anchor the podosome to the underlying extracellular matrix and likely couples mechanical forces from the actin core to adhesion signaling pathways[26]. AFAP1 regulates not only the formation of podosomes but also their stability and turnover‚Äîstudies have shown that AFAP1 phosphorylation by PKCŒ± plays a role in regulating podosome formation and lifespan, suggesting that AFAP1-mediated signaling directly controls the temporal dynamics of podosome assembly and disassembly[49][52].</p>
<p>Both c-Src and the associated phosphatase PTP1B are required for proper podosome dynamics and turnover, with CSK (a negative regulator of Src) also playing a regulatory role[29]. This indicates that AFAP1, as the primary mechanism through which PKC activates Src for podosome formation, is embedded within a broader regulatory network that balances activation and inactivation signals to produce the appropriate temporal pattern of podosome formation and regression. In certain cell types such as vascular smooth muscle cells treated with phorbol esters or Src-transformed fibroblasts, podosomes form rapidly (in less than 15 minutes) from disassembling focal adhesions, with AFAP1 and c-Src activity being central to this transition[29]. This direct transformation of focal adhesions into podosomes suggests that AFAP1 participates in a structural remodeling process that converts one actin-based adhesion structure into another, a process that would require simultaneous cross-linking of new actin assemblies while disrupting existing ones.</p>
<h2 id="invadopodia-invasive-structures-and-cancer-cell-invasion">Invadopodia: Invasive Structures and Cancer Cell Invasion</h2>
<p>Beyond its role in podosome formation, AFAP1 participates in the assembly and regulation of invadopodia, which are F-actin-rich membrane protrusions that breach basement membrane barriers during cell invasion[39][42]. Invadopodia differ from podosomes in that they are particularly prominent in cancer cells with high metastatic potential and function primarily as degradative structures rather than adhesion organelles, though they share many molecular components including actin filaments, adhesion molecules, and regulatory proteins[26][29][39]. The formation of invadopodia, like podosomes, requires integration of growth factor signaling and adhesion signaling, with different stages of invadopodium maturation being regulated by distinct signaling inputs[26]. AFAP1 has been shown to regulate cellular responses requiring actin cytoskeletal changes such as adhesion, invadopodia formation, and invasion in breast and prostate cancer cells[5][12]. The precise role of AFAP1 in invadopodia formation and function appears to parallel its role in podosomes, with AFAP1 and c-Src working together to organize F-actin core structures and recruit associated proteins.</p>
<p>The functional consequence of AFAP1-mediated invadopodium assembly is enhanced capacity for extracellular matrix degradation and cellular invasion. Invadopodia contain matrix metalloproteinases (particularly MT1-MMP) that are localized to the ventral membrane and oriented toward the extracellular matrix where they perform localized proteolysis[26][39]. The stability of MT1-MMP at invadopodia is promoted by direct interaction with invadopodial F-actin, providing a direct linkage between the actin core organized by AFAP1 and other proteins, and the proteolytic machinery that actually degrades matrix[39][26]. The assembly of invadopodia occurs in stages, with growth factor signaling (particularly PI3K signaling) promoting initial formation, while adhesion to the extracellular matrix promotes maturation and localized protease exocytosis, resulting in a functional degrading structure[26]. AFAP1's role in organizing the actin core that forms the structural foundation of invadopodia thus directly enables matrix degradation and cellular invasion, providing a molecular mechanism linking cytoskeletal organization to the invasive phenotype of cancer cells.</p>
<h2 id="signaling-integration-pkc-integrin-signaling-and-fak">Signaling Integration: PKCŒ±, Integrin Signaling, and FAK</h2>
<p>AFAP1 functions as a critical integrator of multiple signaling pathways, most notably receiving input from protein kinase C (PKCŒ±) and transducing signals through c-Src to organize actin cytoskeletal responses. PKCŒ± activates AFAP1 through phosphorylation of serine 277, which enhances AFAP1's ability to bind and activate c-Src[49][54]. This PKC-AFAP1-Src axis is particularly important in response to phorbol esters, which are natural PKC activators, and in response to growth factors that activate PKC through phospholipase C-mediated generation of diacylglycerol[54]. Beyond PKCŒ± input, AFAP1 receives signals through integrin-mediated adhesion, as integrin ligation to the extracellular matrix activates Src through FAK (focal adhesion kinase), and activated c-Src in turn phosphorylates AFAP1[54]. The result is that AFAP1 becomes a convergence point for signals emanating from both growth factor receptors (via PKC) and integrin receptors (via Src), allowing cells to coordinate cytoskeletal changes that occur in response to both growth-promoting and adhesion signals.</p>
<p>AFAP1 also appears to participate in the regulation of focal adhesion dynamics and turnover, though this function is less completely characterized than its roles in podosomes and invadopodia. Src-mediated phosphorylation of FAK at multiple tyrosine residues is necessary to enhance the adaptor function of FAK and promote focal adhesion turnover through calpain-mediated proteolysis[44]. Since AFAP1 serves as a primary activator of Src in response to PKC, AFAP1 indirectly regulates focal adhesion turnover through this mechanism. Moreover, AFAP1's direct interaction with actin filaments means that it can modulate the mechanical coupling between focal adhesions and the actin cytoskeleton, potentially influencing the contractile forces that stabilize focal adhesions or the mechanical transitions that occur during focal adhesion disassembly. In the context of PKC activation with phorbol esters, focal adhesions dissolve and then reorganize around newly formed actin puncta that will become podosomes, suggesting that AFAP1-mediated cytoskeletal remodeling directly drives the transition between focal adhesion and podosome architecture[26][29].</p>
<h2 id="the-afap1-as1-long-noncoding-rna-oncogenic-regulation-of-cytoskeletal-dynamics">The AFAP1-AS1 Long Noncoding RNA: Oncogenic Regulation of Cytoskeletal Dynamics</h2>
<p>In parallel with the protein-level functions of AFAP1, a long noncoding RNA (lncRNA) transcribed from the antisense strand of the AFAP1 gene locus, termed AFAP1-AS1 (or AFAP1-AS in earlier literature), has emerged as a critical regulator of cancer progression and metastasis. AFAP1-AS1 localizes to the antisense genomic DNA strand near the C-terminus of AFAP1, at the actin binding domain of AFAP1, and is transcribed as an independent RNA molecule[2][21]. The long noncoding RNA functions primarily through competing endogenous RNA (ceRNA) mechanisms, in which AFAP1-AS1 contains multiple binding sites for microRNAs and functions as a "molecular sponge" that sequesters miRNAs and prevents them from binding to and suppressing their target messenger RNAs[2][21]. In the context of Hirschsprung disease (a developmental disorder affecting neural crest cell migration), AFAP1-AS was found to be downregulated compared to normal tissues, and knockdown of AFAP1-AS inhibited neural crest cell proliferation and migration by competitively binding miR-181a and thereby allowing increased expression of RAP1B[2][21]. This ceRNA regulatory network (AFAP1-AS/miR-181a/RAP1B) demonstrates that the lncRNA participates in the regulation of neural crest cell colonization, a process fundamentally dependent on cell migration and cytoskeletal dynamics[2][21].</p>
<p>However, in the context of cancer, AFAP1-AS1 is typically upregulated and functions as an oncogene promoting tumor progression. Overexpression of AFAP1-AS1 is associated with enhanced cell proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), and metastasis, thereby correlating with poor clinical outcomes across multiple cancer types[9][14][25][36][38]. AFAP1-AS1 has been found to be abnormally expressed in numerous cancers, including cholangiocarcinoma, pancreatic adenocarcinoma, non-small cell lung cancer, nasopharyngeal carcinoma, breast cancer, osteosarcoma, gastric cancer, esophageal squamous cell carcinoma, colorectal cancer, and prostate cancer[25][36][38][9]. In non-small cell lung cancer (NSCLC), AFAP1-AS1 enhances migration and invasive properties through activation of IRF7 and the RIG-I-like receptor signaling pathway, and also interacts with the epigenetic regulator EZH2 to repress expression of the cell cycle inhibitor p21[38]. In breast cancer, particularly in triple-negative breast cancer (TNBC), AFAP1-AS1 sequences miR-145 to allow increased expression of MTH1, thereby enhancing proliferation and invasiveness[38]. The lncRNA also sequesters miR-2110 in breast cancer cells, leading to enhanced expression of the transcription factor Sp1[38].</p>
<p>Remarkably, in breast cancer cells resistant to the therapeutic antibody trastuzumab (Herceptin), AFAP1-AS1 can be secreted into exosomes and transmitted to other cells, where it induces trastuzumab resistance through interaction with the RNA-binding protein AUF1 and subsequent induction of ERBB2 (also known as HER2) translation[38]. This exosomal transmission of AFAP1-AS1 represents a novel form of intercellular communication in cancer, where the lncRNA can disseminate therapy resistance to other cancer cells in the tumor microenvironment[15]. In osteosarcoma, AFAP1-AS1 promotes tumorigenesis through the RhoC/ROCK1/p38MAPK/Twist1 cascade, and can sequester miR-497 and miR-4695-5p, thereby increasing expression of IGF1R and TCF4, which activate Wnt-Œ≤ catenin signaling[38]. In gastric cancer, AFAP1-AS1 promotes proliferation and metastasis through sequestration of miR-155-5p, leading to enhanced expression of FGF7[38]. The mechanistic studies indicate that AFAP1-AS1 modulates actin filament integrity by influencing the expression of key molecules in cytoskeletal regulation and can affect the protein level of its sense counterpart, AFAP1, either directly or via interactions with regulatory factors such as EZH2 and SNIP1[9][14].</p>
<p>Importantly, studies in animal models (particularly BALB/c nude mice) have verified the oncogenic roles of AFAP1-AS1 in different cancer types, with knockdown of AFAP1-AS1 consistently leading to significant reduction in tumor size and weight, attenuation of tumor growth rate, and enhancement of response to therapeutic modalities[38]. In NSCLC, AFAP1-AS1 silencing not only reduces tumorigenicity but also confers chemosensitivity[38]. In breast cancer, AFAP1-AS1 downregulation can reduce trastuzumab resistance, suggesting therapeutic potential for targeting this lncRNA[38]. The cellular localization of AFAP1-AS primarily to the cytoplasm indicates that it functions through interaction with miRNAs and mRNA regulation rather than nuclear transcriptional regulation[2][21]. Loss of stress fiber formation in cells with reduced AFAP1-AS1 expression suggests that the lncRNA somehow influences actin dynamics, possibly through mechanisms involving AFAP1 protein or through direct effects on expression of actin regulatory proteins via its ceRNA activities[2][21][42][60].</p>
<h2 id="genetic-variation-and-disease-association">Genetic Variation and Disease Association</h2>
<p>Population-based genetic studies have identified associations between variants in the AFAP1 gene locus and common human diseases, particularly primary open-angle glaucoma, the most common form of glaucoma and a leading cause of blindness worldwide. A genome-wide association study identified a SNP (rs4619890) within the AFAP1 gene that confers risk of primary open-angle glaucoma, with the associated SNP rs28495790 (in high linkage disequilibrium with rs4619890) likely affecting binding of proteins such as CTCF and RAD21, and altering the sequence of regulatory motifs for binding of several proteins including PAX6[33]. The functional mechanism underlying the association appears to involve AFAP1's role in regulating the actin cytoskeleton in ocular tissues, as actin cytoskeleton-modulating signals have been demonstrated to be involved in the regulation of aqueous outflow and intraocular pressure, which are critical parameters in glaucoma pathogenesis[33]. AFAP1 is expressed in retinal ganglion cells (the cells that undergo apoptosis in glaucoma), as well as in the trabecular meshwork, retina, optic nerve, and optic nerve head[33]. Both the neuronal A isoform and the ubiquitously expressed B isoform of AFAP1 are detected in human retinal tissue, with the B isoform more broadly distributed in ocular tissues including iris, ciliary body, lens, optic nerve, and optic nerve head[33].</p>
<p>The involvement of AFAP1 in glaucoma likely reflects its function in regulating actin dynamics and cell morphology in tissues critical for maintaining normal intraocular pressure. In the trabecular meshwork, which controls aqueous humor outflow, AFAP1-mediated regulation of the actin cytoskeleton may influence cell shape and the spacing of trabecular meshwork cells, thereby affecting fluid filtration capacity. In retinal ganglion cells, AFAP1 may regulate axonal morphology and cell survival through its effects on cytoskeletal organization. The association between AFAP1 variants and glaucoma risk provides strong evidence that normal AFAP1 function is important for maintaining ocular homeostasis, and furthermore suggests that AFAP1-based therapeutic approaches might be relevant to glaucoma treatment, though this remains speculative at present.</p>
<h2 id="tissue-expression-and-specialized-cell-types">Tissue Expression and Specialized Cell Types</h2>
<p>AFAP1 shows a broad but selective pattern of expression across human tissues, with particularly high expression in tissues with significant cytoskeletal dynamics and specialized cellular structures. Analysis of gene expression data reveals that AFAP1 is expressed in numerous tissues including nervous system tissues (hippocampal formation, amygdala, basal ganglia, midbrain, spinal cord, cerebral cortex, cerebellum, hypothalamus, retina), endocrine tissues (thyroid gland, parathyroid gland, adrenal gland, pituitary gland), gastrointestinal tissues (esophagus, stomach, duodenum, small intestine, rectum, colon), hepatic tissues (liver, gallbladder), urinary tissues (kidney, urinary bladder), reproductive tissues (testis, epididymis, prostate, seminal vesicle, vagina, breast, cervix, endometrium, fallopian tube, ovary), and cardiovascular tissues (heart muscle, blood vessels)[23][28][59]. AFAP1 expression in specialized cell types such as retinal ganglion cells suggests its involvement in ocular physiology and possibly in the pathogenesis of glaucoma, as mentioned above[9][14][33][36].</p>
<p>The ubiquitous expression pattern of at least the AFAP1 B isoform across tissues suggests that AFAP1 performs fundamental functions in actin cytoskeletal organization that are required in virtually all cell types. However, the existence of the neuronal A isoform and the selective expression of AFAP1 in particular tissues like retinal ganglion cells indicates that specialized variants of AFAP1 may be required for tissue-specific functions. The expression profile of AFAP1 in tissues with high cellular motility, adhesion dynamics, or specialized membrane structures (such as the nervous system and reproductive tissues) is consistent with its proposed roles in regulating actin-based adhesion and migration. In the context of cancer, AFAP1 expression is often elevated in tumor tissues compared to normal tissue, and in some cases expression level predicts clinical outcomes, as demonstrated for AFAP1L1 in colorectal cancer[20][45][48].</p>
<h2 id="the-afap1-family-structural-relationships-and-functional-diversification">The AFAP1 Family: Structural Relationships and Functional Diversification</h2>
<p>AFAP1 is the prototype member of a family of actin filament-associated proteins that includes AFAP1L1 and AFAP1L2 (also termed XB130), with all three members sharing similar modular domain structures containing PH domains and SH2/SH3 binding motifs for Src interaction[57]. However, despite this structural similarity, the AFAP family members show important differences in subcellular localization, binding partner specificity, and cellular functions. AFAP1 binds strongly to c-Src via its SH3 binding motif and shows prominent localization to focal adhesions and podosomes[1][10][54][56]. AFAP1L1, in contrast, does not bind strongly to Src but instead preferentially associates with cortactin and colocalizes with cortactin within invadopodia[20][45][48]. AFAP1L1 was identified as a metastasis-predicting marker for spindle cell sarcomas and has been found to be elevated in colorectal cancer tissues, where high expression serves as an independent factor predicting recurrence of rectal cancers[20][45][48]. AFAP1L1-expressing cells exhibit increased motility, enhanced invasion, resistance to anoikis (death upon loss of cell-matrix contact), and accelerated tumor growth in vivo[20][45]. The localization of AFAP1L1 to the ringed structure of invadopodia together with vinculin indicates that AFAP1L1 forms novel complexes distinct from those formed by AFAP1[20][45][48].</p>
<p>AFAP1L2/XB130 appears to have additional functions not shared by AFAP1 or AFAP1L1, including involvement in growth factor signaling and cell survival pathways. The existence of this family of proteins with related structures but divergent binding partners and functions suggests that the AFAP family evolved to provide specialized adaptor functions in different cellular compartments and in response to different signaling pathways. Notably, AFAP1L1 interacts with vinculin, a major focal adhesion protein, through novel mechanisms that appear to disrupt normal focal adhesion architecture and promote cell invasion and EMT[20][45][48]. This diversification within the AFAP family may reflect an evolutionary strategy to enable flexible regulation of different aspects of cell adhesion and migration in different cellular contexts. The structural similarity but functional divergence of AFAP family members underscores the principle that protein domains and interaction motifs can be combined in modular fashion to generate proteins with distinct cellular functions.</p>
<h2 id="summary-of-key-biological-processes-and-functions">Summary of Key Biological Processes and Functions</h2>
<p>AFAP1 participates in multiple interconnected biological processes that collectively enable cells to dynamically modulate their adhesion and migratory behavior in response to environmental and developmental signals. At the molecular level, AFAP1 functions as a scaffolding protein that couples signals from activated protein kinase C and Src family kinases to the actin cytoskeleton, thereby promoting formation of actin-based structures including stress fibers, focal adhesions, podosomes, and invadopodia[9][12][14][54]. These structures are essential for fundamental cellular processes including cell adhesion, spreading, migration, and invasion. In the context of normal physiology, AFAP1 likely participates in developmental processes requiring coordinated cell migration, such as neural crest cell migration and vascular development, and also in maintaining cellular functions in differentiated tissues such as the mammary gland during lactation[54]. In the context of cancer, elevated AFAP1 expression and enhanced activity of the AFAP1-AS1 lncRNA promote the metastatic potential of cancer cells by enhancing migration, invasion, and cellular plasticity through epithelial-mesenchymal transition[9][14][25][36][38].</p>
<p>The physiological regulation of AFAP1 involves both post-translational modification of the AFAP1 protein itself and transcriptional/post-transcriptional regulation of expression through both the AFAP1 gene and the AFAP1-AS1 lncRNA. PKCŒ±-mediated phosphorylation at serine 277 enhances AFAP1's ability to bind and activate Src, while tyrosine phosphorylation by Src itself stabilizes the AFAP1-Src complex through SH2 domain engagement[49][54]. The expression of AFAP1 is modulated in response to developmental signals and in cancers, with elevated expression generally associated with enhanced invasive and migratory potential. The AFAP1-AS1 lncRNA, which can either promote or suppress cancer depending on the specific cancer context, functions primarily as a ceRNA that regulates the availability of microRNAs and thus modulates expression of microRNA target genes[2][9][14][21][36][38]. This multilevel regulation‚Äîencompassing transcriptional control of both AFAP1 and AFAP1-AS1, post-translational modification of AFAP1 protein, and post-transcriptional control via AFAP1-AS1 ceRNA activity‚Äîenables precise spatial and temporal control of AFAP1-mediated cytoskeletal responses.</p>
<h2 id="clinical-and-therapeutic-implications">Clinical and Therapeutic Implications</h2>
<p>The identification of AFAP1 and AFAP1L1 as factors promoting cancer progression has led to consideration of these proteins as potential therapeutic targets. In animal models (BALB/c nude mice), local administration of short interfering RNA (siRNA) targeting AFAP1L1 significantly suppressed tumor growth of colorectal cancer xenografts, suggesting the feasibility of targeting AFAP1 family members therapeutically[20][45][48]. Similarly, knockdown of AFAP1-AS1 in various cancer models consistently reduces tumorigenicity and can enhance chemosensitivity[38]. However, the essential roles of AFAP1 in normal cellular processes including adhesion, migration, and cytoskeletal organization necessitate careful consideration of toxicity to normal tissues if AFAP1 were to be targeted therapeutically. The tissue-restricted expression of the AFAP1 A isoform in neurons suggests that complete inhibition of AFAP1 function might not be tolerated in the nervous system, whereas AFAP1L1 targeting might be more selectively toxic to cancer cells if AFAP1L1 expression is elevated in tumors but remains low in normal tissues.</p>
<p>The association between AFAP1 variants and glaucoma risk opens the possibility of developing AFAP1-based therapies for glaucoma management, potentially by modulating AFAP1 activity or expression to enhance actin cytoskeletal dynamics in trabecular meshwork cells and thereby improve aqueous humor outflow[33]. The finding that AFAP1-AS1 is secreted in exosomes and can disseminate trastuzumab resistance in breast cancer suggests that blocking exosomal AFAP1-AS1 or its cellular uptake might represent a novel therapeutic strategy to prevent therapy resistance in cancer[15][38]. However, therapeutic approaches targeting AFAP1 or AFAP1-AS1 remain largely preclinical and would require substantial development before clinical application. Future research should focus on understanding tissue-specific functions of AFAP1 to identify contexts in which AFAP1 inhibition would be beneficial with acceptable toxicity, and on developing selective inhibitors of AFAP1-Src interaction or AFAP1-mediated cytoskeletal reorganization that might have therapeutic utility.</p>
<h2 id="future-directions-and-outstanding-questions">Future Directions and Outstanding Questions</h2>
<p>Despite substantial progress in understanding AFAP1 biology, significant questions remain regarding the precise mechanisms of actin cross-linking and filament organization by AFAP1, the detailed structural basis for AFAP1 interactions with Src and actin, and the complete spectrum of AFAP1 functions in normal physiology. The three-dimensional crystal structure of AFAP1, particularly in complex with c-Src and actin filaments, would provide crucial insights into the molecular details of AFAP1's catalytic mechanisms and its role in organizing actin-based structures. The relative roles of AFAP1-mediated Src activation versus AFAP1's direct actin cross-linking activity in promoting different cellular processes remain incompletely understood, and future studies using mutants specifically defective in either Src binding or actin binding might clarify these distinct contributions. The mechanisms by which AFAP1-AS1 lncRNA regulates AFAP1 protein expression, either directly or indirectly through its various ceRNA interactions, warrant further investigation, as does the question of whether there are direct interactions between AFAP1 protein and AFAP1-AS1 RNA. The tissue-specific and developmental stage-specific functions of the AFAP1 A and B isoforms require deeper investigation, particularly in the context of nervous system development and function.</p>
<p>The relationship between AFAP1 function and other actin regulatory pathways, particularly those involving Arp2/3 complex, mDia formin family proteins, and cofilin-mediated actin depolymerization, remains incompletely characterized despite clear functional connections in the literature. The coordination of AFAP1-mediated signaling with growth factor signaling pathways, particularly PI3K/Akt and ERK/MAPK pathways, appears critical for proper regulation of invadopodia formation and cancer cell invasion but has not been thoroughly characterized at the molecular level. The potential for targeted disruption of the AFAP1-Src interaction or AFAP1-AS1 function as cancer therapeutics requires further preclinical development and optimization. Finally, the role of AFAP1 in regulating cell-matrix adhesion at the mechanical level, particularly the coupling between AFAP1-organized actin structures and the mechanotransduction signaling through focal adhesion kinase and Src, remains an important area for future investigation that could inform approaches to preventing cancer metastasis and treating fibrotic diseases.</p>
<h2 id="conclusion">Conclusion</h2>
<p>AFAP1 (actin filament-associated protein 1) is a multifunctional adapter protein that plays central roles in organizing the actin cytoskeleton and transducing signals from protein kinase C and integrin receptors to actin-based structures critical for cell adhesion, migration, and invasion. The protein functions through multiple interconnected mechanisms: direct interaction with and activation of c-Src kinase through its N-terminal SH3 binding motif; cross-linking of actin filaments through its C-terminal actin-binding domain; integration of signals from PKCŒ± through PKC-mediated phosphorylation at serine 277; and recruitment of signaling complexes to sites of actin remodeling[1][4][9][12][14][54]. AFAP1 achieves these functions through a modular protein architecture featuring two Pleckstrin Homology domains, Src interaction motifs, and actin-binding regions that collectively enable AFAP1 to serve as a hub for coordinating multiple signaling inputs and translating them into coherent changes in cytoskeletal organization. AFAP1 is required for formation of podosomes (in response to PKC activation) and invadopodia (specialized invasive structures in cancer cells), and regulates the assembly and dynamics of focal adhesions and stress fibers critical for cell adhesion and migration[12][16][17][26][29][41]. In addition to its protein-level functions, the AFAP1 gene locus produces AFAP1-AS1, a long noncoding RNA with oncogenic functions in numerous cancer types that acts primarily as a competing endogenous RNA to sequester microRNAs and modulate gene expression[2][9][14][21][25][36][38].</p>
<p>AFAP1 is broadly expressed across tissues, with particularly prominent expression in tissues with high cellular motility and dynamic adhesion requirements including the nervous system, reproductive tissues, and vascular tissues[23][28][59]. The protein is regulated through multiple mechanisms including post-translational phosphorylation and transcriptional control of both the protein-coding AFAP1 mRNA and the lncRNA AFAP1-AS1. Dysregulation of AFAP1 and AFAP1-AS1 has been implicated in cancer progression and metastasis across numerous cancer types, and genetic variants in the AFAP1 locus have been associated with primary open-angle glaucoma, suggesting that normal AFAP1 function is critical for maintaining actin dynamics in tissues controlling intraocular pressure. Future research should aim to elucidate the three-dimensional structure of AFAP1 in complex with its binding partners, clarify the tissue-specific functions of AFAP1 isoforms, and develop approaches to selectively target AFAP1 function therapeutically with minimal toxicity to normal tissues. The remarkable functional versatility of AFAP1‚Äîcoupling multiple signaling inputs to coordinate changes in actin filament organization across diverse cellular contexts‚Äîexemplifies how multidomain scaffold proteins achieve regulatory specificity through modular domain architecture and selective binding partner interactions.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://en.wikipedia.org/wiki/AFAP1</li>
<li>https://www.medsci.org/v14p1022.htm</li>
<li>https://zfin.org/ZDB-GENE-100316-6</li>
<li>https://www.ncbi.nlm.nih.gov/gene/60312</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4302073/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3085893/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11114525/</li>
<li>https://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=DetailsSearch&amp;Term=60312</li>
<li>https://maayanlab.cloud/Harmonizome/gene/AFAP1</li>
<li>https://www.uniprot.org/uniprotkb/Q8N556/entry</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11772456/</li>
<li>https://www.oncotarget.com/article/16880/text/</li>
<li>https://onlinelibrary.wiley.com/doi/full/10.1002/cam4.237</li>
<li>https://pubchem.ncbi.nlm.nih.gov/protein/P12931</li>
<li>https://www.proteinatlas.org/ENSG00000196526-AFAP1</li>
<li>https://www.deciphergenomics.org/gene/afap1/overview/clinical-info</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9509167/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3711196/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/31081081/</li>
<li>https://www.proteinatlas.org/ENSG00000196526-AFAP1/tissue</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3085414/</li>
<li>https://www.europeanreview.org/wp/wp-content/uploads/3284-3290.pdf</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC1456526/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/12058076/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4177327/</li>
<li>https://www.pnas.org/doi/10.1073/pnas.2202723119</li>
<li>https://www.molbiolcell.org/doi/abs/10.1091/mbc.e02-01-0018</li>
<li>https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.777849/full</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5110387/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/17520695/</li>
<li>https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.681576/full</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC515031/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4303145/</li>
<li>https://olink.com/assay/explore/oncology/proto-oncogene-tyrosine-protein-kinase-src</li>
<li>https://string-db.org/network/9031.ENSGALP00000036444</li>
<li>https://www.uniprot.org/uniprotkb/P12931/entry</li>
<li>https://stacks.cdc.gov/view/cdc/192171/cdc_192171_DS1.pdf</li>
<li>https://www.uniprot.org/uniprotkb/Q90738/entry</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC9835296/</li>
<li>https://platform.opentargets.org/target/ENSG00000196526</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5885413/</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q8N556
gene_symbol: AFAP1
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  AFAP1 (Actin filament-associated protein 1, also known as AFAP-110) is a modular
  adaptor/scaffold protein that crosslinks F-actin and directly regulates Src-family
  kinase signaling. The protein contains two PH domains (PH1 binds PKCalpha), N-terminal
  proline-rich SH3-binding motifs and SH2-binding motifs that engage c-Src, a central
  leucine-zipper/coiled-coil for multimerization, and a C-terminal actin-binding domain
  (ABD) that mediates F-actin binding. AFAP1 localizes to stress fibers and focal adhesions
  under basal conditions but redistributes to podosomes/invadopodia upon PKC/Src activation.
  It functions as an adapter linking Src and PKC to the actin cytoskeleton, and is required
  for proper c-Src activity spatially and temporally during lactation in mammary epithelium.
  AFAP1 is implicated in cancer cell invasion and metastasis through its role in cytoskeletal
  remodeling and podosome/invadopodia formation.
existing_annotations:
- term:
    id: GO:0005884
    label: actin filament
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      AFAP1 localizes to actin filaments through its C-terminal actin-binding domain (ABD).
      The protein is distributed along actin filaments and can directly activate c-Src
      through binding to its SH3 and/or SH2 domains (PMID:15485829). Deep research confirms
      that AFAP1 contains a C-terminal ABD that mediates F-actin binding and multimerization
      enables actin cross-linking (AFAP1-deep-research-falcon.md).
    action: ACCEPT
    reason: &gt;-
      This annotation is well-supported by the phylogenetic analysis (IBA) and is consistent
      with the extensive literature documenting AFAP1 localization to actin filaments via
      its C-terminal ABD. PMID:15485829 demonstrates AFAP1 distribution along actin filaments.
    supported_by:
      - reference_id: PMID:15485829
        supporting_text: &gt;-
          Distributed along the actin filaments, AFAP can directly active c-Src through
          binding to its Src homology 3 and/or 2 domains
      - reference_id: file:human/AFAP1/AFAP1-deep-research-falcon.md
        supporting_text: &gt;-
          C-terminal actin-binding domain (ABD) with mapped ABD motifs (~residues 593-637)
          [from deep research summary]

- term:
    id: GO:0009966
    label: regulation of signal transduction
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      AFAP1 regulates Src-family kinase signaling through direct binding to c-Src via
      proline-rich SH3-binding motifs and can activate Src. Mechanical stretch-induced
      c-Src protein tyrosine kinase activation is mediated through AFAP (PMID:15485829).
      The deep research confirms AFAP1 functions in the PKC-AFAP1-Src signaling axis
      (AFAP1-deep-research-falcon.md).
    action: ACCEPT
    reason: &gt;-
      This biological process annotation is appropriate for AFAP1, which functions as an
      adaptor that regulates Src kinase signaling. The IBA evidence is supported by extensive
      experimental literature showing AFAP1&#39;s role in signal transduction pathways.
    supported_by:
      - reference_id: PMID:15485829
        supporting_text: &gt;-
          mechanical stretch-induced c-Src protein tyrosine kinase activation is
          mediated through the actin filament-associated protein (AFAP)
      - reference_id: file:human/AFAP1/AFAP1-deep-research-falcon.md
        supporting_text: &gt;-
          Key axes include PKC-&gt;AFAP1-&gt;Src (PKCalpha binding to PH1 and Ser277
          phosphorylation facilitate Src activation) [from deep research summary]

- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      AFAP1 can exist in the cytosolic fraction, particularly when not associated with the
      actin cytoskeleton. The deep research indicates that deletion of the actin-binding
      domain shifts AFAP1 from the Triton-insoluble cytoskeletal fraction to the soluble
      fraction (AFAP1-deep-research-falcon.md).
    action: ACCEPT
    reason: &gt;-
      The IBA annotation is consistent with biochemical fractionation studies showing that
      AFAP1 partitions between cytoskeletal and soluble fractions. While the primary
      functional localization is at actin structures and focal adhesions, cytosolic
      localization is a valid secondary location.
    supported_by:
      - reference_id: file:human/AFAP1/AFAP1-deep-research-falcon.md
        supporting_text: &gt;-
          Deletion of the ABD shifts AFAP1 from the Triton-insoluble cytoskeletal fraction
          to the soluble fraction [from deep research summary citing Xiao et al. 2012]

- term:
    id: GO:0001725
    label: stress fiber
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &gt;-
      AFAP1 localizes to stress fibers under basal conditions. Knockdown of AFAP-110
      expression in MDA-MB-231 cells results in loss of actin stress fiber cross-linking
      (PMID:17520695), demonstrating a functional requirement for stress fiber formation.
    action: ACCEPT
    reason: &gt;-
      This IEA annotation based on UniProt subcellular location vocabulary mapping is
      well-supported by primary literature. AFAP1 localization to stress fibers is a core
      aspect of its function, and the annotation is consistent with experimental evidence
      showing that AFAP1 is required for stress fiber formation.
    supported_by:
      - reference_id: PMID:17520695
        supporting_text: &gt;-
          Knockdown of AFAP-110 expression in MDA-MB-231 cells does not result in any
          changes in cell proliferation but did result in a loss of actin stress fiber
          cross-linking and decreased adhesion to fibronectin

- term:
    id: GO:0003779
    label: actin binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      AFAP1 binds F-actin directly through its C-terminal actin-binding domain. The protein
      is an actin-binding and cross-linking protein that can cross-link actin filaments into
      both network and bundle structures through multimerization. AFAP-110 is described as
      an actin cross-linking protein in PMID:17885682.
    action: ACCEPT
    reason: &gt;-
      The IEA annotation based on UniProt keyword mapping accurately reflects the core
      molecular function of AFAP1. The actin-binding activity is well-documented through
      functional studies. This is a defining function of the protein.
    supported_by:
      - reference_id: PMID:17885682
        supporting_text: &gt;-
          The actin filament-associated protein AFAP-110 is an actin cross-linking protein
          first identified as a substrate of the viral oncogene v-Src
      - reference_id: file:human/AFAP1/AFAP1-deep-research-falcon.md
        supporting_text: &gt;-
          C-terminal ABD mediates F-actin binding; AFAP1 multimerizes enabling actin
          cross-linking similar to alpha-actinin [from deep research summary]

- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      AFAP1 contains PH domains that mediate membrane binding and can localize to the
      plasma membrane, particularly at sites of cell-matrix adhesion and in podosomes/
      invadopodia at the cell periphery. The annotation is transferred from mouse ortholog.
    action: ACCEPT
    reason: &gt;-
      The IEA annotation from Ensembl ortholog transfer is consistent with AFAP1 domain
      architecture (two PH domains for membrane binding) and its functional localization
      at membrane-associated structures like focal adhesions and podosomes. While not the
      primary localization, plasma membrane association is biologically relevant.
    supported_by:
      - reference_id: file:human/AFAP1/AFAP1-deep-research-falcon.md
        supporting_text: &gt;-
          AFAP1 relocates to podosomes/invadopodia and lamellipodia upon PKC/Src activation
          [from deep research summary]

- term:
    id: GO:0060090
    label: molecular adaptor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      AFAP1 functions as an adaptor/scaffold protein linking Src kinase and PKC to the
      actin cytoskeleton. It regulates actin cytoskeleton integrity but also functions
      as an adaptor protein that affects crosstalk between Src and PKC (PMID:17885682).
    action: ACCEPT
    reason: &gt;-
      This molecular function annotation accurately captures the core role of AFAP1 as an
      adaptor protein. The IEA annotation from Ensembl ortholog transfer is well-supported
      by primary literature describing AFAP1 as an adapter molecule linking Src and PKC
      to the actin cytoskeleton.
    supported_by:
      - reference_id: PMID:17885682
        supporting_text: &gt;-
          AFAP-110 regulates actin cytoskeleton integrity but also functions as an adaptor
          protein that affects crosstalk between Src and PKC

- term:
    id: GO:0015629
    label: actin cytoskeleton
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  review:
    summary: &gt;-
      AFAP1 localization to the actin cytoskeleton is documented by immunofluorescence
      data from the Human Protein Atlas. This is consistent with extensive literature
      showing AFAP1 association with F-actin stress fibers, focal adhesions, and podosomes.
    action: ACCEPT
    reason: &gt;-
      The IDA annotation based on immunofluorescence data provides direct experimental
      evidence for AFAP1 localization to the actin cytoskeleton. This is a well-supported
      core localization for AFAP1 and is consistent with its role as an actin-binding
      adaptor protein.
    supported_by:
      - reference_id: PMID:15485829
        supporting_text: &gt;-
          Distributed along the actin filaments, AFAP can directly active c-Src through
          binding to its Src homology 3 and/or 2 domains

- term:
    id: GO:0005925
    label: focal adhesion
  evidence_type: HDA
  original_reference_id: PMID:21423176
  review:
    summary: &gt;-
      AFAP1 was identified in the focal adhesion proteome by mass spectrometry (Kuo et al.
      2011, PMID:21423176). AFAP1 localization to focal adhesions is consistent with its
      role in cell-matrix adhesion and regulation of focal contact dynamics. Downmodulation
      of AFAP-110 results in defective focal adhesions (PMID:17885682).
    action: ACCEPT
    reason: &gt;-
      The HDA (high-throughput direct assay) annotation is based on proteomic identification
      of AFAP1 in isolated focal adhesions. The finding is consistent with the known function
      of AFAP1 in regulating cell-matrix adhesions and focal contacts.
    additional_reference_ids:
      - PMID:17885682
    supported_by:
      - reference_id: PMID:21423176
        supporting_text: &gt;-
          We identified 905 focal adhesion proteins, 459 of which changed in abundance with
          myosin II inhibition, defining the myosin-II-responsive focal adhesion proteome
      - reference_id: PMID:17885682
        supporting_text: &gt;-
          downmodulation of AFAP-110 resulted in decreased cell-matrix adhesion and cell
          migration, defective focal adhesions, and reduced integrin beta1 expression

references:
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings:
    - statement: IBA annotations for actin filament localization, regulation of signal transduction, and cytosol
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings:
    - statement: IEA annotation for actin binding based on Actin-binding keyword
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
  findings:
    - statement: IEA annotation for stress fiber localization
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings:
    - statement: IDA annotation for actin cytoskeleton localization from Human Protein Atlas
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
  findings:
    - statement: IEA annotations for plasma membrane and molecular adaptor activity from mouse ortholog
- id: PMID:21423176
  title: &#34;Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for \u03B2-Pix in negative regulation of focal adhesion maturation.&#34;
  findings:
    - statement: Proteomic identification of AFAP1 in isolated focal adhesions from HFF1 fibroblasts
      supporting_text: &gt;-
        We identified 905 focal adhesion proteins, 459 of which changed in abundance with
        myosin II inhibition, defining the myosin-II-responsive focal adhesion proteome
- id: PMID:15485829
  title: Conversion of mechanical force into biochemical signaling.
  findings:
    - statement: AFAP1 is distributed along actin filaments
      supporting_text: &gt;-
        Distributed along the actin filaments, AFAP can directly active c-Src through
        binding to its Src homology 3 and/or 2 domains
    - statement: AFAP mediates mechanical stretch-induced c-Src activation
      supporting_text: &gt;-
        mechanical stretch-induced c-Src protein tyrosine kinase activation is
        mediated through the actin filament-associated protein (AFAP)
- id: PMID:17520695
  title: AFAP-110 is required for actin stress fiber formation and cell adhesion in MDA-MB-231 breast cancer cells.
  findings:
    - statement: Knockdown causes loss of actin stress fibers
      supporting_text: &gt;-
        Knockdown of AFAP-110 expression in MDA-MB-231 cells does not result in any
        changes in cell proliferation but did result in a loss of actin stress fiber
        cross-linking and decreased adhesion to fibronectin
- id: PMID:17885682
  title: AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts.
  findings:
    - statement: AFAP-110 is an actin cross-linking protein and adaptor
      supporting_text: &gt;-
        The actin filament-associated protein AFAP-110 is an actin cross-linking protein
        first identified as a substrate of the viral oncogene v-Src. AFAP-110 regulates
        actin cytoskeleton integrity but also functions as an adaptor protein that
        affects crosstalk between Src and PKC
    - statement: AFAP-110 regulates focal contacts
      supporting_text: &gt;-
        downmodulation of AFAP-110 resulted in decreased cell-matrix adhesion and cell
        migration, defective focal adhesions, and reduced integrin beta1 expression
- id: file:human/AFAP1/AFAP1-deep-research-falcon.md
  title: Deep research synthesis for AFAP1
  findings:
    - statement: AFAP1 domain architecture and function from literature synthesis
      supporting_text: &gt;-
        AFAP1 contains two PH domains (PH1 binds PKCalpha), multiple SH2- and SH3-binding
        motifs, a central leucine-zipper/coiled-coil that mediates multimerization, and
        a C-terminal actin-binding domain (ABD)
- id: file:human/AFAP1/AFAP1-deep-research-cyberian.md
  title: Comprehensive deep research synthesis for AFAP1
  findings:
    - statement: &gt;-
        Original identification of AFAP-110 as v-Src substrate and cloning by Flynn et al.
      supporting_text: &gt;-
        The protein was first identified in the early 1990s as a major substrate of the
        oncogenic viral tyrosine kinase v-Src and was subsequently cloned by Flynn and
        colleagues [PMID:8247004]
    - statement: &gt;-
        Leucine zipper mediates auto-inhibition through intramolecular contacts with PH1 domain
      supporting_text: &gt;-
        The leucine zipper motif serves a dual regulatory role in AFAP1 function. On one hand,
        it facilitates multimerization and thus enables actin crosslinking. On the other hand,
        it participates in an auto-inhibitory mechanism by making intramolecular contacts with
        sequences in the amino-terminal PH1 domain [PMID:14755689]
    - statement: &gt;-
        PKC phosphorylation at Ser277 enhances actin crosslinking, contrary to most other
        actin-regulatory proteins
      supporting_text: &gt;-
        PKC phosphorylation uniquely enhances the actin crosslinking ability of AFAP1. This is
        in marked contrast to other actin-regulatory proteins such as fascin, MARCKS, SSeCKS,
        and VASP, for which PKC phosphorylation decreases actin crosslinking activity
        [PMID:12134071]
    - statement: &gt;-
        AFAP1 is required for PKCalpha to activate c-Src and induce podosome formation
      supporting_text: &gt;-
        In cell lines lacking AFAP1 expression, PKC activation by phorbol esters was unable to
        activate c-Src or induce podosome formation. Ectopic expression of wild-type AFAP1
        rescued these responses [PMID:15314167]
    - statement: &gt;-
        AFAP1 knockout mice show lactation defect due to reduced c-Src activity
      supporting_text: &gt;-
        AFAP1-null mice displayed a striking lactation defect resulting in inability to
        efficiently nurse their pups. The lactation defect was associated with reduced c-Src
        activity during early lactation and selective loss of active c-Src localization at the
        apical surface of luminal epithelial cells [PMID:25043309]
    - statement: &gt;-
        AFAP1 mediates TNF-alpha-induced attenuation of P-glycoprotein activity at blood-brain barrier
      supporting_text: &gt;-
        Knockdown of AFAP1 expression blocked the TNF-alpha-induced reduction in P-gp efflux
        activity, establishing AFAP1 as essential for this regulatory mechanism at the
        blood-brain barrier [PMID:28112407]
    - statement: &gt;-
        GWAS identifies AFAP1 variants as risk factors for primary open-angle glaucoma
      supporting_text: &gt;-
        Meta-analysis identified a common variant within the AFAP1 gene (rs4619890[G]) that
        conferred significantly increased risk of POAG (odds ratio = 1.20, P = 7.0 x 10^-10)
        [PMID:25173106]
    - statement: &gt;-
        S403C polymorphic variant enhances c-Src activation constitutively
      supporting_text: &gt;-
        In cells with elevated c-Src expression, AFAP1(403C) directs c-Src activation and
        podosome formation independently of upstream signals, in contrast to wild-type AFAP1
        which requires PKC activation [PMID:20689769]
- id: PMID:8247004
  title: &gt;-
    Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin
    filament-associated pp60src substrate.
  findings:
    - statement: Original cloning and identification of AFAP-110 as v-Src substrate
      supporting_text: &gt;-
        Activated forms of the Src protein-tyrosine kinase stably associate with
        tyrosine-phosphorylated proteins, including a protein of 110 kDa, pp110
- id: PMID:11607843
  title: &gt;-
    The actin filament-associated protein AFAP-110 is an adaptor protein that modulates
    changes in actin filament integrity.
  findings:
    - statement: AFAP-110 domain structure and adaptor function review
      supporting_text: &gt;-
        AFAP-110 contains additional protein binding modules including two pleckstrin
        homology domains, a leucine zipper motif and a target sequence for serine/threonine
        phosphorylation
- id: PMID:12134071
  title: &gt;-
    PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments.
  findings:
    - statement: PKC phosphorylation enhances actin crosslinking
      supporting_text: &gt;-
        Deletion of the leucine zipper motif or PKC phosphorylation affected AFAP-110&#39;s
        conformation, which correlated with changes in multimerization and increased the
        capability of rAFAP-110 to cross-link actin filaments
    - statement: AFAP-110 is substrate and binding partner of PKC
      supporting_text: &gt;-
        AFAP-110 is both a substrate and binding partner of PKC. On PKC activation, stress
        filament organization is lost, motility structures form, and AFAP-110 colocalizes
        strongly with motility structures
- id: PMID:14755689
  title: &gt;-
    Analysis of the role of the leucine zipper motif in regulating the ability of AFAP-110
    to alter actin filament integrity.
  findings:
    - statement: Leucine zipper mediates auto-inhibition and multimerization
      supporting_text: &gt;-
        An analysis of opposing binding sites indicated that the carboxy terminus/Lzip motif
        can contact sequences within the amino terminal pleckstrin homology (PH1) domain
        indicating an auto-inhibitory mechanism for regulating multimer stability and actin
        filament crosslinking
- id: PMID:15314167
  title: &gt;-
    Protein kinase Calpha activates c-Src and induces podosome formation via AFAP-110.
  findings:
    - statement: AFAP1 is required for PKCalpha-mediated Src activation and podosome formation
      supporting_text: &gt;-
        In a cell line (CaOV3) that has very little or no detectable AFAP-110, PMA treatment
        was unable to activate c-Src or effect podosome formation. Ectopic expression of
        AFAP-110 in CaOV3 cells rescued PKCalpha-mediated activation of c-Src
- id: PMID:17360811
  title: &gt;-
    PI3K activation is required for PMA-directed activation of cSrc by AFAP-110.
  findings:
    - statement: PI3K is required for AFAP1-mediated c-Src activation and cell migration
      supporting_text: &gt;-
        Thus PI3K activity is required for PMA-induced colocalization between AFAP-110 and
        cSrc and subsequent cSrc activation, and this signaling pathway promotes cell migration
- id: PMID:25043309
  title: &gt;-
    Actin filament-associated protein 1 is required for cSrc activity and secretory
    activation in the lactating mammary gland.
  findings:
    - statement: AFAP1 knockout mice have lactation defect
      supporting_text: &gt;-
        these animals displayed a defect in lactation that resulted in an inability to nurse
        efficiently. Histologically, the mammary glands of the lactating knockout mice were
        distinguished by the accumulation of large cytoplasmic lipid droplets in the alveolar
        epithelial cells
    - statement: AFAP1 required for c-Src localization at apical surface during lactation
      supporting_text: &gt;-
        the activity of cSrc in the mammary gland was reduced during early lactation in the
        AFAP1-null mouse and the localization of active cSrc at the apical surface of luminal
        epithelial cells during lactation was selectively lost in the absence of AFAP1
- id: PMID:28112407
  title: &gt;-
    Actin filament-associated protein 1 (AFAP-1) is a key mediator in inflammatory
    signaling-induced rapid attenuation of intrinsic P-gp function in human brain
    capillary endothelial cells.
  findings:
    - statement: AFAP1 mediates TNF-alpha regulation of P-glycoprotein at blood-brain barrier
      supporting_text: &gt;-
        knockdown of AFAP-1 expression blocked the reduction in P-gp efflux activity by
        TNF-alpha treatment
- id: PMID:25173106
  title: &gt;-
    Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing
    intraocular pressure and susceptibility to glaucoma.
  findings:
    - statement: GWAS identifies loci associated with IOP and POAG risk
      supporting_text: &gt;-
        We confirm genetic association of known loci for IOP and primary open-angle glaucoma
        (POAG) and identify four new IOP-associated loci
- id: PMID:20689769
  title: &gt;-
    A Polymorphic Variant of AFAP-110 Enhances cSrc Activity.
  findings:
    - statement: S403C polymorphism enables constitutive c-Src activation
      supporting_text: &gt;-
        In cells that express enhanced levels of cSrc, AFAP-110(403C) directed the activation
        of cSrc and the formation of podosomes independently of input signals, in contrast to
        wild-type AFAP-110

core_functions:
  - description: &gt;-
      AFAP1 functions as an actin-binding adaptor protein that links Src kinase and PKC
      to the actin cytoskeleton, regulating cytoskeletal dynamics and signal transduction.
    molecular_function:
      id: GO:0003779
      label: actin binding
    directly_involved_in:
      - id: GO:0009966
        label: regulation of signal transduction
    locations:
      - id: GO:0005884
        label: actin filament
      - id: GO:0001725
        label: stress fiber
      - id: GO:0005925
        label: focal adhesion
  - description: &gt;-
      AFAP1 acts as a molecular adaptor linking Src and PKC to cytoskeletal structures,
      facilitating signal transduction at sites of cell-matrix adhesion.
    molecular_function:
      id: GO:0060090
      label: molecular adaptor activity
    directly_involved_in:
      - id: GO:0009966
        label: regulation of signal transduction
    locations:
      - id: GO:0015629
        label: actin cytoskeleton
      - id: GO:0005886
        label: plasma membrane
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>